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Abstract
Periplakin and envoplakin are components of the epithelial cornified cell envelope 
(CE). The CE is a crosslinked protein structure that forms beneath the plasma 
membrane of differentiating keratinocytes and is essential for epidermal barrier 
function.
Periplakin and envoplakin belong to the plakin family of cytolinker proteins. Their N 
termini are thought to mediate their interaction with the plasma membrane. I found that 
the N terminus of envoplakin does not efficiently localise to desmosomes or microvilli, 
suggesting a dependence on periplakin for membrane localisation. I found that the first 
133 amino acids of periplakin targets the protein to the apical plasma membrane. In a 
yeast two-hybrid screen, using this region as ‘bait’, a novel protein was identified and 
named kazrin. There are four alternatively spliced transcripts, encoding three proteins 
with different N termini. The interaction between periplakin and all three kazrin 
isoforms was confirmed by pull-down reactions.
Kazrin was expressed in all layers of stratified squamous epithelia and was incorporated 
into the CEs of cultured keratinocytes. Kazrin localised to the cell periphery of 
differentiated cells, however it was more diffusely localised in cells of the basal layer. 
In stratified keratinocyte cultures kazrin partially colocalised with desmoplakin and 
periplakin at the desmosomes and periplakin at the interdesmosomal plasma membrane. 
In transient transfections, kazrin proteins localised predominantly to the apical plasma 
membrane of primary keratinocytes. The exogenous expression of kazrin proteins 
caused changes in keratinocyte cell shape and the actin cytoskeleton.
I carried out in vivo analysis of the function of periplakin and envoplakin using mice 
lacking periplakin, envoplakin and involucrin expression. Triple knockout mice 
produced slightly larger CEs and had a slight delay in epidermal barrier formation 
relative to control mice. In future it would be interesting to establish the consequence of 
deleting the kazrin gene in mice.
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Chapter 1. Introduction
The topic of my thesis is periplakin and envoplakin, members of the plakin family of 
cytolinkers and components of the epithelial comified cell envelope (CE). I examine the 
domains of periplakin and envoplakin that are necessary for their plasma membrane 
localisation. I also describe kazrin, a novel protein that associates with periplakin.
In this introductory chapter, I will present an overview of the epidermis and the 
structure of the CE. In particular I will focus on what is known about periplakin and 
envoplakin as members of the plakin family and components of the CE.
1.1 Organisation of the epidermis
The skin serves as a mechanical, chemical, microbial and water barrier between the 
organism and the environment (reviewed in Holbrook, 1994; Odland, 1991 ). The skin 
comprises an outer stratified epithelium, the epidermis, and an inner dermis. The 
epidermis is separated from the dermis by the basement membrane, composed of a 
variety of proteins, such as type IV collagen and laminin 1. Underlying the skin is fatty 
and areolar connective tissue.
The epidermis consists of a stratified squamous epithelium, the interfollicular epidermis 
with associated hair follicles, sebaceous glands and sweat glands. In this thesis I will 
focus on the interfollicular epidermis. The interfollicular epidermis contains several 
specialised cell types such as sensory Merkel cells, antigen-presenting Langerhans cells 
and pigment-producing melanocytes. By far the major cell type of the interfollicular 
epidermis is the keratinocyte.
Epidermal keratinocytes form distinct cell layers known as the basal, spinous, granular 
and cornified layers. The cells of each layer have distinct morphologies, differentiation 
statuses and express different proteins (Fig 1.1). Cells furthest away from the dermis are 
the most differentiated and have become anucleate, tough, water-resistant squames. 
These cells carry out much of the protective function of the skin.
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Fig 1.1 Organisation of the interfollicular epidermis. The epidermis 
is composed of several cell layers. The basal layer is attached to the 
basal membrane through hemidesmosomes. The desmosomes tether 
keratinocytes to each other. The keratin intermediate filament cyto­
skeleton which links into the desmosomes is not shown. Keratohyalin 
granules and lamellar bodies accumulate in the granular layer. Comi­
fied cells are anucleate and highly flattened. Comified cells are 
continually shed from the surface of the skin to be replaced by differ­
entiating cells from below.
In the basal layer, closest to the dermis, cells are small, low columnar and proliferative. 
Cells of the basal layer are anchored to the basement membrane by hemidesmosomes. 
As basal keratinocytes detach from the basement membrane and move into the spinous 
layer, they begin to terminally differentiate (Fig. 1.1).
The spinous layer is composed of non-proliferative, early-differentiated keratinocytes. 
Human epidermis typically has three or four layer of spinous cells. The cells of the 
spinous layer are polygonal with those closest to the granular layer more flattened than 
those below.
The granular layer comprises two or three cell layers, and are the last viable cell layer of 
the epidermis. Granular layer cells are flat and contain numerous cytoplasmic 
keratohyalin granules and lipid-containing lamellar bodies.
As cells enter the comified layer the nuclei and organelles are destroyed. Comified cells 
are composed of a tough structure of crosslinked proteins known as the CE. The CE has 
an extracellular lipid layer, known as the comeocyte lipid envelope (CLE), covalently 
attached. The interstices of the comified cells are filled with lamellar lipids, which are 
crucial components of the water barrier of the skin. The structure and formation of the 
CE and CLE are discussed further below. The comified cell layer comprises 15-20 
layers of dead, anucleate squames, which are continually sloughed off from the surface 
of the epidermis to be replaced by newly differentiated cells from below. The transition 
of a cell from the basal layer to the outer comified layer takes between 26-42 days, 
depending on the region of the body.
The cells of the epidermis are held together by intercellular adhesive structures known 
as desmosomes. Desmosomes are linked, on their intracellular sides, to the distinctive 
cytoskeleton of keratinocytes, the keratin intermediate filament cytoskeleton.
1.2 Keratin intermediate filaments
There are over 45 different keratin genes, which can be divided into two groups, group I
(acidic) keratins and group II (basic) keratins. Keratins form filaments through the
multimerisation of coiled coil heterodimers. Heterodimers contain one group I keratin
15
protein and one group II keratin protein. Keratin expression is controlled in a tissue and 
differentiation specific manner. Keratins 5 and 14 are expressed in keratinocytes of the 
basal layer. Cells of the spinous layer express keratins 1 and 10. In specialised 
epidermal areas other keratins may be expressed e.g. keratin 9 in the palms of the hands 
and soles of the feet (Porter and Lane, 2003).
In the basal layer, keratin accounts for ~30% of the cell proteins; this increases up to 
85% in the cornified layer. Keratin filaments aggregate and align as cells become 
cornified. Keratohyalin F-granules, visible in the granular layer of the epidermis, 
contain profilaggrin. Profilaggrin is proteolytically processed as cells differentiate to 
form filaggrin. Filaggrin, a matrix protein, is important for the formation of the thick 
keratin bundles, tonofibrils, of differentiated keratinocytes (Holbrook, 1994).
1.3 Desmosomes
Desmosomes are cell-cell adhesive complexes, particularly prominent in tissues that are 
subjected to mechanical stress such as the skin. The association of the desmosomes with 
the intermediate filament cytoskeleton allows them to integrate the cytoskeletal 
networks of cells, thereby helping to distribute tensile and shearing forces and maintain 
tissue integrity. As cells of the epidermis differentiate the number of desmosomes and 
the size of the desmosomes increases ( 5kerroco et al., 19 ).
Desmosomes have a central core, lying between the plasma membranes of adjacent
cells, and an intracellular plaque. The extracellular domains of the desmosomal
cadherins, desmoglein 1 to 4 and desmocollin 1 to 3, form the desmosomal core. The
intracellular domains of the desmosomal cadherins, desmoplakin and the armadillo-
family members plakoglobin, plakophilin (PKP 1 to 3) and p0071 are components of
fe v ieu te c i Vjrv
the desmosomal plaque (Fig. 1.2) ^jetsios et al., 2004; Kowalczyk et al., 1999a).
The importance of desmosomal adhesion is highlighted by a variety of autoimmune and
genetic diseases. Patients with the autoimmune diseases pemphigus foliaceus and
pemphigus vulgaris produce antibodies to desmoglein 1 (Dsg 1) and desmoglein 3 (Dsg
3), respectively. The autoantibodies cause a loss of intercellular adhesion and skin
16
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Fig 1.2 Model of desmosome structure. Desmoplakin (Dp) forms parrailel homodimers. 
The C terminus of Dp links the desmosomes to the intermediate filament (IF) cytoskeleton. 
The N terminus of Dp associates predominantly with itself, plakoglobin (Pg) and 
plakophilin (PKP) which in turn interact with the desmosomal cadherins, desmogleins 
(Dsg) and desmocollins (Dsc). Figure based on model described in Haisell and Cowin, 
2001. See text for further details of the protein-protein interactions of the desmosome. 
Model is not to scale.
blistering (Amagai et al., 1995; Amagai et al., 1994). The level of desmoplakin 
expression is crucial for normal cell-cell adhesion. Loss of one copy of the desmoplakin 
gene causes a form of palmoplantar keratoderma in which affected skin shows a 
reduction in the linkage of the desmosomes to the keratin intermediate filament 
cytoskeleton and reduced cell-cell adhesion (Armstrong et al., 1999).
Analysis of the interactions of desmosome components, in vitro, in yeast two hybrid 
analysis, in stable cell lines expressing deletion mutants of desmosome components and 
desmosomal protein knock out mice, has yielded a model of the desmosome as depicted 
in Fig. 1.2.
1.3.1 Desmosomal cadherins
Desmosomal cadherins are type I integral membrane glycoproteins. The extracellular 
domains of the desmosomal cadherins are composed of 5 extracellular subdomains. 
Each of the subdomains contains a Ca2-binding motif. Based on analysis of the highly 
related classical cadherins, the extracellular domains of the desmosomal cadherins are 
predicted to form an elongated curved structure (Boggon et al., 2002; He et al., 2003). 
Electron tomography of neonatal mouse epidermis suggests that the extracellular 
domains are flexible and interact with each other though their tips. The interactions 
occurred in trans to generate W and S shapes between adjacent cells. A third interaction 
formation is seen, the X shape, between three desmosomal cadherin extracellular 
domains. The X formation is generated from the interaction of two cadherins in cis with 
another in trans (He et al., 2003). Only a small proportion (<9%) of cadherin molecules 
were not involved in W, S or X type interactions (He et al., 2003).
The electron tomography analysis did not differentiate between desmoglein and
desmocollin proteins. Expression of desmosomal cadherins in cells that lack
endogenous desmosomal components or express them at low levels and analysis of the
interactions of recombinant desmosomal cadherins extracellular domains have been
used to elucidate the interactions between desmoglein and desmocollin proteins.
Analysis suggests that the extracellular domains of the desmogleins and desmocollins
can form homo and hetero-dimers (Chitaev and Troyanovsky, 1997; Marcozzi et al.,
1998; Syed et al., 2002). The heterophilic interactions of desmoglein and desmocollin
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proteins are Ca2+-dependent (Chitaev and Troyanovsky, 1997; Marcozzi et al., 1998; 
Syed et al., 2002). The Ca2+-dependence of desmoglein and desmocollin homophilic 
interactions are less clear (Marcozzi et al., 1998; Syed et al., 2002).
The intracellular domains of the desmosomal cadherins are components of the 
desmosomal plaque and specifically interact with many components of the plaque. The 
intracellular domains of desmoglein proteins are composed of several subdomains: a 
membrane proximal intracellular anchor domain, intracellular catenin-binding site 
segment, a proline-rich linker, a repeating unit domain and a C-terminal desmoglein 
terminal domain. The desmocollin intracellular domains are much smaller. Desmocollin 
‘a’ splice variants have an intracellular anchor domain and a C-terminal catenin-binding 
site segment. Desmocollin ‘b ’ variants have an intracellular anchor domain and a short 
C-terminal region the function of which is not well understood (Getsios et al., 2004).
1.3.2 Plakoglobin and plakophilins
Plakoglobin and plakophilin 1-3 are members of the Armadillo family of proteins. The 
family also includes a  and p catenin, components of the actin-associated adherens 
junctions.
Plakoglobin is a component of both the desmosomes and adherens junctions. In the
desmosomes plakoglobin interacts with the intracellular domains of desmogleins and
desmocollin ‘a’ splice forms through a central Armadillo repeat-containing domain (Fig.
1.2) (Bomslaeger et al., 2001; Witcher et al., 1996). In adherens junctions plakoglobin
interacts with classical cadherins and, via a-catenin, to the actin cytoskeleton 
retfieiAefl *uv
(ffereZ'rtareno et al., ^O O i),The binding sites for a-caten in  and the desmosomal 
cadherins are mutually exclusive, helping to segregate desmosome components from 
adherens junction components (IDvfccher et al., 199G ; Troyanovsky et al., 1994). In 
the absence of plakoglobin the components of the junctions become mixed up, as seen 
in plakoglobin null embryos. In plakoglobin null mice p -ca ten in  localises to 
desmosomes and associates with desmogleins 1 and 3 (Bierkamp et al., 1999; Ruiz et 
al., 1996).
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Strong cell-cell adhesion through desmosomal cadherins is dependent upon both types 
of desmosomal cadherin and plakoglobin (Marcozzi et al., 1998). The association of 
plakoglobin with the desmoglein tails may be stronger than its interaction with the 
desmocollin cytoplasmic tails (Smith and Fuchs, 1998). Overexpression of plakoglobin 
lacking a C-terminal domain causes the formation of extended desmosomal junctions 
between cells. Based on these results, plakoglobin is important for limiting the size of 
the desmosome possibly by limiting lateral protein:protein interactions between 
desmosome components (Palka and Green, 1997). However, the desmosomes of 
plakoglobin"7' mouse epidermis^although ultrastructurally altered, lacking an inner dense 
plaque and having a reduced linkage to the IF cytoskeleton, have not been reported to 
be larger (Bierkamp et al., 1996; Bierkamp et al., 1999; Ruiz et al., 1996).
Plakophilin proteins are related to p i20°™, an adherens junction component that is also 
found in the nucleus. Plakophilin proteins localise to desmosomes and the nucleus 
(Bonne et al., 1999; Mertens et al., 1996; Schmidt et al., 1997). There are three 
plakophilin genes, plakophilin 1, 2 and 3. Plakophilins 1 and 2 are expressed as ‘a’ and 
‘b ’ splice variants (Mertens et al., 1996; Schmidt et al., 1997). Based on data from 
p i20°™, plakophilin may regulate the stability and clustering of desmosomal cadherins 
and in the nucleus may associate with transcription factors (Getsios et al., 2004).
Loss of plakophilin 1 expression in humans results in skin fragility, with a reduction in 
the size and number of desmosomes formed and reduced insertion of keratin filaments 
into the desmosomes, especially in lower suprabasal layers (McGrath et al., 1997). 
Plakophilin 1 has been shown to interact with desmocollin la  and to a lesser extent to 
desmoglein 1 (Smith and Fuchs, 1998). Plakophilin 2 interacts with desmoglein 1 and 2 
and desmocollin la  and 2a (Chen et al., 2002). Plakophilin 3 interacts with all three 
desmogleins and with desmocollins la, 2a, 3a and 3b (Fig. 1.2) (Bonne et al., 2003).
There are reports that plakophilins are able to interact with keratin intermediate 
filaments in vitro (Bonne et al., 2003; Hofmann et al., 2000; Smith and Fuchs, 1998). 
Immuno-electron microscopy of plakophilin 1 suggests that it is located close to the 
plasma membrane and therefore far from the region at which the keratin fibres insert 
into the desmosome (North et al., 1999). Plakophilin may interact with forms of keratin 
filaments that penetrate further into the desmosomal plaque; alternatively it may interact
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with cortical bands of keratin filaments (Fig. 1.2) (North et al., 1999; Vasioukhin et al., 
2001). Thus plakophilin may increase the interaction of the desmosomes with the 
keratin intermediate filament cytoskeleton directly.
1.3.3 Desmoplakin
Desmoplakin is a ubiquitous component of the desmosomal plaque and member of the 
plakin family of cytolinker proteins, to which envoplakin and periplakin also belong 
(Leung et al., 2001). The N-terminal globular region targets desmoplakin to the 
desmosomes. Desmoplakin forms a parallel coiled coil homodimer through its central 
rod domain. The C-terminal domain is crucial for mediating the connection of the 
desmosomes with the intermediate filament cytoskeleton (Fig. 1.2) (Stappenbeck et al., 
1993). Desmoplakin has two splice variants, which differ only in the length of their 
central rod domains. Desmoplakin 1 is the longer form; desmoplakin 2 is the shorter 
form. Both isoforms are widely expressed, although desmoplakin 2 is expressed at 
slightly lower levels in simple epithelia and is absent in the heart ( fo y t  etoA.y WOj 
Gmee*v et odl.# W o).
The desmoplakin N-terminus interacts with many components of the desmosomal 
plaque (Fig. 1.2). There are weak interactions between desmoplakin and the 
desmosomal cadherins; but by far the more crucial interactions are via the Armadillo- 
family members, plakoglobin and plakophilin (Bomslaeger et al., 2001; Chen et al., 
2002; Hatzfeld et al., 2000; Kowalczyk et al., 1997; Smith and Fuchs, 1998; 
Troyanovsky et al., 1994). The head domain of desmoplakin binds itself and the central 
armadillo repeats of plakoglobin. Expression of desmoplakin is necessary to cluster the 
desmosomal cadherins and plakoglobin at the plasma membrane (Kowalczyk et al., 
1997; Smith and Fuchs, 1998). The interaction between desmoplakin and plakoglobin is 
disrupted upon epidermal growth factor receptor-dependent tyrosine phosphorylation of 
plakoglobin. The C-terminal phosphorylation of plakoglobin does not affect the 
interaction of plakoglobin with the Dsg 2 tail domain ( Gaudry et al.,
2001).
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The head domain of desmoplakin interacts with plakophilin 1, 2 and 3 (Bonne et al., 
2003; Chen et al., 2002; Kowalczyk et al., 1999b). Two desmoplakin binding sites have 
been identified on plakophilin 3 (Bonne et al., 2003). The potential of plakophilins to 
interact with more than one desmoplakin molecule may allow them to increase lateral 
interactions between desmosome components and thereby increase desmosome size, as 
seen in the differentiated layers of the epidermis (Bonne et al., 2003; Kowalczyk et al., 
1999b). Plakophilin 2 and 3 have also been shown to interact with plakoglobin; an 
interaction between plakophilin 1 and plakoglobin has thus far not been identified 
(Bonne et al., 2003; Chen et al., 2002).
Desmoplakin preferentially binds plakophilin 1 to plakoglobin in transfected cells, but 
both proteins are important components of the desmosomal plaque. The formation of 
punctate desmosomal plaque structures in cells that have few desmosomes requires the 
coexpression of desmoglein 1 and desmoplakin in the presence of plakoglobin and 
plakophilin 1 (Bornslaeger et al., 2001). Quadruply transfected cells form punctate 
structures resembling desmosomal plaques and have numerous associated IFs while 
cells lacking plakophilin form extended desmosomal plaque structures (Bornslaeger et 
al., 2001).
The C-terminus of desmoplakin is crucial to link the desmosomes to the IF cytoskeleton. 
Overexpression of the head domain of desmoplakin disrupts the linkage between the 
desmosomal plaque and the intermediate filament cytoskeleton. The disruption results 
in reduced intercellular adhesion (Bornslaeger et al., 1996; Huen et al., 2002).
In mice, the loss of expression of desmoplakin has drastic effects early in development. 
Embryos die at embryonic day 6.5 (E6.5) due to a failure to form sufficient and 
effective desmosome structures in embryonic and extra-embryonic tissues (Gallicano et 
al., 1998). Desmoplakin'7' desmosomes are considerably smaller in number and size than 
wild type desmosomes and are not linked to the IF cytoskeleton, indicating that 
desmoplakin is important for assembly or stability of the desmosomal plaque. 
Desmoplakin'^embryos generated by tetraploid aggregation, to bypass the defects in the 
extra-embryonic tissues, die at E10.5. At this stage the embryos die due to defects in the 
microvasculature due to problems in the formation of complexus adherens junctions. 
There are also defects in many desmosome-containing tissues such as the skin and heart
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(Gallicano et al., 2001). An epidermis-specific knock-out of desmoplakin was generated 
by crossing mice in which exon 2 of the desmoplakin gene was bordered by loxP sites 
with mice expressing Cre recombinase under the control of the K 14 promoter. The K14 
promoter becomes active in the developing skin epithelium, and specifically deletes the 
desmoplakin gene there, around E13.5 (Vasioukhin et al., 2001). Deletion of 
desmoplakin specifically in the epidermis indicates that desmoplakin is crucial for 
maintenance of an interaction of the desmosome with the IF cytoskeleton. The 
keratinocytes are able to adhere but intercellular adhesion is weaker, particularly in 
lower epidermal layers. Coincident with a defect in desmosome structure and function, 
the adherens junctions fail to mature (Vasioukhin et al., 2001).
1.3.4 Changes in the protein composition of desmosomes during epidermal terminal 
differentiation
The composition of desmosomes varies in a tissue- and differentiation-specific manner. 
Plakophilin 1 is expressed in all layers of the epidermis but is upregulated as cells 
differentiate (Moll et al., 1997). Plakophilin 2 is expressed predominantly in the basal 
layer of the epidermis (Mertens et al., 1996). Plakophilin 3 is expressed in all living 
layers of the epidermis (Bonne et al., 2003).
Periplakin and envoplakin localise to the desmosomes of differentiated keratinocytes. 
Periplakin and envoplakin are expressed in the spinous layer of the epidermis (Ma and 
Sun, 1986; Ruhrberg et al., 1997; Ruhrberg et al., 1996).
Desmoglein 2 and desmocollin 2 are expressed preAomufsafikhj
in the basal layer (Schafer et al., 1994; Theis et 
al., 1993). Desmoglein 1 and desmocollin 1 are upregulated in the spinous layer 
(Amagai et al., 1996; Arnemann et al., 1993). Desmocollin 3 and desmoglein 3 are 
expressed in the basal and immediately suprabasal layers of the epidermis (Amagai et 
al., 1996; Arnemann et al., 1993). Desmoglein 4 is expressed in suprabasal layers of the 
epidermis (Kljuic et al., 2003).
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The complex expression patterns of desmosomal components suggests that there are 
functional differences between the desmosomes of different tissues or between the 
desmosomes of cells at different stages of differentiation*
Transgenic mice expressing Dsg 3 from the involucrin promoter and from its 
endogenous promoter thereby express Dsg 3 throughout the epidermis (Elias et al.,
2001). The mice exhibit loss of cell-cell adhesion at the transition of the granular layer 
and the comified layer in contrast to wild type mice where the loss of cell-cell adhesion 
occurs within the cornified layer. The epidermis of these mice does not function 
efficiently as a permeability barrier; thus the desmoglein isoform type is important for 
proper comified layer structure (Elias et al., 2001).
Desmoglein 3 knock-out mice have cyclical baldness due loss of cell-cell adhesion 
between the outer root sheath of the hair follicle and the telogen hair club (Hanakawa et 
al., 2002). Expression of Dsg 1 in these mice from the K14 promoter,thereby replacing 
Dsg 3 with Dsg 1 in the basal layer, rescues the hair phenotype suggesting that the 
desmoglein isoforms can compensate for each other in some cases (Hanakawa et al.,
2002).
Thus some differences in the epidermis can be seen as a result of altering the relative 
levels of expression of different desmogleins within the epidermis (Elias et al., 2001). 
The desmosomes of the K14-Dsg 1 mice crossed with Dsg 3'1' mice function under 
normal conditions, however it cannot be mled out that there are subtle differences in the 
stmcture or strength of the desmosomes of the transgenic mice versus wild type mice 
(Hanakawa et al., 2002).
In order to fully understand the differences between the desmosomes of different tissues 
we need to know more about the biophysical properties of desmosomes and the 
interactions of proteins within the desmosome.
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1.4 The cornified cell envelope and corneocyte lipid envelope
The stratum corneum, the outer layer of the epidermis, is composed of cornified 
anucleate, squamous cells (Holbrook, 1994; Odland, 1991). Comified cells have lost 
many of the organelles and structures found in other cells such as mitochondria and 
nuclei. The cornified cells contain a cornified cell envelope (CE), which encases a 
cytoplasm filled with thick keratin bundles (Holbrook, 1994; Odland, 1991). The CE is 
an insoluble lOnm thick layer of crosslinked protein with a 5nm thick extracellular layer 
of covalently attached ceramide lipids. The CE forms beneath the plasma membrane of 
terminally differentiating keratinocytes. The ceramide lipids, which are covalently 
linked to CE proteins form the corneocyte lipid envelope (CLE). In this introduction I 
will talk separately about the formation of the crosslinked protein component of the CE 
and the crosslinking of ceramide lipids to CE component proteins i.e. formation of the 
CLE. Lipid lamellae lie between the comified cells (Kalinin et al., 2001; Kalinin et al.,
2002).
The CE with the covalently attached CLE and the lamellar lipids are important 
components of the physical and water barrier of the skin (Holbrook, 1994). The CE is 
formed in many stratified squamous epithelia, however formation of the CLE and the 
deposition of lamellar lipids are unique to dry epithelia such as foreskin epidermis, as 
well as the rodent forestomach (Jamik et al., 1996; Kalinin et al., 2001).
The proteins of the CE are predominantly crosslinked by the action of tranglutaminase 1 
and 3 (TGase 1 and 3). TGase 1 and 3 catalyse the formation of N-s-(y-glutamyl)lysine 
bonds, between glutamine and lysine side chains of substrate proteins, in a C a -  
dependent manner. In addition to protein crosslinking TGase 1 is thought to catalyse the 
attachment of ceramide lipids to CE components (Marekov and Steinert, 1998; Nemes 
et al., 1999a). TGase 1 has an acyl lipid adduct which targets the protein to the plasma 
membrane (Chakravarty and Rice, 1989). TGase 3 is cytosolic (Kim et al., 1990).
In mice lacking TGase 1 there is a large reduction in the number of CE and CLE 
produced and the lamellar lipids are disorganised (Kuramoto et al., 2002). The skin of 
TGase l 'A mice no longer functions as a water barrier and the mice die within hours of 
birth due to dehydration (Matsuki et al., 1998). In patients with lamellar ichthyosis (LI)
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there is often a loss of TGase 1 expression or crosslinking activity. LI patients fail to 
form normal CEs and the lamellar lipids are disorganised (Elias et al., 2002; Huber et 
al., 1995; Russell et al., 1995). In the absence of TGase 1, mice and LI patients form 
thick scaly skin to prevent dehydration from the skin surface (Kuramoto et al., 2002). 
No diseases in which there is loss of TGase 3 have thus far been reported (Lorand and 
Graham, 2003).
CE proteins, such as involucrin and periplakin, were initially identified as protein that 
became insoluble upon induction of CE formation by the activation of TGase enzymes 
(Rice and Green, 1979; Simon and Green, 1984). More detailed analysis of the protein 
composition and mechanism of formation of the CE has been done by sequential 
proteolysis of CEs and identification of the peptides released, by immunoelectron 
microscopy of CEs and by comparison of the amino acid composition of CEs relative to 
the amino acid compositions of known CE components (Steinert and Marekov, 1999).
The CE is thought to form in three main stages. In the first stage early CE proteins, 
periplakin, envoplakin and involucrin, are crosslinked by TGase 1 to themselves and 
each other to form an insoluble protein scaffold beneath the plasma membrane. The CE 
scaffold encompasses the desmosomes and interdesmosomal plasma membrane 
(Kalinin et al., 2001; Steinert and Marekov, 1999). During or after CE scaffold 
formation lamellar bodies, containing the lipids necessary for the formation of the CLE 
and lipid lamellae, fuse with the plasma membrane to release their contents into the 
intercellular spaces. At this stage a proportion of the ceramide lipids is crosslinked to 
protein components of the CE including periplakin and envoplakin. Finally late CE 
proteins, such as loricrin, which make up the bulk of the CE^are crosslinked to the CE 
scaffold to form the mature CE structure (Fig. 1.3) (Kalinin et al., 2001).
Mature CE can be isolated from the outer layers of the epidermis and other tissues such 
as the rodent forestomach (Jamik et al., 1996; Michel et al., 1988). Immature or early 
forms of the CE can be isolated from lower layers of the epidermis or from cultured 
cells (Michel et al., 1988; Steinert and Marekov, 1999).
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Fig 1.3 Model of cornified envelope (CE) formation. (A) Envoplakin, periplakin and 
involucrin are expressed early in differentiation and form the scaffold between and around 
the desmosomes on the inner side of the plasma membrane. (B) Lipid-containing lamellar 
bodies are pinched off from the Golgi complex. The lamellar bodies fuse with the plasma 
membrane to release the lipids into the intercellular space. The long ceramide lipids span 
the plasma membrane and are crosslinked to CE components. (C) In the final stages loric­
rin, small proline-rich proteins and other CE poteins are crosslinked onto the CE scaffold 
to form the mature CE structure. See text for further details. Model based on Kalinin et 
al., 2001.
1.4.1 Early components of the CE and formation of the CE scaffold
Envoplakin, periplakin and involucrin were first identified as proteins that become 
insoluble upon induction of terminal differentiation of cultured epidermal keratinocytes 
(Rice and Green, 1979; Simon and Green, 1984).
1.4.1.1 Involucrin
Involucrin is expressed in the upper spinous layer of the epidermis and is absent from 
the dermis (Rice and Green, 1979). Involucrin is a highly soluble, extended protein 
containing numerous peptide repeats (Eckert and Green, 1986; Rice and Green, 1979). 
Human involucrin contains 39 repeats of a 10 amino acid sequence flanked by less 
repetitive head and tail regions (Eckert and Green, 1986). Each of the repeats contains 
lysine and glutamine residues which act as substrates for TGase-catalysed protein 
crosslinking. Sequence analysis of the involucrin gene from different species suggests 
that it evolved by repeated duplication and mutation to generate an elongated protein 
with a high percentage of glutamine and lysine residues (Eckert and Green, 1986; 
Teumer and Green, 1989; Tseng and Green, 1988). Early experiments in vitro indicated 
that involucrin is a good TGase substrate and is crosslinked to membrane-associated 
proteins over 80 times more effectively than other cytoplasmic proteins (Simon and 
Green, 1985).
Involucrin associates with synthetic lipid vesicles (SLV), which contain phosphatidyl- 
serine and replicate the composition of eukaryotic plasma membrane, at Ca2+ 
concentrations as low as lpM  (Nemes et al., 1999b). In vitro, at concentrations of 
lOpM Ca2+ or above, TGase 1 is activated and crosslinks involucrin proteins associated 
with SLVs (Nemes et al., 1999b). In vivo Ca2+ levels rise as keratinocytes differentiate. 
The increase in Ca2+ concentration activates TGase enzymes and is thought to increase 
the association of involucrin with the inner plasma membrane where it may 
subsequently be crosslinked to form part of the CE scaffold (Nemes et al., 1999b). 
Members of the annexin and S I00 Ca2+-dependent family of proteins, which localise to 
the plasma membrane in a Ca2+-dependent manner, may help anchor involucrin at the 
plasma membrane (Robinson et al., 1997).
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Involucrin is readily detected in immature CEs generated in culture or isolated from the 
epidermis (Steinert and Marekov, 1997; Steinert and Marekov, 1999). Proteolysis of 
epidermal CEs indicates that extensive digestion is necessary in order to release 
involucrin-derived peptides (Steinert, 1995). In contrast, if the CEs are treated with 
methanol and potassium hydroxide to remove the CLE lipids from the outside of the CE 
prior to proteolysis, involucrin-derived peptides are released quickly (Steinert and 
Marekov, 1997). This suggested that involucrin is an early CE component.
Involucrin expression is not restricted to the interfollicular epidermis; it is also 
expressed in the inner root sheath and the companion layer of the hair follicle (Li et al.,
2000). Involucrin is expressed in the suprabasal layers of the epithelia of the oral cavity, 
oesophagus, anus, vagina and exocervix. Involucrin is also detected in the transitional 
epithelia of the renal pelvis, ureter and urinary bladder (Li et al., 2000; Rice et al., 
1984). Involucrin is expressed in the Hassell’s corpuscles of the thymus (Rice et al., 
1984).
1.4.1.2 Envoplakin and periplakin
In the epidermis envoplakin and periplakin expression is highest in the upper spinous 
and granular layers. Neither envoplakin nor periplakin is expressed in the dermis (Ma 
and Sun, 1986; Ruhrberg et al., 1997; Ruhrberg et al., 1996). Periplakin and envoplakin 
are proteins of 195 and 210 kDa respectively (Ma and Sun, 1986; Ruhrberg et al., 1997; 
Ruhrberg et al., 1996). They are composed of an N-terminal globular head domain, a 
central a-helical rod domain and a C-terminal globular domain. Envoplakin and 
periplakin form envoplakin/periplakin heterodimers and periplakin homodimers through 
their central rod domain (Kalinin et al., 2004; Ma and Sun, 1986; Ruhrberg et al., 1997; 
Ruhrberg et al., 1996). Envoplakin homodimers are also thought to form (DiColandrea 
et al., 2000; Ruhrberg et al., 1997). The domain structure and functions of the domains 
of envoplakin and periplakin are discussed in more detail below.
Periplakin and envoplakin localise to the plasma membrane of keratinocytes, where 
they partially colocalise with desmoplakin at desmosomes. Periplakin and envoplakin 
can also be detected at the interdesmosomal plasma membrane. Confocal microscopy
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reveals that desmosomes labelled with antibodies to desmoplakin and desmocollins are 
surrounded more diffuse periplakin and envoplakin staining (DiColandrea et al., 2000; 
Ma and Sun, 1986; Ruhrberg et al., 1997; Ruhrberg et al., 1996). At the apical 
interdesmosomal membrane periplakin localises to plasma membrane projections 
known as microvilli (Bretscher et al., 2002; Ma and Sun, 1986).
Full length recombinant periplakin and envoplakin, like involucrin, are able to bind 
SLV in a Ca2+-dependent manner (Kalinin et al., 2004). The desmosomal and 
interdesmosomal plasma membrane localisation of periplakin and envoplakin is 
important for their crosslinking by TGase 1, which is localised at the plasma membrane.
Envoplakin and periplakin are thought to be early CE components as they localise to the 
site of formation of the CE early in differentiation. In the case of envoplakin it is 
frequently found crosslinked to involucrin and desmoplakin, which are early CE 
components (Steinert et al., 1998; Steinert and Marekov, 1999).
The expression of periplakin and envoplakin is not restricted to the
interfollicular epidermis. Periplakin is expressed in the inner root sheath of the hair 
follicle (Ma and Sun, 1986). Envoplakin and periplakin expression can be detected at 
the cell periphery of cells in keratinized and non-keratinized oral mucosa, cervical 
mucosa, corneal epithelium, the transitional epithelium of the urinary bladder, the 
pseudostratified epithelium of the mammary glands and the simple gastric mucosa (Ma 
and Sun, 1986; Ruhrberg et al., 1997; Ruhrberg et al., 1996). In the oesophageal mucosa 
periplakin is found in all suprabasal layers of the epithelium, in contrast to envoplakin, 
which is detected only in the outermost layers (Ruhrberg et al., 1997; Ruhrberg et al., 
1996). Periplakin is also expressed in the Hassell’s corpuscles of the thymus (Ruhrberg 
et al., 1997). Periplakin is found at the cell periphery in association with the cortex 
adhaerens of lens fiber cells. The cortex adhaerens junctions are adhesive junctions, 
which also contain ezrin, desmoyokin and periaxin (Straub et al., 2003). Periplakin is 
not confined to epithelial cells as ^eripiau^ mRNA transcripts are detected in several 
regions of the brain. The cellular localisation and the function of periplakin in the brain 
are not known. However, recent data suggests that periplakin may interact with mu 
opioid G protein-coupled receptors thereby modulating their signalling output (Feng et 
al., 2003; Ma and Sun, 1986).
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1.4.1.3 Early crosslinking partners
Steinert and Marekov analysed the protein composition, localisation and crosslinking 
pattern of CEs generated in culture. Confluent human epidermal keratinocytes were 
cultured for 2 to 7 days in high calcium medium to induce CE formation. The CE yield 
and the extent of protein crosslinking increases as the cells are grown at confluence for 
longer periods. The culture system allows the analysis of the earliest stages of CE 
formation as at all time points the CEs are immature relative to those direct from 
epidermis (Steinert and Marekov, 1999). At the early stages desmosomal remnants are 
clearly visible on the surface of the CEs (Steinert and Marekov, 1999). Desmoplakin 
remains unequally localised along the length of the CE, suggesting that desmoplakin 
and possibly other desmosomal proteins are components of mature CEs (Robinson et 
al., 1997; Steinert and Marekov, 1999). Indeed,Robinson et al. (1997) have in addition 
to desmoplakin isolated desmoglein** desmocollinr plakoglobin-and plakophilin-derived 
peptides from proteolytically digested CEs from cultured keratinocytes.
In the early stages of CE formation envoplakin and periplakin, like involucrin, are found 
predominantly at interdesmosomal areas of early CEs. As the CEs develop further, the 
epitopes for envoplakin and involucrin can be found equally distributed along the CE 
(Steinert and Marekov, 1999). The epitope for periplakin is not detected in later CE 
preparations possibly due to loss or masking of the epitope (Steinert and Marekov, 
1999). Immuno-EM data from other labs and from epidermal CEs and peptide 
sequencing data of epidermal CEs, suggest that periplakin is a component of mature 
- CEs, is located at the outer edge of the CE and is covalently linked to ceramide lipids of 
the CLE (Marekov and Steinert, 1998; Simon and Green, 1984).
In the initial stages, involucrin and envoplakin are predominantly crosslinked to 
themselves and each other in the CEs. At this stage involucrin makes up about 50% of 
the protein mass of the CEs. Involucrin proteins are crosslinked to each other in a head 
to head and head to tail fashion. At later stages involucrin and envoplakin both become 
crosslinked to desmoplakin (Steinert and Marekov, 1999). The crosslinking of 
desmoplakin with envoplakin and involucrin is concomitant with the presence of 
envoplakin and involucrin epitopes in both interdesmosomal and desmosomal areas of
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the CE. The change in the pattern of crosslinking of the CE components and their 
localisation suggests that the formation of the CE scaffold initiates at the 
interdesmosomal plasma membrane and subsequently incorporates desmosomal areas of 
the plasma membrane (Steinert and Marekov, 1999). The localisation of envoplakin and 
periplakin to the sites of initiation of CE scaffold formation and their crosslinking to 
involucrin at the plasma membrane suggests that they are important components of the 
CE scaffold (Fig. 1.3 A) (Steinert and Marekov, 1999).
Periplakin, envoplakin and involucrin single knockout mice have been generated in our 
lab and others (Aho et al., 2004; Djian et al., 2000; Maatta et al., 2001). Periplakin, 
envoplakin and involucrin single knock-out mice develop normally and are fertile. All 
three typer of knock-out mice are able to produce CEs and to generate a functional 
epidermal water permeability barrier. However, in the case of envoplakin the formation 
of the barrier is slightly delayed (Aho et al., 2004; Djian et al., 2000; Maatta et al.,
2001). Periplakin, envoplakin and involucrin single knock-out mice are described in 
more detail in Chapter 6.
1.4.2 Formation of the CLE
The CLE is a monomolecular layer of co-OH-ceramide lipids covalently attached to the 
outside of the CE. As keratinocytes differentiate they produce a variety of 
differentiation-specific lipids. The lipids accumulate in the trans Golgi network. Lipid- 
containing vesicles bud off from the trans Golgi to form cytoplasmic lamellar bodies 
(LBs) (Fig. 1.3 B). The LBs contain long chain (C28-C36) co-OH-ceramide lipids, which 
span the limiting membrane. Within the LBs are ceramide lipids, free fatty acids, 
cholesterol and cholesterol derivatives (Kalinin et al., 2002).
In the upper granular layer of the epidermis the LBs fuse with the plasma membrane and
release their contents into the intercellular space. The co-OH ceramide lipids span the
keratinocyte plasma membrane and become covalently linked to CE proteins. The
phospholipids of the plasma membrane are gradually reabsorbed and replaced by the co-
OH ceramides as differentiation proceeds (Kalinin et al., 2002). The remaining LB lipids
form lipid lamellae, which separate the comified cells (Kalinin et al., 2002). It is thought
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that the CLE is important for the organisation of the lipid lamellae. In the absence of co- 
OH ceramide lipid synthesis there is a disruption in the formation of organised lipid 
lamellae and the CLE (Behne et al., 2000).
co-OH ceramide lipids are attached to glutamine residues of CE proteins via an ester 
linkage. Greater than 50% of the ceramide-linked peptides isolated from proteolytically 
digested foreskin CEs are derived from involucrin, periplakin and envoplakin (Marekov 
and Steinert, 1998). The lipopeptides isolated do not contain crosslinks to other proteins, 
suggesting that the sites of protein crosslinking and ceramide attachment are different 
(Marekov and Steinert, 1998).
The ceramides are attached to various glutamine residues in the head domain of
involucrin. One ceramide attachment site is located in the central rod domain of
involucrin. The central rod domains of envoplakin and periplakin are used predominantly
for ceramide lipid attachment (Marekov and Steinert, 1998). The remaining lipid- 
are
associated peptidesArelated to sequences found in many different CE proteins (Marekov 
and Steinert, 1998). The attachment of many of the ceramide lipids to periplakin, 
envoplakin and involucrin is consistent with the idea that they are early CE components 
and are important for the formation of the CLE (Fig. 1.3 B).
In vitro, TGase 1 can catalyse the addition of an analog of a natural ceramide lipid to 
several specific glutamine residues in the head domain of involucrin. The sites of 
attachment of the ceramides in vitro have been shown to also occur in vivo (Nemes et al., 
1999a). The dual function of TGase 1 in protein crosslinking and ceramide lipid 
attachment may explain why TGase l 7' mice fail to form CEs, have sparse CLEs and 
disorganised lipid lamellae (Kuramoto et al., 2002). Some patients with LI are able to 
form CLEs, as evidenced by EM, but have defective CEs and lipid lamellae (Elias et al., 
2002). Thus, at present it is not known if TGase 1 is responsible for catalysing the 
attachment of all ceramide lipids to CE proteins.
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1.4.3 CE scaffold reinforcement
Analysis of CEs suggests that the CE scaffold is reinforced by the addition of other CE 
proteins, such as loricrin and members of the small proline-rich (SPR) protein family 
(Fig. 1.3 C).
1.4.3.1 Loricrin and the small proline-rich proteins
Loricrin is a major component of many mature CEs (Hohl et al., 1991; Mehrel et al., 
1990; Steinert et al., 1998). Loricrin is first detected in the granular layer of the 
epidermis, where it accumulates in small insoluble aggregates known as keratohyalin L- 
granules (Hohl et al., 1991; Mehrel et al., 1990; Steven et al., 1990). Keratohyalin L- 
granules are smaller and more regularly shaped than the keratohyalin F-granules, which 
contain profilaggrin (Steven et al., 1990). As cells become cornified loricrin is detected 
at the cell periphery, on the inner side of the CE (Mehrel et al., 1990).
Loricrin has an unusual amino acid composition with a high percentage of glycine and 
serine residues (77%) separated by cysteine and aliphatic residues (tyrosine, 
phenylalinine, isoleucine). There are four clusters of glutamine/lysine-rich sequences, 
two internally, one at the G*terminus and one at the N-terminus. Loricrin is predicted to 
form a series of flexible glycine loops, which come together at the aliphatic residues 
(Candi et al., 1995; Hohl et al., 1991). The clusters of glutamine/lysine residues are 
within areas that are predicted to be inflexible and accessible for crosslinking reactions 
(Hohl et al., 1991). Loricrin is predicted to form a compact yet flexible protein 
structure. The amino acid composition and the formation of intra- or inter-peptide 
disulphide bonds are thought to contribute to the insolubility of loricrin in the granular 
layer (Hohl et al., 1991).
Members of the SPR family of proteins are important components of the CE. The SPR 
genes are located in a cluster in the epidermal differentiation complex (Cabral et al., 
2001; Song et al., 1999). The epidermal differentiation complex is a region on human 
chromosome lq21 where many other genes for proteins important in keratinocyte 
differentiation, such as involucrin and loricrin, are located (Mischke et al., 1996).
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The SPR proteins have a common structure, with glutamine/lysine-rich head and tail 
domains. The head and tail domains are crosslinked to other CE proteins by 
transglutaminase enzymes. The central domain of the SPR proteins consists of a 
variable number of short proline-rich repeats (Cabral et al., 2001). The sequences of the 
repeats are predicted to confer different levels of flexibility to the proteins. SPR2 
proteins (A to I) are thought to be less flexible than SPR1 A, B and SPR3 (Kartasova et 
al., 1995).
The majority of the SPR proteins are upregulated as keratinocytes differentiate (Cabral 
et al., 2001). The level of expression of the different SPR proteins varies between 
tissues. SPR proteins expressed at higher levels in dry epithelia are generally expressed 
at lower levels in wet internal epithelia, and vice versa (Cabral et al., 2001).
Loricrin, in insoluble keratohyalin L-granules, is crosslinked to itself or to the soluble 
SPR proteins, by TGase 3 to form small homo-and heteromultimers. The multimers are 
thought to be more soluble and more easily incorporated into the CE scaffold (Candi et 
al., 1999). In vitro experiments indicate that TGase 3 activity is necessary prior to 
TGase 1 activity in order to produce large crosslinked protein complexes of SPR1 and 
loricrin. TGase 3 and TGase 1 use different lysine and glutamine residues on SPR1 for 
crosslinking. Data suggest that TGase 1 and 3 have nonoverlapping crosslinking 
functions, which is consistent with the finding that TGase 3 cannot compensate for the 
absence of TGase 1 in TGase I'1' mice (Candi et al., 1999). In TGase \ '' mice abnormal 
loricrin aggregates were detected at the cell periphery, but these were not sufficiently 
crosslinked to function as a CE (Matsuki et al., 1998).
1.4.3.2 Modulation o f the biomechanical properties o f the CE
The sum of the level of loricrin and SPR proteins in the CEs of different tissues is 
between 83 and 85% (Steinert et al., 1998). The actual levels of SPR proteins in the CE 
varij greatly and depend on the physical requirements of the tissue (Jarnik et al., 
1996; Steinert et al., 1998). Higher levels of SPR proteins are found in the mouse 
forestomach (22%), which undergoes large amounts of mechanical stress, relative to 
human foreskin epidermis (4%) or human/mouse trunk epidermis (<1%) (Steinert et al., 
1998). The incorporation of loricrin into the CE is thought to increase the pliability of
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the CE due the proposed flexible nature of the loricrin molecule (Hohl et al., 1991; 
Steinert et al., 1998). The addition of SPR proteins, which act as crossbridgers, is 
thought to increase the rigidity and strength of the CE, while maintaining its flexibility 
(Jamik et al., 1996; Steinert et al., 1998). The level of specific SPR proteins is also 
influenced by external insults, such as UV radiation, or by ageing and disease. Thus the 
composition of the CE and the type of barrier formed is adapted in response to various 
physiological and environmental states (Cabral et al., 2001).
Analysis of the CEs from cultured cells suggests that SPRs are not only involved in late 
stages of CE formation but also in the early stages. SPR1 is predominantly 
interdesmosomal in early CE structures. Isolated CE peptides suggest SPR1 and 2 
proteins can be crosslinked to envoplakin, involucrin and desmoplakin (Steinert and 
Marekov, 1999). Thus SPR proteins may be important for increasing the mechanical 
strength of early CE structures as well as modulating the physical properties of mature 
CEs.
Late envelope proteins (LEPs) constitute a family of 18 related proteins expressed late 
in terminal differentiation (Marshall et al., 2001). LEPs are small proteins (89-118aa), 
which contain numerous proline/lysine/cysteine repeats at their N -term in i. 
Proline/lysine/cysteine repeats are also found in members of the SPR family of proteins. 
At the C-terminus LEPs are rich in serine/glycine/cysteine residues, which is also a 
feature of loricrin (Marshall et al., 2001). The LEPs accumulate in intracellular 
aggregates. The numerous lysine and glutamine residues of the LEPs make them 
suitable TGase substrates. LEPs are crosslinked to the CE after the incorporation of 
loricrin into the CE. The LEP proteins have tissue-specific expression patterns. Through 
their tissue specific expression patterns and/or subtle differences in protein sequence the 
LEPs, like SPRs, are predicted to affect the biomechanical properties of the CE 
(Marshall et al., 2001).
1.4.3.3 Keratins and other CE components
Keratins 1, 2e, 5, 6 and 10 are crosslinked directly to components of the CE (Candi et 
al., 1998; Steinert and Marekov, 1995; Steinert and Marekov, 1999). A conserved lysine 
in the head domain of group II keratins is frequently used as the crosslinking site.
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Mutation of the conserved lysine in keratin 1 to an isoleucine results in a dominant 
form of diffuse nonepidermolytic palmar-plantar keratoderma (Candi et al., 1998). The 
mutant keratin monomers are able to form filaments. However, in cells of the granular 
and comified layers there is retraction of the keratin tonofibrils from the desmosomes 
and cell periphery and distortion of cell shape (Candi et al., 1998). The association of 
keratin tonofibrils to the CE is necessary for proper structural integrity of the comified 
cell and is most prominent in cells that are subjected to large amounts of mechanical 
stress, such as the human palmar-plantar skin and rodent forestomach (Candi et al., 
1998; Steinert et al., 1998).
Keratin filaments are crosslinked to both early (involucrin, envoplakin) and late 
(loricrin, SPRs) CE components (Candi et al., 1998). This suggests that keratin 
filaments may be associated with CE components at desmosomal remnants in addition 
to associating with CE components at the cytoplasmic side of the CE (Candi et al., 
1998; Steinert and Marekov, 1995; Steinert and Marekov, 1999). Filaggrin, which is 
associated with the keratin filaments of terminally differentiated cells, can be 
crosslinked to loricrin (Steinert and Marekov, 1995).
There are many other components and putative components of the CE such as elafin, 
cystatin a  , S100A10 and A l l  and annexin 1 (Nakane et al., 2002; Robinson et al., 
1997; Steinert et al., 1998; Steinert and Marekov, 1995; Steinert and Marekov, 1997). 
The function of these proteins within the CE is not well understood.
Elafin is a serine proteinase inhibitor found in lamellar bodies and the CE. In the CE, 
elafin is crosslinked to keratins, loricrin and SPR proteins as well as envoplakin and 
involucrin (Nakane et al., 2002; Steinert and Marekov, 1995; Steinert and Marekov, 
1997; Steinert and Marekov, 1999). Cystatin a  is a cysteine proteinase inhibitor protein 
found in keratohyalin granules and the CE. In the CE, cystatin a  is crosslinked to 
loricrin, SPR proteins, keratin, envoplakin, desmoplakin and involucrin (Steinert and 
Marekov, 1997; Steinert and Marekov, 1999; Takahashi et al., 1992). Annexin 1, 
S100A10 and S100A11 belong to the Ca2+-binding S100 protein family. Annexin I t  
SlOOAlO-and S100A11-derived peptides have been identified in proteolytically digested 
CEs. However, immunoEM of annexin 1 suggests that it is not major component as 
annexin 1 antibody staining of CEs from human keratinocyte cultures is not above
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background levels (Robinson et al., 1997; Steinert and Marekov, 1999). In response to 
the increased Ca2+ levels of differentiating keratinocytes, S100A11 translocates from the 
cytoplasm along microtubules to the cell periphery, thereby placing it in proximity to 
TGase 1 at the plasma membrane (Broome and Eckert, 2004).
1.5 Plakin family proteins
Envoplakin and periplakin belong to the plakin family of cytolinker proteins, whose 
other members include desmoplakin, plectin, bullous pemphigoid antigen 1 (BPAG1), 
microtubule-actin crosslinking factor (MACF1) and epiplakin. Plakin family members 
are large multi-domain proteins that impart mechanical stability to cells and tissues by 
linking cytoskeletal networks to each other and to membrane-associated adhesive sites 
such as desmosomes and hemidesmosomes (Fig. 1.4).
Conventional plakin proteins have an N-terminal plakin domain, a central rod domain, a 
series of C-terminal plakin repeats and a conserved linker subdomain. Some 
conventional plakin proteins such as plectin have an actin-binding domain and MT~ 
binding domain. The spectraplakins have actin*binding domains, a plakin domain, a 
central spectrin repeat domain and C-terminal putative Ca2+-binding EF hands, a GAR 
domain and a GSR domain. In general, the domains required for association with 
desmosomes and hemidesmosomes or the actin cytoskeleton are located in the N** 
terminus of plakins, while those involved in binding to intermediate filaments (IFs) or 
microtubules are found in the G*terminus.
The central coiled-coil rod domain of plakins is responsible for their dimerisation. 
Spectraplakins do not have a coiled-coil rod domain but have a central domain 
composed of multiple spectrin repeats (Jefferson et al., 2004; Leung et al., 2002). 
Spectrin repeats are composed of 110-120 amino acids, which fold into a three-helix 
bundle. Spectrin repeats are though to impart flexibility to spectraplakin proteins and 
may mediate their dimerisation (Jefferson et al., 2004; Leung et al., 2002).
Many plakin proteins are alternatively spliced, bringing together different functional
domains. Many of the splice variants are expressed in a tissue-specific manner, such that
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the type of cytolinker protein and its exact crosslinking capabilities are variable. 
However, thus far no splice variants of periplakin and envoplakin have been identified.
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Fig 1.4 The plakin family of cytolinker proteins. See text for description of the domains and their function. Proteins and protein domains are not drawn to 
scale.The plakin domain is composed of NN, Z, Y, X, W and V subdomains. In the case of the spectraplakins (marked by *) the central coiled-coil rod domain 
is replaced by a series of spectrin repeats. The spectrin repeats may mediate antipamallei dimerisation. Several of the plakin splice variants are shown. However, 
plectin, MACF1 and BPAG1 have many alternative 5 ’ start sites generating proteins which differ in the length of the actin-binding domain and N-terminal 
extensions; these are not shown. In additionfdesmoplakin 2 is identical to desmoplakin 1 except it has a shorter rod domain. The plakin repeats which cannot 
be described as being of the A, B or C variety are marked with a ?.
Epiplakin is a large protein (>700KDa) and an unconventional plakin family member. 
Murine epiplakin is composed solely of B type subdomains (16) with intervening linker 
regions. Epiplakin does not have an IF-binding domain, plakin domain or other domains 
typically found in plakin family members. The function of epiplakin is not known 
(Spazierer et al., 2003).
The importance of the plakin family members and their role of integrating cytoskeletal 
networks with each other or membrane attachments sites is highlighted by the 
phenotypes of knock-out mice and D rosoph ila  mutants. As described earlier, 
desmoplakin knock-out mice are early embryonic lethal due to failure of attachment of 
the desmosomes to the IF network in embryonic and extraembryonic tissues (Gallicano 
et al., 1998). Plectin is important for the crosslinking of IF, actin and MT networks and 
can be associated with desmosomes, hemidesmosomes and focal adhesions (Leung et 
al., 2002). In the absence of plectin mice and humans develop a form of epidermolysis 
bullosa simplex with muscular dystrophy (Andra et al., 1997; McLean et al., 1996). The 
mechanical stability of the hemidesmosomes of plectin'7' mice is severely reduced 
causing skin blistering. Plectin has a similar reinforcement role in heart and skeletal 
muscle fibres. In the absence of plectin the muscle fibres form but are no longer as 
resistant to mechanical stresses (Andra et al., 1997; McLean et al., 1996). Fibroblasts 
isolated from plectin'7' mice have altered actin cytoskeletons. The cells are more 
adherent, have more focal adhesions and more stress fibers than wild type cells. The 
increased adherence coincides with reduced cell motility suggesting that plectin is 
important f o r  actin dynamics in addition to mechanical stabilisation of cells (Andra et 
al., 1998).
The importance of plakin proteins is further highlighted in Drosophila. Drosophila have 
one plakin gene, shot, which can be alternatively spliced (Fig. 1.4). Drosophila do not 
have an IF cytoskeleton; instead^MTs assume the stabilising role in tissues. Mutants of 
shot have a multitude of defects related to the inability of the proteins to crosslink MT 
and actin cytoskeletons and link them to membrane attachment sites, such as epidermal 
muscle attachment sites (Gregory and Brown, 1998; Prokop et al., 1998). The majority 
of shot mutants are embryonic lethal in the homozygous state. In the absence of 
functional Shot protein there is a loss of attachment of epidermal muscle attachment 
cells to the underlying muscle layer and the outer cuticle and epidermal fragility due to
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loss of adhesion through the actin-associated adherens junctions (Gregory and Brown, 
1998; Prokop et al., 1998; Roper and Brown, 2003). In neurons,lack of Shot protein 
results in defects in axon outgrowth and dendritic branching (Lee and Kolodziej, 2002; 
Prokop et al., 1998). The expression of a Shot protein containing only the actin-and MT- 
binding domains is sufficient to rescue the axon outgrowth defect, provided that the MT 
and actin domains are joined. This emphasises the importance of plakin proteins in 
integrating different cytoskeletal networks (Lee and Kolodziej, 2002). Shot is highly 
related to mammalian forms of MACF1, which are discussed further below.
1.5.1 Intermediate filament binding domain
The IF binding domains are generally located at the C-terminus of plakin proteins. The 
C-terminus encodes a number of plakin repeat domains (PRDs) separated by loops of 
variable length. Each of the PRDs forms a globular subdomain. The PRDs are thought 
tofold up to form a globular end domain (Choi et al., 2002; Foisner and Wiche, 1987; 
O'Keefe et al., 1989). Each PRD is composed of 4 and a half repeats of a 38 amino acid 
sequence, which forms a (3-hairpin followed by two anti-parallel a-helices (Choi et al.,
2002). There are three types of PRDs, A, B and C, based on the sequences of the PRDs 
of desmoplakin (Green et al., 1992). Envoplakin contains one C type PRD and 
periplakin, the smallest plakin family member, contains no PRDs (Ruhrberg et al., 
1997; Ruhrberg et al., 1996).
The linker subdomain is the region most highly conserved between plakin family 
members and between mouse and human envoplakin (Maatta et al., 2000). The linker 
region generally precedes the last PRD. The linker region contains a partial 38 amino 
acid repeat and is thought to form an a-helix (Leung et al., 2002). Envoplakin and 
periplakin both have a conserved linker subdomain (Fig. 1.4).
The IF-binding domain of plakin proteins has been analysed by yeast-two and-three- 
hybrid assays, in vitro binding assays, transient transfections of deletion proteins and 
analysis of their alignment with IF cytoskeletal networks and X-ray crystallographic 
studies. The studies suggest that the linker domain is important for IF binding but that 
the PRDs also play a part in stabilising the interactions and/or in proper folding and
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alignment of the protein domains (Choi et al., 2002; Fontao et al., 2003; Karashima and 
Watt, 2002; Kazerounian et al., 2002; Nikolic et al., 1996; Steinbock et al., 2000).
The periplakin linker subdomain coaligns with the IF cytoskeletons of cultured 
keratinocytes and Cos7 cells (DiColandrea et al., 2000). Two regions, known as 
homologous boxes 1 and 2, within the linker subdomain are highly conserved between 
plakin family members. Homologous boxes 1 and 2 of periplakin are both necessary for 
strong interactions with IFs, such that the interaction is maintained even if the Cos7 
cells are extracted in an imidazole buffer containing 1% Triton X-100 or 0.6% saponin 
prior to staining (Karashima and Watt, 2002). Overlay assays suggest that periplakin 
has different affinities for different IF proteins (Karashima and Watt, 2002). The 
envoplakin C terminus does not efficiently coalign with the IF cytoskeletons of 
keratinocytes or Cos7 cells. In contrast when it is cotransfected with a C-terminal 
periplakin construct the binding of both proteins with IFs is strong, as assessed by non- 
extractability of the envoplakin and periplakin mutant proteins in the extraction buffer 
described above. Thus, periplakin is important for the association of periplakin and 
envoplakin with IFs (Karashima and Watt, 2002).
The desmoplakin C-terminal domain colocalises with simple keratin and vimentin IF 
u
networks in transient^transfected cells (Stappenbeck et al., 1993). Removal of more than 
48 amino acids from the very C-4erminus of desmoplakin disrupts the ability of 
desmoplakin to coalign with simple keratin filaments but does not affect vimentin 
binding (Stappenbeck et al., 1993).
X-ray crystallographic analysis of the B-and C-type PRDs indicated that they are 
globular and contain a groove on their surface lined with basic residues. It was 
hypothesised that this groove was important for binding the vimentin rod domain. This 
idea is somewhat disputed as the in vitro binding of vimentin by the B and C PRDs 
alone is very weak in contrast to the in vitro binding affinity of B-and C*PRDs together 
with the linker subdomain. Further transient transfection analysis and yeast three hybrid 
assays suggest that the linker subdomains and the C-terminal region of desmoplakin are 
important sites for IF binding, while the B^and O type PRDs are though to play a minor 
role in IF binding (Fontao et al., 2003). The B-and G-type PRDs are thought to be 
important for the proper folding and alignment of the major IF-binding domains (Fontao
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et al., 2003). Desmoplakin interacts with epidermal and simple keratins in addition to 
vimentin and desmin of cardiac myocytes (Fontao et al., 2003; Meng et al., 1997). The 
relative importance of the major IF binding sites is different for different IF types 
(Fontao et al., 2003). The interaction of desmoplakin with epidermal keratins is most 
dependent upon the C-terminal tail and is stabilised by the presence of the C-type PRD. 
Interactions with vimentin and the simple keratins (K8 and K 18) are dependent upon the 
linker subdomain. The interaction of desmoplakin and vimentin or the simple keratins is 
stabilised by the presence of the upstream B-type PRD. Simple keratins can also bind 
desmoplakin through the linker subdomain and B-type PRD (Fontao et al., 2003).
Phosphorylation of a serine residue within the desmoplakin C-terminal tail inhibits its 
interaction with keratins K8/K18 (Stappenbeck et al., 1994). Mutation of this serine to a 
glycine, thereby preventing phosphorylation at this site, increases the interaction of 
desmoplakin with keratins K8/K18. Interestingly, though the C-terminal tail of 
desmoplakin is not essential for vimentin binding phosphorylation at this site influences 
the strength of the interaction between desmoplakin and vimentin. Mutation of the 
phosphorylatable serine of the desmoplakin C-terminal tail to a glycine increases the 
strength of binding between vimentin and desmoplakin (Meng et al., 1997).
BPAG1 is a component of hemidesmosomes of basal keratinocytes. BPAG1 specifically 
interacts with K5/K14 heterodimers but not with simple keratins or vimentin. The 
interaction requires the linker subdomain and surrounding B-and C-type PRDs and the 
short C-terminal tail of BPAG1 (Fontao et al., 2003).
The plectin C-terminus is composed of 5 B-type PRDs, a linker subdomain and a C-type 
PRD. The IF-binding domain of plectin has been mapped to part of the terminal B-type 
PRD and half of the linker subdomain. Within the region of the linker subdomain used, 
four basic residues are essential for the binding activity (Nikolic et al., 1996). The 
intermediate filament-binding region of plectin also mediates oligomerisation and 
binding to the hemidesmosomal protein p4-integrin (Geerts et al., 1999; Rezniczek et 
al., 1998; Steinbock et al., 2000). An additional intermediate filament binding site may 
be located within the actin-binding domain of plectin proteins (Sevcik et al., 2004).
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The binding affinity of plectin to vimentin increases upon in vitro phosphorylation of 
plectin by protein kinase A and decreases upon cell cycle specific phosphorylation by 
cdkl and phosphorylation by PKC (Foisner et al., 1996; Foisner et al., 1991). The cdkl 
phosphorylation site of plectin is located within the C-type PRD. Thusaregions outside 
of the mapped IF-binding domains can affect the extent of binding thereby allowing 
fine-tuning of the interaction of plectin with IFs in a cell type-and cell state-specific 
manner (Foisner et al., 1996; Nikolic et al., 1996).
1.5.2 Periplakin linker subdomain interacting proteins
Periplakin has been found to associate with a variety of other proteins via regions 
involving the latter part of the rod domain and linker subdomain.
A region of protein kinase B (PKB) interacts with the latter part of the rod and linker 
subdomain of periplakin. The binding of PKB with periplakin does not affect the 
activation of PKB directly as insulin-mediated PKB activation is unaffected by 
overexpression of periplakin (van den Heuvel et al., 2002). In MCF7 cells, which 
express relatively high levels of periplakin and low levels of vimentin, periplakin is 
associated with IFs and mitochondria and can be seen in the nucleus. Coexpression of 
PKB in these cells suggests that in the presence of periplakin, PKB is retained in the 
cytoplasm thereby preventing nuclear PKB signalling. Thus periplakin does not affect 
PKB signalling directly but can modulate the extent Jiuclear PKB signalling by acting as 
a scaffold protein to PKB (van den Heuvel et al., 2002).
Periplakin also interacts with periphilin, a novel protein, through a small portion of the 
rod domain and the entire linker subdomain (Kazerounian and Aho, 2003). Periphilin, 
contains a functional nuclear localisation signal in the N-terminal region and 
homodimerises through a domain in the C-terminus. Periphilin partially colocalises with 
periplakin at the cell-cell junctions of differentiated keratinocytes and is crosslinked by 
TGases in vitro suggesting it may be a CE component (Kazerounian and Aho, 2003).
A portion of the periplakin rod domain and the periplakin linker subdomain links 
periplakin to the C-terminal tail of the mu opiod G-protein-coupled receptors (MOP-1
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and M 0P-1A) (Feng et al., 2003). The mu opiod receptors mediate the effects of 
morphine and heroin in the brain. The interaction between periplakin and MOP-1/MOP- 
1A does not disrupt agonist-induced internalisation of the receptors. However, the 
interaction specifically disrupts the activation of the downstream G protein thereby 
affecting the MOP-1/MOP-1A signalling pathway (Feng et al., 2003).
Immunoglobulin receptors (FcRs) are important for immunological responses. The 
cytoplasmic domain of FcyRI (CD64), which is a receptor for immunoglobulin of the y 
type, interacts with a portion of the rod domain and the linker subdomain of periplakin. 
FcyRI is expressed specifically in myeloid cells and is upregulated during inflammation. 
The interaction decreases ligand binding by the receptor and exogenous expression of 
the FcyRI-interaction domain of periplakin increases ligand-bound FcyRI endocytosis 
(Beekman et al., 2004).
1.5.3 Actin-and microtubule-binding domains
Many members of the plakin family, including the spectraplakin sub-family, contain 
actin-binding domains (ABDs) at their N-termini (Leung et al., 2002). The ABDs are 
composed of two adjacent calponin-homology domains (CHI and CH2). The CHI 
domain is capable of efficiently binding actin, in contrast to CH2, which only has a 
weak actin-binding activity (Fontao et al., 2001). The ABDs, and upstream regions, of 
plectin and BPAG1 isoforms can homodimerise and heterodimerise with each other, 
thereby crosslinking actin filaments (Fontao et al., 2001; Young et al., 2003).
Many plakin proteins are alternatively spliced, with some of the splicing events 
affecting the ABDs and upstream sequences (Fuchs et al., 1999; Karakesisoglou et al., 
2000; Yang et al., 1996; Young et al., 2003). Some plectin 5 ’ splice variants have a 
higher affinity for actin filaments than others, allowing modulation of the strength of 
actin binding in a tissue-specific manner (Fuchs et al., 1999). BPAGln3 and MACFla3 
are splice variants that do not have a CHI domain (Karakesisoglou et al., 2000; Yang et 
al., 1999).
46
Some isoforms of plectin localise to the hemidesmosomes where they interact directly 
with |34-integrin. The hemidesmosomal targeting domain of plectin coincides with the 
ABD and the binding of actin and |34-integrin are mutually exclusive such that 
hemidesmosomes are linked exclusively to IFs (Geerts et al., 1999; Rezniczek et al., 
1998).
Microtubule (MT)-binding domains of plakin proteins are generally located at the C- 
terminal end. The spectraplakins contain both a GAR domain and a glycine-serine- 
arginine (GSR) repeat domain (Fig. 1.4). The GAR domain of plakins was so named 
due to its sequence similarity to domains in growth arrest specific-2 (GAS2) and GAS2- 
related protein on chromosome 22 (GAR22). The GAR domains of GAS2 and GAR22 
coalign with MTs of transfected cells (Jefferson et al., 2004). The GAR and GSR 
domains of MACF1 and BPAG1 can independently associate with MTs in transfected 
cells (Sun et al., 2001). The GAR and GSR domains together, in one molecule, bind MT 
very strongly causing the MTs of transfected cells to bundle and rendering them 
resistant to MT-depolymerising drugs (Sun et al., 2001).
Some of the conventional plakins, plectin and desmoplakin, have a C-terminal GSR 
domain but lack the GAR domain (Fig. 1.4). The GSR domain of plectin coaligns with 
the MT cytoskeleton in contrast to the GSR domain of desmoplakin (Sun et al., 2001).
Loss of the CHI domain in the N*terminus of BPAGln3 prevents its association with 
the actin cytoskeleton and is thought to reveal an otherwise cryptic microtubule - 
binding domain within its head domain (Yang et al., 1999). A weak MT binding site is 
also present in this region of MACF1 (Karakesisoglou et al., 2000).
1.5.4 Rod domains
The rod domains of conventional plakins, such as desmoplakin and BPAG1, are 
composed of heptad repeats, which allow the proteins to form a-helical coiled-coil 
homodimers. Purified desmoplakin and BPAG1 proteins form long, flexible, parallel, 
in-register homodimers (O'Keefe et al., 1989; Tang et al., 1996). Plectin proteins also 
form parallel in-register homodimers; these in turn form antiparallel homodimers, i.e.
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plectin tetramers, which associate through their folded end domains (Foisner and 
Wiche, 1987; Wiche et al., 1991).
Periplakin and envoplakin both have a central heptad repeat containing-region predicted 
to form a coiled*coil rod (Ruhrberg et al., 1997; Ruhrberg et al., 1996). The rod domains 
of envoplakin and periplakin are more related to each other than to those of other plakin 
family members (Ruhrberg et al., 1997). Sequence analysis of the heptad repeat regions 
of envoplakin and periplakin suggests that parallel in-register periplakin and envoplakin 
homodimers can form in addition to parallel in-register envoplakin/periplakin 
heterodimers (Ruhrberg et al., 1997; Ruhrberg et al., 1996). The formation of 
heterodimers between envoplakin and periplakin is unusual and thus far has not been 
seen for other members of the plakin family.
Periplakin/envoplakin hetero-oligomers were first identified in immunoprecipitation 
(IP) experiments, which showed that immunoprecipitation with an antibody to 
envoplakin pulled down periplakin and vice versa (Ruhrberg et al., 1997).
In transient transfections of keratinocytes^full length human envoplakin forms nuclear 
and cytoplasmic aggregates (DiColandrea et al., 2000). The envoplakin rod domain is 
necessary for the formation of these aggregates. Coexpression of full length periplakin 
in a 1:1 ratio with full length envoplakin prevents the formation of envoplakin 
aggregates. The periplakin rod domain is necessary and sufficient to prevent the 
formation of envoplakin aggregates (DiColandrea et al., 2000).
In vitro experiments with recombinant envoplakin and periplakin proteins, as well as 
their individual head, rod and tail domains, suggests that full length and rod-containing 
envoplakin protein fragments are insoluble in vitro (Kalinin et al., 2004). In contrast, 
full length periplakin and periplakin rod domain-containing fragments are soluble in 
vitro. Periplakin forms parallel in-register homodimers, as seen by electron microscopy 
and as previously predicted by Ruhrberg et al. (1997) (Kalinin et al., 2004). Envoplakin 
proteins become soluble when refolded, by gradual dialysis out of an 8M urea- 
containing buffer, in the presence of periplakin. Protein gel electrophoresis indicates 
that envoplakin and periplakin form heterodimers and their rod domains are sufficient 
for heterodimer formation.
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Though periplakin can form hom odim ers in vitro it preferentially forms 
envoplakin/periplakin heterodimers (Kalinin et al., 2004). Periplakin/envoplakin 
heterodimers form higher order oligomers, in vitro, in the presence of their tail domains. 
These hetero-oligomers are further stabilised by the presence of their head domains 
(Kalinin et al., 2004). These in vitro experiments and the finding that periplakin and 
envoplakin can interact in transiently transfected cells where either one lacks a rod 
domain, suggest that envoplakin and periplakin can interact through regions outside 
their rod domains (Karashima and Watt, 2002). The mode of association of the 
heterodimers within the multimers is not known (Kalinin et al., 2004).
Some plectin and BPAG1 isoforms lack both a coiled-coil rod domain and spectrin 
repeats (Elliott et al., 1997; Okumura et al., 2002). The functions of these proteins and 
their ability to dimerise is not known, although the ABDs of plectin and BPAG1 and the 
intermediate filament binding domain of plectin have been shown to mediate 
dimerisation (Fontao et al., 2001; Steinbock et al., 2000; Young et al., 2003).
1.5.5 The amino terminal plakin domains
The N-termini of plakin proteins, including the spectraplakins, are composed of 6 
plakin subdomains known as NN, Z, Y, X, W, and V, which together constitute the 
plakin domain. The NN, Z, Y, X, W, and V subdomains are composed of short heptad 
repeats (<4) thought to form a-helices, which in turn form antiparallel bundles. 
Nonhelical regions separate the antiparallel bundles and thus the subdomains (Green et 
al., 1992; Ruhrberg et al., 1996). The plakin subdomains are thought to fold such that 
they form an elongated globular domain (Green et al., 1992; O'Keefe et al., 1989; Tang 
et al., 1996).
The plakin domain of the conventional plakins acts as a protein-protein interaction
domain and is thought to be important for targeting plakin proteins to membrane
attachment sites (Jefferson et al., 2004). BPAGle localises to the hemidesmosome, via
interactions of the N-terminus with the transmembrane proteins BP 180 and |34-integrin
(Koster et al., 2003). The interaction with BP180 requires the Y subdomain of the
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plakin domain. The N-terminal extension of BPAGle, unique to this isoform, is 
essential for the interaction of the protein with the (34-integrin tail and is stabilised by 
the NN subdomain (Koster et al., 2003). The desmoplakin plakin domain is important 
for orchestrating many of the interactions of desmoplakin at the desmosomal plaque. 
The region involved in interactions with plakoglobin and plakophilin proteins includes 
the NN, Z, Y and most of the X subdomain of desmoplakin (Bomslaeger et al., 2001; 
Kowalczyk et al., 1997).
In the case of plectin and the spectraplakins, such as MACF1 and BPAGla and b, little 
is known about the interaction partners of the plakin domain (Jefferson et al., 2004).
The plakin domains of envoplakin and periplakin have the same predicted structure as 
that of other plakin family members. Preceding the plakin domain, envoplakin has an N- 
terminal extension containing two tandem pairs of KGSP repeats, which are not found 
in other plakin family members and may constitute a PKC phosphorylation site 
(Ruhrberg et al., 1997; Ruhrberg et al., 1996).
Since the plakin domains of BPAGle and desmoplakin mediate the interaction of the 
protein with plasma membrane attachment sites and the envoplakin and periplakin 
plakin domains have a similar predicted structure it was thought that the envoplakin and 
periplakin plakin domains may mediate their localisation to desmosomal and 
interdesmosomal plasma membrane sites. In the case of desmoplakin an N-terminal 
fragment encoding the NN, Z, Y and most of the X subdomains was sufficient to 
localise the protein to plasma membrane attachment sites (Bomslaeger et al., 1996). A 
similar construct of envoplakin (E1/2N, encoding the first 500 amino acids) does not 
efficiently localise to the desmosomes or the interdesmosomal plasma membrane 
(DiColandrea et al., 2000).
In contrast to envoplakin, expression of full length periplakin by transient transfection 
of primary keratinocytes does not cause the formation of protein aggregates. Full length 
periplakin localises to the apical plasma membrane and partially colocalises with 
desmoplakin at the desmosomes (DiColandrea et al., 2000). The first 495 amino acids 
of periplakin (P1/2N), encoding all of the NN, Z, Y and X subdomains^ localise 
efficiently to the apical plasma membrane but hav«limited colocalisation with
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desmoplakin (DiColandrea et al., 2000). At the apical plasma membrane, periplakin 
P1/2N localises to microvilli colocalising there with CD44 and actin (DiColandrea et 
al., 2000). Transfected periplakin P1/2N and endogenous periplakin of stratified 
keratinocyte cultures redistributes to actin-rich patches upon depolymerisation of the 
actin cytoskeleton by latrunculin B or cytochalasin D (DiColandrea et al., 2000).
1.6 Aims of thesis
Periplakin and envoplakin localise to the desmosome and interdesmosomal plasma 
membrane. The localisation of periplakin and envoplakin proteins at the plasma 
membrane, particularly the interdesmosomal plasma membrane, is thought to be 
important for the formation of the CE scaffold onto which the final CE structure is 
assembled (Ma and Sun, 1986; Ruhrberg et al., 1997; Ruhrberg et al., 1996; Steinert and 
Marekov, 1999).
The aim of my thesis was to understand how periplakin and envoplakin localise to the 
plasma membrane. Analysis of envoplakin E1/2N suggests that when transfected this 
domain does not efficiently localise to the desmosomes or microvilli (DiColandrea et 
al., 2000). Thus it was of interest to understand which domains of envoplakin are 
important for its localisation to the desmosomal and interdesmosomal plasma 
membrane and to understand the function of the KGSP repeats at the N-terminus of 
envoplakin, which are not found in other plakin family members.
Results suggest that periplakin can localise to the desmosomes and interdesmosomal 
plasma membrane independently of envoplakin (DiColandrea et al., 2000; Kalinin et al., 
2004). Thus it was of interest to understand how periplakin associates with the actin 
cytoskeleton at the interdesmosomal plasma membrane as this may help us to 
understand more about the initiation of formation of the CE.
Yeast two-hybrid analysis, using the periplakin N-terminus as bait, identified a novel 
protein, which we have named kazrin. I shall describe my analysis of the kazrin gene, 
kazrin mRNA expression and the localisation of endogenous and transfected kazrin 
proteins in primary human keratinocytes.
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In my thesis I describe analysis of triple envoplakin, periplakin and involucrin knock­
out mice generated from the single knock-out mice (Aho et al., 2004; Djian et al., 2000; 
Maatta et al., 2001). Triple knock-out mice were analysed in order to understand further 
the role of envoplakin, periplakin and involucrin in the formation of the CE and the 
water permeability barrier of the skin.
My thesis provides further insight into the role of periplakin and envoplakin in the 
formation of the comified envelope.
Some of the data described in this thesis have been published:
Maatta, A., DiColandrea, T., Groot, K. and Watt, F.M. (2001) Gene targeting of 
envoplakin, a cytoskeletal linker protein and precursor of the epidermal cornified 
envelope. Mol Cell Biol, 21, 7047-7053.
Groot, K.R., Sevilla, L.M., Nishi, K., DiColandrea, T. and Watt, F.M. (2004) Kazrin, a 
novel periplakin-interacting protein associated with desmosomes and the keratinocyte 
plasma membrane. J  Cell Biol, 166, 653-659.
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Chapter 2. Materials and Methods
2.1 Molecular Biology
2.1.1 General solutions
General solutions were supplied by Cancer Research UK (CR-UK) Central Services. 
L-broth (LB) (CR-UK)
L-broth (LB) for bacterial culture comprised 1% Bacto-Tryptone (Difco), 0.5% yeast 
extract (Difco) and 170mM NaCl and was sterilised by autoclaving.
L-asar (CR-UK)
L-agar comprised 1.5% bacto-agar (Difco, w/v) in LB. The agar was dissolved by 
heating in a microwave oven and allowed to cool to 50°C before adding the selection 
antibiotic. The solution was then poured into 100mm bacteriological petri dishes and 
left to set on a level platform. Agar dishes were stored at 4°C, agar side up.
Antibiotic stock solutions
Ampicillin (Sigma, stock 100 mg/ml in dH20 ) was used as a selection antibiotic and 
was added to LB or L-agar to a final concentration of 100 p,g/ml. Kanamycin (Sigma, 
lOmg/ml stock in dH20 )  was used to select at a final concentration of 50p,g/ml
Tris/EDTA buffer (TE)
TE was used as a general storage buffer for DNA and comprised lOmM Tris-HCl and 
ImM EDTA, pH8.0.
Tris-acetate-EDTA buffer (TAE)
A  50x stock solution was prepared by dissolving 242g Trizma base and 57.1ml glacial 
acetic acid (BDH) in dH20 . 100ml 0.5M EDTA, pH8.0 were added and the final 
volume was made up to 11.
Agarose/TAE gel
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This was used in the electrophoresis of DNA. 0.8-2% (w/v) ultra pure agarose (Gibco 
BRL) was melted in a microwave oven in lx  TAE buffer. Ethidium bromide was added 
at 0.05 pg/ml to agarose solution before casting in gel mould. Typically, DNA was 
electrophoresed at constant voltage of 80-100V in lx  TAE buffer.
DNA loading buffer
6x DNA gel loading buffer comprised 0.25% bromophenol blue (Sigma), 0.25% xylene 
cyanol (Sigma) and 30% (v/v) glycerol in dH20 . The loading buffer was stored at RT.
2.1.2 DNA techniques
Polymerase Chain Reaction (PCR) for cloning
PCRs were carried out using PWO (Roche), a high fidelity polymerase, lacking 
nuclease activity but retaining proofreading activity, which generates blunt ended PCR 
products.
PCR reaction mix: 25ng template DNA (plasmid containing sequence of interest)
0.5 units PWO (Roche)
0.2pM dNTP (Roche)
0.5 pmol of each primer
lx buffer with MgCl2 as provided with kit
in total volume of 50 pi
In the case of PCRs of kazrin A and B fragments DMSO was added to 5% in order to 
improve PCR efficiency.
PCR reactions conditions: PCRs were typically carried out using the program below:
l:Initial denaturing step, 94°C for 2 mins
2:Denature at 94°C for 30 secs
3: Annealing carried out at 55 to 65°C for 30 secs
4: Extension at 72°C for 1 min per kilobase of sequence being amplified
5: steps 2 to 4 were repeated 30 times
6: Extension was completed with 2 mins at 72°C.
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Enzymatic manipulation o f DNA fragments
Restriction enzymes and T4 DNA ligase were purchased from NEB and used for 
restriction digestions and DNA ligations, respectively. Calf intestinal alkaline 
phosphatase (Boehringer Mannheim) was used to remove 5’ phosphate groups from 
vector DNA fragments to prevent vector religation, without the incorporation of insert 
DNA (containing 5’ phosphate groups) in ligation reactions.
Bacterial transformation
One Shot TOPIO competent E. coli (Invitrogen) were used for cloning of DNA. 0.1 [xg 
DNA from ligations or lng of plasmid DNA was added to a 25 pi aliquot of competent 
cells. The transformation was performed by heat shock according to the Manufacturer’s 
instructions. BL21 cells (Amersham Pharmacia Biotech), used for production of 
bacterially expressed GST fusion proteins, were transformed by heat shock as per 
Manufacturer’s instructions.
Preparation o f plasmid DNA
To screen colonies after ligation and transformation, single colonies were picked and 
inoculated in 5 ml LB media containing the appropriate antibiotic, then grown overnight 
in a 37°C agitator. 2 ml of the overnight culture was used for small scale preparation of 
plasmid DNA whilst the remainder was stored at 4°C. Qiagen mini-prep kits (Qiagen 
Ltd.) were used for this initial plasmid purification.
For maxi preparations, 0.5 ml of the overnight culture was added to 200 ml LB plus 
antibiotic and incubated overnight at 37°C in an agitator. Bacteria were pelleted by 
centrifugation at 6000 g for 15 min in a Beckman J2-21 centrifuge. The plasmid 
DNA was then purified using a Qiagen maxi kit according to the Manufacturer’s 
instructions.
Quantitation o f nucleic acids
Nucleic acids were diluted in 10 mM Tris-HCl pH 8.5 and placed in disposable plastic 
UVettes (Eppendorf). Absorbance at 260nm and 280nm was read in an Eppendorf 
BioPhotometer with the correct DNA or RNA program set-up.
Purification o f PCR or restriction enzyme digestion products
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Reactions were run out on agarose gels. DNA fragments were visualised by ethidium 
bromide under low power UV light. Bands were excised using clean scalpels. Agarose 
gel fragments were melted and the DNA isolated using the QIAGEN gel extraction kit 
according to the Manufacturer’s instructions.
2.1.3 Vectors and primers
IMAGE clones
IMAGE clones containing the cDNAs encoding mouse kazrin a (No. 3667377), human 
kazrin a (No.6180253), human kazrin b (No.4556194), human kazrin c (No.4651187), 
or human kazrin d (No. 4472821) were obtained from the MRC UK HGMP Resource 
Centre (Cambridge) and confirmed by sequencing the 5 ’ UTRs and coding regions. 
Sequencing reactions were set up as described below.
Vectors
pCINeo (Promega) for transient transfection of mammalian cells
pEFlink-HA in pUC12 for transfection of N-terminal H A -tagged proteins in
mammalian cells
pCINeo-F9 as described DiColandrea et al. (2000) for transfection of N-or C-terminally 
FLAGrtagged proteins in mammalian cells
pGEX6P-l (Amersham Pharmacia Biotech) for expression of GST fusion proteins in E. 
coli
pCR-Blunt (Invitrogen) for subcloning PCR fragments
pGBKT7 (Clontech) for yeast two-hybrid screening. pGBKT7 encodes the GAL4 
DNA-binding domain which can be fused upstream of a bait protein. pGBKT7 can be 
selected for in yeast by growth in media lacking tryptophan
pGADIO (Clontech) was used for yeast two-hybrid screening. pGADT7 encodes the 
GAL4 AD which can be fused upstream of a prey protein. pGADT7 can be selected for 
in yeast by growth in media lacking leucine
Vectors were digested as described below. The resulting fragments were purified and 
treated with CIP to remove 5’ phosphate groups and thus prevent re-ligation of the 
vector in the absence of insert DNA. Ligations were set up with a molar ratio of vector 
to insert of 1:1 and 1:3 or 1:5. Ligations were set up with lxT4 ligase buffer and 1 unit 
T4 ligase (NEB).
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Primers and cloning strategies.
Envoplakin primers were used to amplify DNA, which was inserted into the pCI-neo-F9 
vector (pre-digested with Smal) such that the envoplakin protein encoded was tagged at 
its C-terminus with a FLAG tag (Table 2.1).
Table 2.1 Envoplakin cloning primers
Primer Name Sequence
hEnvN500R.dir AAGGCCAGTGCTGTGGAGTCTCTTCGGCCCAGC
hEnvN500R.rev AGGGCTCTCGGAGCCCTGCTTTGCATCATGGGT
EnvNl.dir GCCACCATGTTCAAGGGGCTGAGCAAAGGCTCCCAG
EnvX.rev CCGAAGAGACTCCACAGCACTGGCCTTCAG
EnvN41.dir CTTCTCATCTCCCGCATGCAAGCCAACGCC
Env27.dir TCCCCCAGCAGGCACAGCCGGGCTGCCACC
hEnvN41.rev AAGGGCCAGCTCCTGGGTGGCAGCCCGGCTGTG
hEnvN32.rev GCTGTGCCTGCTGGGGGAGCCTTTGGG
hEnvN117.rev CTTCTCAATCTCCTCAGCCTGCGGGTGC
hEnvNlOO.rev GTCCAGGAAGAGGTCCTTGAGCAGCAC
hEnvN139.rev CTTCTCGTACAGGGCACGGTACTCCGCAC
Periplakin cloning primers were used to generate DNA fragments which were ligated 
into pCI-neo vectors pre-digested with EcoRI and Sail thus producing vectors encoding 
periplakin tagged with a HA tag at the C-terminus (Table 2.2).
Table 2.2 Periplakin cloning primers
Primer Name Sequence
P63+HA+STOP.rev CT AAGCGT AGTCTGGC ACGTCGT ATGGGT ACCG ACCCTCCTGC AGCCG AGCC 
AGGTCACTCTG
PI 33+HA+STOP.rev CT AAGCGTAGTCTGGCACGTCGTATGGGTAATCCACTTCCTTCACCGCCAGC 
CTGTAG
P80+HA+STOP.rev CTAAGCGTAGTCTGGCACGTCGTATGGGTACTTCTCAGAGTCCAACACCTTC
TGCAGGGTCAC
P16+koz/atg+EcoRl .dir GCGAATTCCGAGCGCCACCATGACTGTGCAGACCCGGAGCATCTC
P1 +koz+ATG+EcoRl .dir GCGAATTCCGAGCGCCACCATGAACTCGCTCTTCAGG
Periplakin PCR products, generated from the primers listed below, were used to 
generate yeast two-hybrid GAL4 DNA binding domain fusion proteins as used in the 
yeast two-hybrid screen which is described in more detail below. The yeast two-hybrid 
vector pGBKT7 was pre-digested with EcoRI and Sail (Table 2.3).
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Table 2.3 Yeast Two-Hybrid Periplakin cloning primers
Primer Name Sequence
P133PP-RlSal CGTCG AC ATCC ACTTCCTTC ACCGCC AGCCTGT A
PI 6 fwd-EcoRl CGAATTCACTGTGCAGACCCGGAGCATCTCTAACAAG
P80 rev-Sall CGTCGACCTTCTCAGAGTCCAACACCTTCTGCAGGGTCAC
P63 rev-Sall CGTCGACCCGACCCTCCTGCAGCCGAGCCAGGTCACTCTG
P500F1-EcoRI CGAATTCATGAACTCGCTCTTCAGGAAGAGAAAC
Kazrin yeast two-hybrid constructs were made by PCR amplification using the primers 
shown in Table 2.4. PCR fragments were digested with EcoRI/XhoI and inserted into a 
similarly digested pGADIO vector.
Table 2.4 Kazrin yeast-two4iybrid cloning primers
Primer Name Sequence
KC1 fwd CTATTCGATGATGAAGATACCCCACCAAA.CC
KC89 fwd GGAATTCCACCGCAAGGAGAGCGAGGATGCGGTCAAA
KC164 fwd GGAATTCCATTCCCTCGCCATGCCGGGCGAGACGGTG
KC240 fwd GGAATTCCCGAGCGACATCAACTCCCCTCGACACCGGACA
KC327 rev GTGAACTTG CGGGGTTTTTCAGTATCTACGAT
KC239 rev GCTCGAGTCATGTGGACGACCGGTCGCCTTCGGCGGCAGA
KC163 rev GCTCGAGTCACCGCTTGGGGACGTCCTTGGTCAGCGTAGC
KC88 rev GCTCGAGTCACTGCTCATAGTTGCGGATGAAGTCTCGGAG
The primers listed below were used for RT-PCR reactions to identify the kazrin mRNA 
isoforms expressed in different cell types (Table 2.5).
Table 2.5 Kazrin alternative splicing primers
Primer Name Sequence
KIAA-5'- R1 CTCTCCTTGCGGTGCTGCTCATAGTTG
KIAA-5'control - FI GGCAGATGAAGGAGATGTTGGCGAAGG
KIAA-la-5' - FI GTGACCAACCTGCGAGCCGAACTC
KIAA-lb-5' - FI GCAGCCTGCGAGCAGTGCGTGGACG
KIAA-lc-5' - FI TTGGAGGAAATTCGGAACCAGAAGAGTG
KIAA-ld-5' - FI CCAGTTCCAGAACCACTGCTCTTCACTG
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Kazrin HA primers were used to generate DNA fragments which were inserted into 
EFplink -H A  in pUC12 predigested with BamHI and EcoRI in the case of kazrin A and 
B, or pre-digested with EcoRI alone in the case of kazrin C (Table 2.6).
Table 2.6 Kazrin HA transfection vector construction
Primer Name Sequence
1A GCGGGATCCATGATGGAAGACAATAAG
IB CGGGGATCCATGCGGGCGGCCGACTCG
1C GGAATTCGCCACCATGAAGGAGATGTTGGCGAAGGACCTGGAG
3’ GCGGAATTCTCACCAGTCCGCGTCCTC
Kazrin GST fusion constructs were made using the pGEX-6P-l vector. A construct 
encoding GST protein fused to amino acids 49-327 of human kazrin C was made by 
excising the original clone obtained from the yeast two-hybrid screen with EcoRI and 
Xhol, followed by ligation into similarly digested pGEX-6P-l. A vector encoding GST 
protein fused to kazrin C was amplified using the primers listed in Table 2.7. The PCR 
fragment was digested with EcoRI and Sail and inserted into a similarly digested 
pGEX-6P-l vector. The 3 ’ primer was used in conjuction with 5 ’ primers 1A and IB 
listed in Table 2.6 to generate PCR fragments which were digested with BamHI and 
EcoRI. PCR fragments were inserted into similarly digested pGEX-6P-l vectors.
Table 2.7 Kazrin GST fusion protein vector construction
Primer Name Sequence
1C GGAATTCGCCACCATGAAGGAGATGTTGGCGAAGGACCTGGAG
3’ GGTCGACTCACCAGTCCGCGTCCTCCTCTATGTAATA
DNA sequencing
In cases where the insert of a construct was generated by PCR the whole insert sequence 
was analysed. In cases where a fragment was subcloned from one vector to another the 
borders of the cloning sites were sequenced. Sequencing reactions were set up using 
BigDyeTerminator mix as made by the Equipment Park (CR-UK). Sequencing reactions 
were set up according to the Manufacturer’s instructions and purified using DyeEx spin 
columns (QIAGEN). Samples were run on capillary sequencing gels (Prism 3730) by 
the Equipment park (CR-UK).
IMAGE clones were sequenced to confirm that the sequence data available on the 
public database were correct. Kazrin a, kazrin b, kazrin c and kazrin d coding sequences 
and 5’UTRs were submitted to GenBank/EMBL/DDBJ under accession numbers 
AY505119, AY505120, AY505121, and AY505122 respectively.
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Primers used for sequencing were either conventional sequencing primers, such as T7, 
T3, Sp6 , M13rev, M l3 forward, were primers previously used for cloning purposes, or 
were specifically designed for sequencing. Primers used specifically for sequencing are 
listed in Table 2.8.
2.8 Sequencing primers
Primer name Primer sequence
T7 AATACGACTCACTATAG
T3 ATTAACCCTCACTAAAC
Sp6 CATACGATTTAGGTGACACTATAG
M l3 reverse CAGGAAACAGCTATGAC
M l3 forward GTAAAACGACGGCCAGT
Envoplakin 1 TGAAGGCCTCGGAGCACGCATGCGCT
Envoplakin 2 CCTACCGCTGCTCTTTGGAGCCCAC
Envoplakin 3 CCCACACCCTTGGAGGACTT
Envoplakin 4 CCGTGCCCTGTACGAGAAGAT
Envoplakin 5 GGAGTACGAGCACTTCAAGC
Envoplakin 6 CCCACACCCTTGGAGGACTTG
Envoplakin 7 CCGTGCCCTGT ACG AG A AG ATG
Kazrin 1 TTGAGACCGCTGCTGTTC
Kazrin 2 ACCACGGGGTCAATGTTCTGC
Kazrin 3 GGCATGCGGGCGGCCGACTC
Kazrin 4 GGACATCAAAAACAGACCAC
Kazrin 5 ATTCGGAACCAGAAGAGTG
Kazrin 6 ATCTGTCCTCAGGCATTGGC
Kazrin 7 CG AGGG AC ATTT AC AAGC AC
Kazrin 8 CAAAAACAGACCACATCCTC
Kazrin 9 GTTTTCACTTGTTAGAGGCG
Kazrin 10 AACCTGCGAGCCGAACTC
Kazrin 11 TCCGAGACTTCATCCGCAAC
Kazrin 12 AACAGACTCTCTACCACTCACAC
Kazrin 13 GGCAGATGAAGGAGATGTT
Kazrin 14 TCACCAGGTCTGTCTTCTCG
Kazrin 15 ACACCGAGCGACATCAACTC
Kazrin 16 ACATCTCCTTCATCTGCCG
Kazrin 17 AAGGCTTCTTTGGCTCTG
Kazrin 18 AGAGCCAAAGAAGCCTTG
60
2.1.4 RNA techniques
RadiolabellinQ o f probes for Northern blottinn
50ng gel-purified DNA fragments were denatured at 95°C for 5 minutes and 
radiolabelled by random priming using the Rediprime DNA labelling system 
(Amersham) and 50pCi [32P]-a-dCTP (ICN). The kit was essentially based on the 
method of Feinberg and Vogelstein (Feinberg and Vogelstein, 1983) with the exception 
that the heat-denatured DNA fragments were labelled for only 30 minutes at 37°C, 
using nonamers as primers instead of hexamers. Un-incorporated [32P]-a-dCTP was 
removed using a Nick column (Pharmacia).
Northern blotting
A MessageMap Northern blot of multiple tissues from BALB-c mice (Stratagene) was 
used according to the Manufacturer’s instructions. The kazrin probe was made by 
digestion of the IMAGE clone 3667377, encoding mouse kazrin a, with Afel/Xhol. The 
probe was 585bp long, corresponding to nucleotides 755 to 1340 of the mouse kazrin A 
mRNA. This probe was able to recognise both kazrin a and b mRNAs. A (3-actin control 
probe was supplied by Stratagene. Northern blots were exposed to Kodak X-Omat film 
at -80°C with an intensifying screen.
2.2 Yeast techniques
2.2.1 Yeast two-hybrid screening
Yeast two-hybrid protein interaction experiments and library screenings were performed 
using the MATCHMAKER GAL4 two-hybrid system 3 (BD Biosciences) according to 
the Manufacturer’s’s instructions. The host yeast strain was AH109 (MATa, trp-901, 
leu2-3, 112, ura3-52, his3-200, gal4D, gal80D, LYS2::GAL1UAS-GAL1TATA-HIS3, 
MEL1, GAL2UAS-GAL2TATA-ADE2, URA3::MELlUAS-MELlTATA-lacZ). The 
plasmids pGBKT7 and pGADIO were used as the DNA-BD cloning vector and the AD 
cloning vector, respectively. Yeast were transformed by the modified lithium acetate 
method, using YEASTMAKER™ Yeast Transformation System 2 according to the 
Manufacturer’s protocol (BD Biosciences).
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The AH 109 yeast host strain was transformed with the bait plasmid and a human 
keratinocyte MATCHMAKER™ cDNA library in the cloning vector pGADlO. 
Interactions were screened by the ability of cells to grow on selective medium (lacking 
leucine, tryptophan, histidine, and adenine) for 7 days at 28°C. Colonies that appeared 
were restreaked onto SD agar, lacking leucine and tryptophan (L T ), but containing X- 
a-G al (BD Biosciences), a chromogenic substrate used to detect a-galactosidase 
activity derived from the MEL1 gene. The pGADIO plasmids from positive blue yeast 
colonies were identified by PCR sequencing. A single clone was obtained during 
screening that was successfully reconfirmed by co-transformation. The sequence was 
rescued by yeast plasmid rescue using YEASTMAKER™ plasmid isolation kit (BD 
Biosciences) according to the Manufacturer’s instructions. The rescued plasmids were 
sequenced and found to encode part of the predicted protein KIAA1026 (kazrin). 
Library screening, reconfirmation and the identification of KIAA1026 was kindly 
performed by Kazunori Nishi (Keratinocyte laboratory, CR-UK).
2.2.2 Yeast transformation
To map the interaction between periplakin and kazrin further yeast transformations were 
carried out. Constructs used in the analysis are listed above. Solutions necessary for 
yeast transformations are listed in Table 2.9
Transformation-competent yeast were made by growing the yeast overnight on YPD 
agar at 30°C. Cells were scraped off the following day using a sterile bacterial loop, and 
swirled into 1ml dH20. Yeast were spun down at 700g for 5mins and resuspended in 
lml solution 1. Yeast were again spun down and resuspended in a volume equivalent to 
50pl per transformation reaction to be carried out.
Each transformation was carried out using 1 pig bait plasmid (pGBKT7) and 1 pig prey 
(pGAD) and 5 pi herring testes carrier DNA (heated to 100°C for 5 mins to linearise the 
DNA and cooled on ice for 5 mins prior to use).
The DNAs were mixed and 50pl competent yeast added. Solution 2 (500pl per
transformation) was added and the cells mixed thoroughly. Cells were incubated at 30°C
for 30 mins and mixed every 10 mins. DMSO (20pl) was added and the cells incubated
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Table 2.9 Yeast transformation solutions and agars
Solution 1 1.1 xTE +1.1 xLiAc in dH20
Solution 2 lxTE + lx  Li Ac + 40% polyethylene glycol (PEG)
Solution 3 0.9% sterile NaCl
YPD agar 10% yeast extract, 20% Bacto-Petone, 20% D-glucose, 20% agar
L'T' agar 6.7% yeast nitrogen base, 20% D-glucose, 20% agar plus 
MATCHMAKER™ yeast transformation kit supplements lacking 
leucine and thymine. L'T' agar selects for presence of prey and bait 
vectors in the transformed yeast.
A'T'H'L'agar 6.7% yeast nitrogen base, 20% D-glucose, 20% agar plus 
MATCHMAKER™ yeast transformation kit supplements lacking 
adenine, leucine, histidine and thymine. A'T'H'L'agar selects for 
presence of prey and bait vectors and interaction of the proteins of 
interest they encode, in the transformed yeast.
lOx TE, lOx Li Ac and 50% PEG stocks were provided with the MATCHMAKER™ 
yeast two-hybrid kit.
at 42°C for 15mins, with mixing every 5mins. Cells were spun down and resuspended in 
120pi solution 3. 60pi was spread on an L'T' control plate and 60pl on a selective A'L' 
T'H' plate. Yeast were grown at 30°C for 4-6 days prior to analysis of growth. 
Individual roughly equal-sized yeast colonies grown on the L'T' plates were diluted in 
lOOpl dH20, a 5pl drop of this was put onto L'T' and A'L'T'H" plates and grown for 2-4 
days at 30°C, in order to accurately score growth or lack of growth on selective 
medium.
2.3 Computer analysis
2.3.1 Computer analysis of the predicted nucleotide sequences
The BLAST 2.0 (NCBI, Bethesda, MD) and BLAT (Golden Path Genome Browser, 
Santa Cruz, CA) programs were used to search mouse and human EST databases and 
genome sequences in order to identify the kazrin mRNA isoforms and genomic layout.
63
2.3.2 Computational analysis of the predicted amino acid sequences
BLAST 2.0 (NCBI, Bethesda, MD) searches were carried of human, mouse and non- 
mouse/non-human EST databases to search for homologies between kazrin and other 
known proteins and to analyse the sequence conservation between species. Mac Vector
6.5.3 (International Biotechnologies Inc., Cambridge, UK) was used for sequence 
alignments, analysis of hydrophilicity, and for predictions of secondary structure and 
the presence of transmembrane domains, molecular weight predictions and analysis of 
the relative amino acid compositions. Coiled-coil analyses were performed using 
COILS version 2.2 (Lupas et al., 1991). Nuclear localisation signals were analysed by 
NLS on Prosite (Cokol et al., 2000). Protein domain searches were performed through 
Pfam 10.0 at the Sanger Centre (Cambridge, UK) and CD-search at the NCBI 
(Bethesda, MD).
2.4 Cell Culture
2.4.1 General solutions
The Central Cell Services of CR-UK provided sterile distilled deionised water (dH20 ) 
and solutions that are indicated by “CR-UK”. All reagents used were of tissue culture 
grade and kept sterile.
Phosphate buffered saline (PBS. CR-UK)
8g NaCl, 0.25g KC1, 1.43g Na2H P04 and 0.25g KH2P 0 4 were dissolved in 11 dH20 , the 
pH was adjusted to 7.2 and the solution was autoclaved. PBS was supplemented with 
ImM CaCl2 (B) and ImM MgCl2 (C) to make PBS-ABC.
EDTA solution (versene. CR-UK)
8g NaCl, 0.2g KC1,1.15g Na2H P04,0.2g KH2P 0 4 and 0.2g ethyldiaminotetraacetic acid 
(EDTA) and 1.5ml 1% (w/v) phenol red solution were dissolved in 11 dH20 , the pH was 
adjusted to 7.2 and the solution was autoclaved.
Trypsin solution (CR-UK)
8g NaCl, O.lg Na2HP04, lg  D-glucose, 3g Trizma Base, 2ml 19% (w/v) KC1 solution 
and 1.5ml of 1% phenol red solution were dissolved in 200ml dH20 ,  the pH was
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adjusted to 7.7 and 0.06g penicillin and O.lg streptomycin (Gibco BRL) were added. 
2.5g pig trypsin (Difco, 1:250) was dissolved in 200ml dH20 ; air was bubbled through 
the solution until the trypsin dissolved. The trypsin solution was added to Tris-buffered 
saline, made up to 11 with dH20 , sterilised by filtration through a 0.22pm filter 
(Millipore) and stored at -20°C.
Mitomvcin C stock solution
Mitomycin C is an inhibitor of DNA synthesis and nuclear division (Tomasz et al., 
1987). It is used to metabolically inactivate J2-3T3 cells for the keratinocyte cultures. 
4mg mitomycin C powder (Sigma) was dissolved in 10ml PBS. The stock solution (0.4 
mg/ml) was sterilised by filtration through a 0 .2 2 pm filter, aliquoted and stored at - 
20°C. In the treatment of J2-3T3 cells, mitomycin C solution was added to the cell 
culture medium at a final concentration of 0.4 pg/ml.
2.4.2 Cultured cell types
Human epidermal keratinocytes were isolated from neonatal foreskins, grown and 
serially passaged as described below. J2-3T3 cells were used as feeder cells to support 
human keratinocyte growth. Primary mouse keratinocytes were isolated from 3-4 day 
old mice as described below, and cultured to generate cell lines.
HeLa, NIH-3T3, EJ-28, COS and A431 cells were obtained from ATCC. Cells were all 
grown in E4 with 10% FBS and passaged every few days at a density of 1:6-12. Cells 
lines were transfected for isolation of protein lysates or the analysis of cells by 
immunofluorescence. Cells lines were transfected with Polyfect-TM (QIAGEN), 
Gene Juice (Novagen), or in the case of COS cells Lipofectamine-2000 (Invitrogen), 
according to the Manufacturer’s instructions.
All cells, except for primary mouse keratinocytes, were cultured on plastic dishes or 
flasks of tissue culture grade (Falcon) in a humidified incubator at 37°C with 5% C 0 2. 
Primary mouse keratinocytes were cultured on Biocoat Collagen I -  coated dishes (BD 
Biosciences) at 32°C, 5% C 0 2 , as above.
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Media or any solutions added to cells were first warmed to 37°C. All cells were 
confirmed by the CR-UK Cell Production Unit as being negative for mycoplasma 
infection. Any cells with mycoplasma contamination were discarded.
2.4.3 J2-3T3 feeder cells
J2-3T3 cell cultures
Clone J2 of 3T3 Swiss mouse embryo fibroblasts is a clone selected for its ability to 
support keratinocyte growth (Rheinwald and Green, 1975; Watt, 1998). J2-3T3 cells 
were cultured in Dulbecco's modification of Eagle’s medium (DMEM) (E4, CR-UK) 
supplemented with 10% (v/v) donor calf serum (DCS, Gibco BRL). When J2 cells 
approached confluence they were harvested by rinsing with versene and incubating at 
37°C in trypsin diluted 1:5 in versene for 5 min. The trypsin was subsequently 
inactivated by dilution in serum-containing culture medium and the cells replated at a 
dilution of 1:10 or 1:20. J2-3T3 cells were replaced every 6-9 weeks with a new batch 
of low-passage cells to avoid overgrowth of transformed J2-3T3s.
Freezing and thaw ins ofJ2-3T3 cells
Cells were harvested as described above and pelleted. Cells obtained were resuspended 
in DCS containing 10% (v/v) sterile dimethyl sulphoxide (Gibco BRL). Cell 
suspensions from a confluent 75cm2 flask were aliquoted into 4-6 cryovials (Nunc). 
Cryovials were stored in an insulated box at -70°C overnight and subsequently 
transferred to liquid nitrogen for long term storage. Cells were thawed by transferring 
the cryotube of cells from liquid nitrogen directly to a water bath at 37°C. As soon as 
the cell suspension was thawed, it was added to 10ml medium and centrifuged at 
2 0 0  5 for 3 min. The recovered cells were resuspended into 15 ml medium and 
plated onto a 75cm2 flask.
2.4.4 Primary human keratinocytes
Keratinocyte culture medium (FAD + FCS + HICE)
FAD powder (F I2 + adenine + DMEM: Imperial Labs) was supplemented with 3.07 g/1 
NaHC03, 100 IU/1 penicillin and 100 jxg/1 streptomycin. FAD medium (CR-UK) was 
bubbled with C 0 2 until the pH dropped below 7.0, then sterilised by filtration through a 
0.22p,m filter. Medium was stored at 4°C until use.
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Stock solutions of additives were kindly prepared by Simon Broad (Keratinocyte Lab, 
CR-UK). 10'5 M cholera enterotoxin (ICN) was stored at 4°C. Hydrocortisone 
(Calbiochem) was dissolved in 95% ethanol at 5 mg/ml and stored at -20°C. 100 mg/ml 
recombinant human epidermal growth factor (Peprotech) was prepared by first 
dissolving in 1/100 volume 0.1M acetic acid (BDH) before adding to FAD medium 
containing 10% (v/v) batch-tested foetal calf serum (FCS, Imperial Labs.) and stored at 
-20°C. The additives were combined into a lOOOx stock solution (HCE): 1ml 
hydrocortisone, 100pi cholera enterotoxin and 1ml epidermal growth factor stock 
solutions were added to 7.9ml FAD medium with 10% FCS and stored at -20°C. The 
final concentrations in the medium were 10 10 M cholera enterotoxin, 0.5 pg /m l 
hydrocortisone and 10 ng/ml epidermal growth factor. lOOOx insulin stock solution (5 
mg/ml in 5mM HC1, Sigma) was stored at -20°C. The final concentration in the medium 
was 5pg/ml insulin. Complete keratinocyte medium (FAD + FCS + HICE) was 
prepared by adding 10% (v/v) FCS, lOOOx HCE stock solution and insulin solutions to 
the FAD medium prior to use (Watt, 1998).
Preparation o f J2-3T3 cells as feeder cells
The culture of human keratinocytes is supported by co-cultivation with mitotically 
inactivated J2-3T3 cells, which are referred to as feeder cells (Rheinwald and Green, 
1975). Feeder cells were incubated with 0.4 pg/ml mitomycin C for 2-3h at 37°C in 
order to inhibit mitosis. Cells were harvested and plated such that a 75cm2 flask of 
treated J2-3T3s was divided equally between 9x 25cm2 flasks. Keratinocytes were 
added within 24 hours of preparing the feeder layer.
Isolation o f primary human keratinocytes
Primary human keratinocytes were kindly prepared by Simon Broad (Keratinocyte 
Laboratory, CR-UK). Neonatal foreskins were provided with the informed consent of 
the parents. Isolation of primary keratinocytes was carried out as soon as possible after 
circumcision (Watt, 1998). Under sterile conditions, using a pair of forceps and curved 
scissors, a piece of foreskin was trimmed of dermal and fatty tissues. The foreskin was 
cut into pieces of about 5mm2 and transferred into a Wheaton Cellstir (Jencons) 
containing 5ml trypsin and 5ml versene and stirred over a magnetic stirrer at 37°C. 
Dissociated cells were collected every 30 min and added to 5ml keratinocyte culture
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medium. The number of cells obtained was counted using a haemocytometer. 
Dissociation of cells from the tissue was continued with addition of fresh versene and 
trypsin solution. This procedure was repeated 2 to 3 times before the number of cells 
obtained started to decrease. The yield from a neonatal foreskin was usually between 1- 
5x 107 cells. Feeder cells had been plated onto 25cm2 flasks in readiness. Isolated cells 
were pooled, pelleted and plated at a density of 105 cells per 25cm2 flask. Cells were 
cultured until just confluent. One flask of cells was tested for mycoplasma infection by 
the CR-UK Cell Production Unit, while the remaining cells were harvested and frozen 
at 106 cells per ml as for J2-3T3 cells.
Serial culture o f human keratinocytes
Frozen keratinocytes (passage 2-5) were thawed as described for J2-3T3 cells. The 
strains used were named km, kq, and kt. Each strain corresponds to keratinocytes 
isolated from a single individual. Cells were typically seeded at a density of l-2x 105 
per 25cm2 flask; keratinocytes which were freshly thawed were plated at a density of 4- 
8x 105 cells per 25cm2 flask to allow for loss of viability resulting from freezing and 
thawing.
Fresh medium was given to keratinocytes every 2 days. A day prior to any experimental 
manipulation, keratinocytes were fed with fresh medium. Keratinocytes were passaged 
just before they reached confluence. The cultures were rinsed once with versene and 
then incubated with versene for 5-10 min at 37°C. This treatment caused any remaining 
feeder cells to detach. Keratinocytes would round up but would not detach from the 
flask. The versene solution was discarded and the remaining keratinocytes were 
incubated in 5ml trypsin/versene solution (1 part trypsin and 4 parts versene) at 37°C 
for about 10 min, until all keratinocytes had detached from the flask. 5ml medium was 
added to the suspension and the number of cells was counted using a haemocytometer. 
The cells were pelleted and resuspended in medium as described and plated onto flasks 
with feeder cells. Keratinocytes could be cultured for up to 6-8  passages before they had 
to be discarded due to poor growth and excessive accumulation of terminally 
differentiated cells. Keratinocytes used for transfections were typically of early passage, 
passage 2-5.
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Depolvmerisation o f actin cytoskeleton
In some cases cells were treated with latrunculin B (Calbiochem) or cytochalasin D 
(Calbiochem) [or depolymerisation of the actin cytoskeleton prior to fixation. 
Latrunculin B (stock solution 400p,g/ml in DMSO, stored at -20°C for no longer than 3 
weeks) was used at a concentration of 200ng/ml for 3 hours. Cytochalasin D (stock 
solution 1.25mM in DMSO, stored at 4°C) was used at a concentration of 1.25pM for 2 
hours as per (Xia et al., 1996).
Transfection o f primary keratinocytes.
Primary keratinocytes were transfected on glass coverslips for immunofluorescence 
analysis. Glass coverslips were prepared as described below. Primary keratinocytes 
were harvested and plated at a density of 5-6.5x 105 per well of a 6 -well plate in 
FAD+FCS+HICE. Cells were allowed to adhere for 1-2 hrs before being rinsed twice in 
PBS to remove any cells not adhered. Cells were subsequently cultured overnight in 
keratinocyte serum-free medium (KSFM, Gibko BRL) supplemented with bovine 
pituitary extract and insulin (Invitrogen) as per the M anufacturer’s instructions. 
Keratinocytes were transfected with Fugene-6  (Roche). Fugene-6 , 6 p,l, was added to 
94p,l of DMEM (Invitrogen) and left for 5 mins at RT. Subsequently the DMEM- 
Fugene mixture was added to 2p,g of DNA to be transfected and mixed well by 
pippetting. The DMEM-DNA-Fugene mix was left at RT for 15-20 mins before 
addition of 700pl of KSFM with additives. The mixture was pippetted gently up and 
down twice before being added to the keratinocytes, which had been pre-washed in 
PBS. The transfection mixture , was left on the cells at 37°C for 2hrs. Following 
transfection, cells were rinsed twice with KSFM with additives, to remove any 
remaining transfection mixture and cultured overnight. Prior to fixation cells were 
grown in FAD+FCS+HICE for 1.5-5 hours. In the case of double transfections the total 
amount of DNA used was 2pg, using lp,g of each plasmid. In some cases the expression 
of one construct was more efficient than the other in this case the ratio of the two 
constructs was 1:2 , i.e. more of the construct that was harder to transfect.
In some cases transfected keratinocytes or keratinocyte cultures were treated with 
inhibitors of signalling molecules. The factors used are listed in Table 2.10
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Table 2.10 Inhibitors
Compound Target
molecule/s
Stock
solution
Working
concentration
Source/references
Bisindolylmaleimide
(G.mlV
PKC 5m M 5 pM Sigma (Martiny-Baron et 
al., 1993)
U0126
All stock solutions wer
MEK1/2 
e made up in
10 mM 
DMSO, aliq
10 pM
uoted and storec
Promega (Favata et al.,
1998)
at -20°C.
Keratinocytes treated with U0126 were treated from the time of transfection. Following 
overnight culture in KSFM with UO126, the keratinocytes were grown a further three 
hours in FAD+FCS+HICE in the presence of the inhibitor before fixation and analysis. 
In the case of BimI cells were treated with the inhibitor post-transfection for 20 mins in 
KSFM and a further 30 mins or 3 hours in FAD+FCS+HICE before fixation and 
analysis. Untransfected keratinocyte cultures were grown in FAD+FCS+HICE and 
treated as per post-transfected cells in the case of BimI, alternatively cells were treated 
with U0126 overnight in KSFM and a further three hours in FAD+FCS+HICE in the 
presence of U0126 prior to processing for immunofluorescence.
Quantitation o f cell shape and actin chanses
Human primary keratinocytes were transfected in parallel with HA-tagged kazrin 
isoforms or GFP vectors and analysed 16-18 hours post-transfection. Cells were stained 
for the HA tag and with phalloidin to stain the actin cytoskeleton and analysed ‘blindly’. 
Cells with loss of the cortical actin band and altered shape were scored as altered. Cells 
that could not be assigned to either the normal or altered group were excluded from the 
statistical analysis. Number of excluded cells/total number cells analysed were as 
follows; Kazrin A 134/437; Kazrin B, 93/380; Kazrin C, 80/421; GFP, 92/464. Data 
were pooled from three independent experiments and statistical analysis performed 
using GraphPad QuickCalcs software.
2.4.5 Mouse keratinocyte culture
Primary mouse keratinocyte culture medium
A low calcium FAD medium was used which was prepared in the same way as normal 
FAD except calcium salts were not included in the DMEM and F I2 formulations. The
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calcium present in the FCS used as a supplement was removed by treatment of the 
serum with Chelex deionising resin (Watt, 1984). Chelex treatment was carried out as 
follows: 300g of Chelex 100 resin (Biorad; 100-200 mesh, sodium form) were.added to 
4L of dH20  and stirred slowly at room temperature for at least an hour to generate a 
swollen resin form. The pH was adjusted to 7.0-7.5 with HC1 and the swollen resin was 
then recovered by filtering through a stericup (Millipore). The recovered Chelex was 
added to 1L of FCS and stirred at room temperature for 1 h before being allowed to sit 
undisturbed for 30-60 min. The Chelex was removed and the FCS sterilised by filtering 
through a 0.22pm stericup (Millipore). The sterile chelated FCS was then aliquoted and 
stored at -20°C. Complete low calcium FAD was prepared by adding 10 % chelated 
FCS to low calcium FAD supplemented with the HICE cocktail at the concentration 
used for standard complete FAD. Additionally, 1 % standard FAD was added to 
produce a final free calcium ion concentration of approximately 0.1 mM.
Isolation o f primary mouse keratinocytes
Keratinocyte isolation from mouse neonates was performed according to (Roper et al., 
2001). Newborn mice (2-4 days old) were killed and placed on ice for at least 1 hour. 
The mice were then washed sequentially with 10 % Pevidine and twice with 80 % 
ethanol. Under sterile conditions the tails, limbs and heads of the mice were amputated.
A longitudinal cut was then made along the backs of the mice and the skin removed 
with forceps. Harvested skins were spread out, epidermis side up, in petri dishes and 
covered with trypsin solution overnight at 4°C. The epidermis was then peeled off from 
the underlying dermis and minced into complete low calcium FAD using a pair of 
forceps. The released epidermal cells were pelleted by centrifugation at 2 oo j  for 3 
min. The pellet was resuspended in complete low calcium FAD and filtered through a 
70p,m cell strainer (to remove debris) onto Biocoat Collagen I-coated dishes (BD 
Biosciences). Typically, the cells isolated from 1 mouse were plated onto 1 well of a 6 - 
well plate. Periplakin null mice, a kind gift of S Aho (Thomas Jefferson University, 
Pennsylvania)(Aho et al., 2004), were used to generate a mouse keratinocyte line 
lacking periplakin expression (MKP-/-). Envoplakin null mice (Maatta et al., 2001) 
were used to generate a mouse keratinocyte line lacking envoplakin expression (MKE-/-).
MKWT cell line was generated from a wild type mouse. MKP-/-, MKE-/- and 
MKWT cell lines were grown in low calcium medium without a J2 feeder layer. 
MKneg2 cells were previously generated in the lab and are described in Romero et al.
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(1999). Mkneg2 cells were grown in high calcium FAD. Mkneg2 cells differentiate as 
they become confluent.
Passaging o f mouse keratinocytes and generation o f cell lines
Primary mouse keratinocytes were cultured at 32°C with 5 % C 0 2 in a humidified 
incubator and fed with complete low calcium FAD every 2 days. Cells were passaged 
when completely confluent and were split at no higher dilution than 1:2 as at low 
densities they tended to differentiate. To remove cells from the dish, they were rinsed 
twice with versene then incubated at 37°C with trypsin solution (not diluted in versene) 
until the keratinocytes detached. Complete low calcium FAD was then added, cells 
pelleted, resuspended in media and plated. Primary mouse keratinocytes could also be 
frozen down in a manner similar to other cell types except that chelated FCS with 10 % 
DMSO was used. Cells were cultured in this way for 10 or more passages at which 
point foci of transformed cells appeared in the cultures. Once the cells were transformed 
cells could be split at higher dilutions, typically 1:5.
MKWT, MKP-/- and MKE-/- cell lines were cultured in low calcium medium. To 
induce the cells to differentiate the cells were grown in high calcium for 4 days.
2.5 Immunological methods
2.5.1 General solutions
Paraformaldehyde solution
A 6% solution was prepared by adding paraformaldehyde powder (BDH) to PBS and 
heating at 60°C until mostly dissolved. A few drops of 1M NaOH were added to 
completely clear the solution which was then allowed to cool to room temperature 
before adjusting the pH to 7.6 with HC1. The stock was aliquoted and stored at -20°C. 
A 3 % paraformaldehyde solution, diluted in PBS-ABC, was used to fix cells and tissue.
Gelvatol/Mowiol mountinQ solution
The Gelvatol or Mowiol mounting solution was prepared as described by Harlow and 
Lane (Harlow and Lane, 1998). 2.4g Gelvatol (Monsanto Chemicals) or 2.4g Mowiol 
(Sigma) was mixed with 6 g glycerol (Sigma) and vortexed. 6 ml dH20  was added, 
mixed and left to stand for 90 minutes at room temperature. 12.5ml of 200mM Tris-
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HC1, pH8.5 was added and the solution was vortexed, heated to 50°C and vortexed 
again. Heating and vortexing were repeated three times and the solution placed on an 
end-over-end mixer overnight at room temperature. DABCO (Sigma) was added as an 
antifade agent to 2.5 % and mixed to dissolve. The solution was then centrifuged at 
5 ^ 0 ^  for 10 minutes at room temperature and stored in aliquots at -20°C until use.
Blocking solutions for immunofluorescence.
PBS-GS/FSG PBS-ABC with 5% goat serum and 0.5% fish skin gelatin 
PBS-FBS PBS-ABC with 10% fetal bovine serum
I
2.5.2 Antibodies
Generation o f antibody to kazrin
A peptide corresponding to the last 20 amino acids of the kazrin protein (DPGLFD 
GTAPDYYIEEDADW) that are conserved between human and mouse kazrin proteins 
was synthesised by Protein and Peptide Chemistry, CR-UK, and conjugated to keyhole 
limpet haemocyanin (Perbio) to increase antigenicity. The conjugated peptide was 
injected into two rabbits (Harlan Sera-Lab limited). The bleed outs from both rabbits 
were used (LS3, LS4). Improved specificity and intensity of signal was produced by 
affinity purification of LS4 bleed outs using an aminolink column (BioRad). LS4 was 
eluted using acidic solutions to generate antibody most efficient for immunostaining, 
and eluted in acidic and basic solutions to generate antibody most efficient for 
immunoblotting. Typical dilutions of the affinity purified antibody used were 1:200 for 
immunostaining and immunoblotting.
A peptide corresponding to a region near the C -term inus of human kazrin 
(RQSQQTLYHSHPPHPADRQA) was synthesised by Protein and Peptide Chemistry, 
CR-UK. The peptide was conjugated to keyhole limpet haemocyanin (Perbio). The 
conjugated peptide was injected into two rabbits (Harlan Sera-Lab limited). The bleed 
outs from both rabbits used (KN1 and KN2). KN1 and KN2 antibodies were tested by 
immunoblotting, immunoprecipitation and immunofluorescence and found not to be 
effective as anti-kazrin antibodies.
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Primary and secondary antibodies
All the antibodies used are listed in Tables 2.11 to 2.12. (Key to antibody uses: WB, 
Western blot; IF, Immunofluorescence).
Table 2.11 Primary antibodies
Antibody
Name
Antigen specificity Species Dilution References/
Source
D pll5 -F Desmoplakin mouse
monoclonal
IF 1:30- 
100
Generous gift of Prof. A. 
Magee (Parrish et al., 
1987)4 fm f.D .G w tb*.
CR3 Periplakin rabbit
polyclonal
IF 1:500 (Ruhrberg et al., 19^7)
TD2 Periplakin rabbit
polyclonal
IF 1:500 
WB 1:500
(Maatta et al., 2001)
AE11 Periplakin mouse
monoclonal
IF 1:100 
WB 1:500
Generous gift of Dr H. Sun 
(Ma and Sun, 1986)
CR5 Envoplakin rabbit
polyclonal
IF 1:500 
WB 1:500
(Ruhrberg et al., 1997)
SY5 Human involucrin mouse
monoclonal
IF 1:100 (Ruhrberg et al., 1997)
VB3 Plakoglobin Rabbit
polyclonal
WB
1:1000
(Braga etal., 1995)
TUB-
1A2
Tyrosinated
tubulin
Mouse
monoclonal
IF 1:100 Sigma
Biosciences(Hudson et 
al., 1992)
LP34 pan keratin (K6 , 
K18, K5)
mouse
monoclonal
IF 1:100. Generous gift of Dr A. 
Jetten (Lane et al., 1985)
AC40 Actin Mouse
monoclonal
WB 1:500 Sigma Biosciences 
(Herman, 1993)
IM7 CD44 rat
monoclonal
IF 1:2-10 Generous gift of Dr. C. 
Isacke (Trowbridge et al., 
1982)
ERK2 ERK2 Rabbit WB Santa Cruz
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Sc-1647 polyclonal 1:1000
GST Glutathione S- 
transferase (GST)
Goat
polyclonal
WB
1:1000
Amersham Pharmacia 
Biotech
HA-Y11 
Sc-805
Haemagluti run  
tag
rabbit
polyclonal
IF 1:400 Santa Cruz
M2 FLAG tag mouse
monoclonal
IF 1:1200 Sigma Biosciences
Table 2.12 Secondary antibodies
Antigen specificity Conjugate Species Dilution Source
mouse IgG, whole 
molecule
Alexa 488 Goat 1:500 Molecular Probes
rat IgG, whole molecule Alexa 488 Goat 1:500 Molecular Probes
rabbit IgG, whole molecule Alexa 488 Goat 1:500 Molecular Probes
mouse IgG, whole 
molecule
Alexa 594 Goat 1:500 Molecular Probes
rat IgG, whole molecule Alexa 594 Goat 1:500 Molecular Probes
rabbit IgG, whole molecule Alexa 594 Goat 1:500 Molecular Probes
rabbit IgG, whole molecule Alexa 633 Goat 1:500 Molecular Probes
mouse IgG, whole 
molecule
HRP Sheep 1:5000 BD Biosciences
rabbit IgG, whole molecule HRP Donkey 1:5000 BD Biosciences
goat IgG, whole molecule Biotin Rabbit 1:5000 DAKO
Streptavidine HRP - 1:10000 DAKO
2.5.3 Preparation of Cells for Immunofluorescence Staining
Cells were cultured on glass coverslips (Chance Propper Ltd.). Coverslips were first 
boiled in 7x detergent (ICN) for 30 minutes to remove silicone coating. They were 
rinsed thoroughly first in tap water and then in dH20 . Washed coverslips were rinsed 
briefly in absolute ethanol and spread out on filter paper to dry completely before 
autoclaving.
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Fixation o f cells
Culture medium was discarded from cells and they were rinsed in PBS before fixing in 
3% paraformaldehyde solution for 20 minutes at room temperature. The specimens 
were rinsed three times in PBS and stored in PBS-ABC at 4°C. In some cases cells were 
treated with CSK buffer for 5 mins at room temperature prior to fixation with 
paraformaldehyde.
Prior to us^ specimens were rinsed in PBS and then incubated in blocking solution, to 
reduce binding to non-specific proteins, for at least 40 minutes at room temperature. In 
general, samples were blocked in PBS-GS/FSG, but in the case of the M2 antiFLAG 
antibody samples were blocked in PBS-FBS. In some cases cells were fixed using ice- 
cold methanol at -20°C for 2mins, or using a mixture of ice-cold 1:1 Methanol: Acetone 
for 2 mins at -20°C. Cells were rinsed thoroughly with PBS after fixation with methanol 
and stored in PBS-ABC at 4°C until ready for use.
Permeabilisation o f cells
In order for the primary antibody to enter the cells and access the antigens cells were 
permeabilised using 0.2% Triton X-100 in PBS for 4 minutes at room temperature 
before rinsing three times in PBS and then incubated in blocking solution. Cells fixed 
with a methanol-containing mixture did not require additional permeabilisation with 
Triton X-100.
2.5.4. Preparation of Cryosections of human foreskin
Human tissue* were obtained with appropriate consent. Cryosections were prepared by 
the Histopathology department (CR-UK). Using a cryomicrotome (Reichart-Jung), 6 pm 
sections were cut from the tissue block in an orientation perpendicular to the surface of 
the tissue. The sections were mounted onto slides (Superfrost Plus, BDH) and stored at 
-70°C. All sectioning was performed by the CR-UK Histopathology Unit. To examine 
the morphology of the tissues frozen sections were stained with haematoxylin and eosin 
(H&E). For immunofluorescence staining, frozen sections were thawed at room 
temperature for 15-20 minutes. Sections were either stained after extraction in 0.1% 
Triton X-100 for 5 mins at room temperature or after fixation in ice-cold methanol at 
-20°C for 2 mins.
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2.5.5. Immunofluorescence staining protocol
Tissue sections or cultured cells were incubated in blocking solution for 40 minutes at 
room temperature. Primary antibodies were diluted in the blocking solution (dilutions 
shown in Table 2.1) and applied to cells for lh r at room temperature. The cells were 
rinsed three times in blocking solution and then incubated with the secondary antibody 
diluted in blocking solution (dilutions shown in Table 2.2) for lh r at room temperature. 
The cells were then rinsed once in PBS, and three times in dH20 ,  before mounting in 
Gelvatol/Mowiol solution. In some cases coverslips were mounted atop a small pedestal 
created by nail varnish to avoid squashing the sample as the Gelvatol/Mowiol dried and 
set.
In co-localisation experiments using a double immunofluorescence method, cells were 
stained with two primary antibodies. Both primary antibodies were of distinct species 
and these were subsequently probed with species-specific secondary antibodies 
conjugated to different fluorophores. The antibodies were applied in the following 
sequence: first primary; second primary; first and second secondary in combination, 
with thorough washes in blocking solution between each antibody application.
Stained samples were viewed with a Zeiss Axiophot microscope (Carl Zeiss) or with a 
laser scanning confocal microscope (LSM 510 equipped with an Argon laser to detect 
458nm, 488nm wavelengths, and a helium-neon laser to detect 633nm wavelengths; 
Carl Zeiss, Inc.) A multitrack set-up was used so that bleed-through between channels 
was avoided. Pinhole sizes were equal in each laser track such that the thickness of the 
confocal slice analysed in each channel was equal and thus colocalisation was 
accurately detected. Lenses used were 63x and 40x pan-APOCHROMAT oil immersion 
lenses (numerical aperture 1.4) or C-APOCHROMAT water immersion lens (numerical 
aperture 1.2). Digital images were prepared using AdobePhotoshop 6.0 and Imaris 3.1.
Counter staining.
TRITC-conjugated phalloidin (Sigma) was used to detect F-actin. A stock solution was 
made up in ethanol (0.25mg/ml) and diluted 1:500 in blocking solution. Phalloidin was 
applied to the cells for 15 mins after the secondary antibodies. DAPI (Molecular 
Probes) was used to detect the nuclei; a stock solution (lm g/ml) was made up in dH20
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and used at a dilution of 1:10,000 in dH20. DAPI was applied to the cells for 30 mins 
after the secondary antibodies.
2.5.6 Immunogold electron microscopy
Adult breast epidermis was subjected to cryofixatiori using the HPM 010 high pressure 
freezing equipment (Leica) as described by (Studer et al., 1989).The frozen sample was 
freeze substituted in a Leica CS auto freeze substitution apparatus (Leica, Milton 
Keynes, UK), first in anhydrous acetone at -70°C for 72 hours, and then by warming to 
-50°C  for 48 hours. The samples were washed with anhydrous acetone and embedded 
in Lowicryl HM20 resin at -50°C, followed by UV polymerisation at -50°C for 48 
hours. Thin sections were prepared with a diamond knife on a Reichert Ultracut E 
microtome (Leica) and mounted on carbon-coated grids.
To label epidermal sections, grids were incubated on a drop of PBS for 10 min, blocked 
with 0.05% fish skin gelatin in PBS (FSG/PBS) for 30 min and then incubated with a 
1:5 dilution of the primary antibody for two hours at room temperature. Primary 
antibodies used were LS4 affinity purified polyclonal antibody to kazrin and D p ll5 F  
monoclonal to desmoplakin. D p ll5 F  antibody was concentrated five-fold for use in 
immunogold electron microscopy, using Microcon-30000 concentrators as per the 
M anufacturer’s instructions (Millipore). Sections were washed three times with 
FSG/PBS and then incubated with the appropriate secondary antibody for 30 min. 
Protein A conjugated to lOnm gold (Cell Biology Department, Utrecht, The 
Netherlands) was diluted 1:65 for detection of kazrin polyclonal antibody; goat anti­
mouse IgG conjugated to lOnm gold (BBInternational, Cardiff, UK) was used for 
detection of desmoplakin monoclonal antibody. After three washes each in PBS and 
distilled water, the sections were air-dried, contrasted with saturated aqueous uranyl 
acetate (10 min) and lead citrate (4 min), and examined with a Jeol TEM 1010 electron 
microscope (JEOL UK Ltd. Hertfordshire, UK). Negative control grids were stained 
using the method as described above but with omission of the primary antibody. Images 
were captured using a digital Gatan 2K camera (Gatan UK, Oxford, UK). Immunogold 
electron microscopy and immuno-EM staining was kindly performed by R. Watson and 
S. Gschmeissner (Electron Microscopy Laboratory, CR-UK).
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2.6 Biochemistry
2.6.1 Extraction of proteins
General lysis buffers
Western lvsis buffer lOmM Tris pH 7.4, 150mM NaCl, 0.5% NP40, 0.2% CHAPS, 
0.1% NaN3 and 5mM EDTA pH 8.0.
Cvtoskeletal extraction buffer (CSK1 50mM NaCl, 300mM sucrose, lOmM PIPES, pH 
6 .8 , 3mM MgCl2 and 0.5% (v/v) Triton X-100 (Fey et al., 1984).
Laemmli sample buffer (LSB1 125mM Tris, pH 6 .8 , 2% (w/v) SDS, 20% (w/v) 
glycerol, 10% (3-mercaptoethanol and lOmM EDTA, pH 8.0.
Extraction o f proteins for Western blot analysis
Keratinocytes that were to be harvested for Western blot analysis were washed twice in 
PBS, then lysed on ice. The buffer was supplemented with protease inhibitor tablets 
without EDTA (Roche), 1 per 10ml.
Cells were scraped in the relevant lysis buffer on ice. Cell debris was pelleted by 
centrifugation at 16000^  for 10 min at 4°C in a bench top centrifuge. The 
supernatant was transferred to a new tube and the lysate stored at -70°C. Immediately 
prior to use samples were thawed and assayed for protein content.
BCA protein assay
The concentration of protein in samples was determined using a BCA protein assay kit
(Pierce). The kit is based upon the Biuret reaction involving the reduction of Cu2+ ions
to the Cu1+ (cuprous) ion by protein in alkaline medium. Chelation of the cuprous ion to
bicinchoninic acid (BCA) molecules provides a sensitive colorimetric detection method
with the reaction product exhibiting a strong absorbance at 562nm. The absorbance is
linear over a 20-2000 pg/ml protein concentration range. A protein standard curve was
produced from 0 to 2000 pg/ ml protein by making dilutions of a 2 mg/ml BSA solution
(Pierce) into PBS according to the Manufacturer’s instructions. Protein samples to be
assayed were diluted 1:5 to 1:20 in PBS to minimise interference of lysis buffer
detergent and supplements with the reaction, and also to place the protein concentration
within the standard curve. The assay was set up on a 96-well plate (DYNEX
Technologies) according to the M anufacturer’s instructions and all standards and
samples were assayed in triplicate wells. The plate was incubated at 37°C for 30 min
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and the absorbance at 595nm was then read on a Molecular Devices microplate reader. 
The protein concentration of each sample was determined against the standard curve.
2.6.2 SDS-PAGE and Western blotting
Laemmli sample buffer
2x Laemmli sample buffer (reducing) comprised 125mM Tris-HCl, pH6 .8 , 2% SDS, 
20% glycerol, 0.02% bromophenol blue and 10% (v/v) p-mercaptoethanol. The sample 
buffer was aliquoted and stored at RT. p-mercaptoethanol was added just prior to use.
SDS-PAGE
Vertical mini-gel electrophoresis apparatus (Atto) was used. Gels were prepared 
between glass plates using the method of Laemmli (Laemmli, 1970). Table 2.13 
describes the gel compositions. Immediately after pouring the resolving gel solution, 
0.5 ml of dH20  was carefully applied to ensure a level interface, as well as to eliminate 
an air-acrylamide interface. Gels were allowed to polymerise at room temperature for 
approximately 60 min. The dH20  layer was discarded from the top of the resolving gel 
and the stacking gel solution was then poured. An 8-or 12-well comb was inserted to 
create wells and the gel was left to polymerise. After the gel had set, the comb was 
removed and the wells were flushed with SDS-PAGE running buffer comprising 50mM 
Trizma base, 384mM glycine and 0.1% SDS.
Equal amounts of protein from each sample (typically 10-20jxg total protein) were 
diluted into Laemmli sample buffer and placed in a 100°C hot block for 5 min before 
being briefly spun down in a bench^top centrifuge and applied to the wells using 
capillary pipette tips. W hen running samples to detect the presence of transfected 
proteins equal volumes from parallel transfected 6 -well plate wells was loaded, 
typically 10p.l from 100p«l total. 10pl pre-stained rainbow molecular weight markers 
(Amersham) were added to 10pl Laemmli sample buffer, boiled for 5 min and loaded 
into one of the wells. Samples were electrophoresed at 120V until the dye front had run 
off the bottom of the gel and the gel was then removed and prepared for Western blot.
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Table 2.13 Preparation of SDS-PAGE gels
Solution Contents
Solution A 40 % Acrylamide mix (37.5:1 acrylamide to bis-acrylamide ratio) 
(Amresco)
Solution B 1.5M Tris-HCl, pH 8.8  (BDH)
Solution C 10 % SDS in dH20
Solution D 0.5M Tris-HCl, pH 6.8  (BDH)
AP 10 % ammonium persulphate (Bio-Rad) in dH20 .
TEMED N,N,N’ ,N’ -tetramethylethylenediamine (Bio-Rad)
Resolving gels (16 ml)
A B C dH20 AP TEMED
8 % 3.2 ml 4 ml 0.15 ml 8.6  ml 50 ml 10 ml
1 0 % 4 ml 4 ml 0.15 ml 7.8 ml 50 ml 10 ml
Stacking gel (10 ml)
A C D dH20 AP TEMED
1.25 ml 0.1 ml 2.5 ml 6.09 ml 50 ml 10 ml
In some cases 4%-12% gradient pre-cast gels (Invitrogen) were used according to the 
Manufacturer’s instructions. These gels were treated the same as self-cast gels.
Transfer buffer
The transfer buffer for Western blotting was made up freshly each time: 9.085g Trizma 
base and 42.75g glycine were dissolved in 500 ml dH20  to which was added 15 ml of a 
10 % SDS solution. The buffer was made up to 1.21 before the addition of 300 ml of 
methanol and was then thoroughly mixed.
Western blotting
After electrophoresis, proteins were transferred onto reinforced nitrocellulose 
(Amersham Biosciences). Mini-Trans Blot Cells (Bio-Rad) were used to transfer the 
proteins and were set up according to the Manufacturer’s instructions. Transfer took 
place on the bench for 1 hour 15 min at 350mA current using the supplied cooling units. 
The blot was then rinsed briefly in PBS containing 0.1 % Tween-20 (PBST) before
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blocking with 5 % milk powder (99 % fat free, Premier Brands UK Ltd.) dissolved in 
PBST, for at least 1 hour at room temperature.
Probing blots with antibodies and ECL detection
Blocked membranes were incubated with primary antibody typically diluted in 5 % 
milk powder solution in PBST. Some antibodies (according to the M anufacturer’s 
instructions) were diluted in 5 % BSA in PBST. Incubation with primary antibody was 
at 4°C overnight or 2-3 hours at RT, with gentle agitation. After 4 x 15-20 min washes 
with PBST, the blots were incubated for 1 hour at room temperature with HRP-coupled 
secondary antibody diluted 1:5000 in 5 % milk, PBST. Membranes were then washed 4 
times with PBST again. To detect bound HRP, a chemiluminescence kit was used 
according to the Manufacturer’s instructions (ECL western blot analysis, Amersham 
Biosciences). X-ray films were exposed in autoradiography cassettes lined with 
reflective screens.
Prior to the reprobing, blots were stripped in a 200 mM glycine pH 2.5 solution 
containing 0.4 % SDS for 30 min at room temperature with agitation. Blots were then 
rinsed in 1M Tris-HCl pH 7.5 and washed 3 times for 5 min each with PBST before re­
blocking and subsequent incubation with another primary antibody.
Coomassie staining o f SDS-PAGE gels.
In some cases proteins were not transferred to nitrocellulose, but were stained with 
Coomassie (0.1% Coomassie blue-acid blue 15 in 40% methanol, 10% acetic acid). 
Gels were stained for 20-60 mins with gentle agitation at room temperature. Gels were 
subsequently placed in destain (40% methanol, 10% acetic acid) with several changes 
for 2-6  hrs at room temperature, until distinct protein bands on the gel could be seen.
Coomassie stained gels were placed onto 3mm filter paper and dried in a gel drier at 
80°C for 2 hours. Dried gels were kept for further analysis or storage.
2.6.3 Calf intestinal alkaline phosphatase treatments of protein lysates.
COS cells were transfected with Lipofectamine-2000 according to the Manufacturer’s 
instructions in 6 -well plates. Cells were transfected with 2p,g DNA using 6 fxl of 
Lipofectamine reagent, according to the M anufacturer’s instructions. 20hrs post-
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transfection cells were lysed in WLB as described above. lOOjig of protein was used per 
calf intestinal alkaline phosphatase (CIP) reaction. In control reactions the CIP was 
replaced by an equal volume of dH20.
The reaction mix consisted of: lOOpg protein, ImM Mg2+> and 25 units CIP (or dH20) in 
a total volume of 100p,l. The reactions were carried out for 10 mins at 30°C and 
quenched by the addition of an equal volume of LSB with p-mercaptoethanol.
2.6.4 Induction of cross-linking by transglutaminases
Confluent keratinocyte cultures were washed twice in serum-free growth medium (FAD 
alone) and subsequently treated in 4 different ways. Untreated samples were incubated 
in serum-free medium for 5 hours. Cells were also treated with 0.04% Triton X-100 in 
serum -free medium for five hours to activate transglutaminases and induce the 
formation of comified envelopes (Rice and Green, 1979). To inhibit the activation of 
transglutaminases by Triton X-100 cells were pretreated with 20mM cystamine, pH7.5 
for 30 mins and subsequently with 20mM cystamine in the presence of 0.04% Triton X- 
100 for 5 hours. As a control for the cystamine treatment, cells were pre-treated with 
20mM cystamine for 30 mins followed by treatment with 20mM cystamine alone for 5 
hours. At the end of the treatments cells were lysed in equal volumes of Laemmli 
sample buffer. Equal volumes of lysate were loaded on gels for analysis.
2.6.5 In vitro transcription and translation
An in vitro transcription and translation (TNT) kit (Promega) was used according to the 
Manufacturer’s instructions. 0.5 pg DNA of each construct was used. Prior to use the 
DNA was cleaned through a PCR purification kit (QIAGEN), used according to the 
Manufacturer’s instructions, in order to remove ions and EDTA which may interfere in 
the TNT reaction. The DNA was added to 8 pl of the TNT reticulocyte lysate and 0.75pl
J j  f h a s 7 * 0 cuO .
S labelled methionine (4p,Ci)^ the volume was made up to 10p,l with dH20 . Reaction 
mixtures were mixed by pi etting and the reaction was carried out at 30°C for 90 mins. 
1 jxl of the reaction was run on a 10% gel for analysis. Gels were stained with 
Coomassie and then dried as described above. The dried gels were exposed to Kodak X- 
Omat photographic film to detect th<*S methionine-labelled proteins.
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2.6.6 GST pull-down assay
GST fusion protein production
pGEX6 P-l vectors encoding kazrin proteins downstream of glutathione S-transferase 
(GST) protein or GST alone, were transformed into BL21 E. coli. BL21 cells are a 
protease-deficient strain for more efficient production and purification of the GST 
fusion proteins. BL21 cells also express lysozyme under the control of isopropyl-p-D- 
galactosidase (IPTG) such that as GST protein production is induced by the addition of 
IPTG to the culture medium, so is the lysozyme. Thus, once cells are pelleted and 
sonicated lysis occurs rapidly, minimising protein degradation.
Single transformed BL21 colonies were grown overnight in Ampicillin (lOOpg/ml) and 
Chloramphenicol (25pg/ml) in LB (see below). The overnight culture was diluted 1:10- 
20 in Ampicillin/Chloramphenicol in 200ml LB. The culture was grown with shaking at 
37°C. At frequent intervals the optical density at 600nm wavelength (O D ^) was 
measured. When the O D ^  of the cultures was between 0.65 and 0.75 and the cells were 
in mid-log phase, IPTG was added to a concentration of ImM. Cultures were 
subsequently grown at 37°C or 32°C for a further 3 or 4 hours. Samples were taken 
before the addition of IPTG and after 3 or 4 hours of growth in its presence; these 
samples were used for analysis as explained below. IPTG induced the production of the 
GST fusion protein encoded by the pGEX6P-l vector.
Three to four hours post-induction of protein production by addition of IPTG, cells were 
pelleted at 4°C for 30 mins at 5000rpm. The supernatant was removed and the pellet 
stored on ice. The cell pellet was resuspended in 10ml PBS containing 1% Triton X-100 
and briefly sonicated (3x5 seconds) on ice in order to lyse the cells and release the 
proteins. Triton X-100 was added to facilitate solubilisation of proteins. The crude 
extract was centrifuged at 10,000g for 5 mins at 4°C to separate the insoluble from the 
soluble proteins. A fraction of the cell pellet and supernatant was analysed on a 
Coomassie-stained gel, in order to determine the efficiency of protein production and 
the proportion of the protein that was in the soluble fraction following cell lysis. The 
level of protein production was roughly equivalent after 3 or 4 hours of induction.
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GST fusion protein purification and quantification
Glutathione*Sepharose 4B beads (Amersham) were prepared by washing in cold PBS 
and pelleting gently at 550g for 3-5 mins at 4°C. The beads were resuspended in cold 
PBS with 1% Triton X-100 and pelleted as before. The supernatants from GST fusion 
protein production were added to the beads and the samples left on a rotor at 4°C for 1 
hour in the presence of a protease inhibitor tablet (Roche). Beads were pelleted once 
more and the unbound proteins removed by two washes in cold PBS with 500mM KC1 
and subsequently with three washes in cold PBS. The GST proteins were eluted off the 
GST beads by the repeated addition of 1ml of Tris pH 8.0 with 5mM glutathione and 
protease inhibitors. The beads were pr.j etted up and down gently and spun down. The 
supernatant was removed as fraction 1. This process was repeated 5 times to obtain 5 
GST fusion protein fractions. 5% glycerol was added to each fraction to improve 
protein stability in storage at -70°C. Small amounts of each fraction of each kazrin 
fusion protein type and GST alone were run on a gel, Coomassie-stained and dried in 
order to determine the quality and quantity of the GST proteins isolated and the 
fractions to use for the pull-down experiment.
GST pull-down experiment
Glutathione-Sepharose 4B beads were prepared as described above. Roughly 40 pi of 
GST bead slurry were used to bind to lOpg of GST fusion protein or GST protein alone; 
the volume was made up to 500pi with CSK lysis buffer containing protease inhibitors. 
The beads and GST proteins were placed on a rotor for 90 mins at 4°C to allow them to 
rebind. Beads were subsequently pelleted and the supernatant removed.
Primary keratinocyte cultures were lysed in CSK buffer, as described above, and the 
lysates added to the GST protein/beads. Lysates were made from 1-2 day post-confluent 
keratinocytes. Lysates generated from 20-25cm2 of culture were used per pull-down 
reaction. The lysates and GST protein/beads were rotated at 4°C for either 4 hours or 
overnight. Beads were pelleted and washed four times with cold PBS. In the final spin 
as much supernatant as possible was removed and 30pl LSB containing lOmM |3- 
mercaptoethanol was added. Samples were run on SDS-PAGE gels together with a 
lysate alone control corresponding to 4% of the lysate used in the pull-down reaction. 
Proteins were subsequently transferred  to n itrocellulose and analysed by 
immunoblotting.
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2.7 Mouse techniques
Mice lacking the envoplakin gene, generated in the lab (Maatta et al., 2001), were bred 
with mice lacking periplakin (Aho et al., 2004) and mice lacking involucrin (Djian et 
al., 2 0 0 0 ) to generate triple knockout mice (lacking expression of envoplakin, periplakin 
and involucrin). Mouse matings were set up by A. Maatta and L. Sevilla (Keratinocyte 
Laboratory, CR-UK) in collaboration with the mouse facilities at Clare Hall (CR-UK).
2.7.1 Toluidine Blue barrier function assay
Toluidine blue barrier function assays were done in collaboration with L. Sevilla 
(Keratinocyte Laboratory, CR-UK). The staining protocol was carried out essentially as 
described (Hardman et al., 1998; Koch et al., 2000). Timed matings of wild type (BL6 ) 
mice and triple knockout mice were set to generate wild type, triple heterozygous and 
triple knockout litters. The matings were set up in a 12 hour time bracket in order to 
minimise differences between litters due to differences in the timing of the mating. The 
middle of the 12 hour time period was considered embryonic day zero. At embryonic 
days 15.5, 16.5 and 17.5 post plugging the mice were sacrificed and the uteri of the 
mothers removed and placed in a dish of ice-cold PBS The amniotic membrane
surrounding each embryo was removed. Embryos were weighed and subsequently 
submerged into a methanol series made in PBS. Embryos were dehydrated by moving 
them sequentially from 25% methanol, to 50%, to 75% to 100%. Embryos were left in 
each methanol solution for 60 seconds. Following dehydration the embryos were 
rehydrated by dipping into 75% methanol solution, followed by dipping in a 50% and a 
25% methanol solution prior to a PBS alone solution, again leaving the embryos in each 
solution for 60 seconds. After the preparations in methanol the embryos were stained in 
0.0125% toluidine blue (Sigma), dissolved in H20 ,  for 60 secs. The embryos were 
destained in several changes of PBS and stored in PBS at 4°C overnight. Images were 
taken using a dissecting microscope and conventional photography.
2.7.2 Isolation of cornified envelopes
Comified envelope (CE) isolation was carried out as described Maatta et al., (2000). A 
5mm by 5mm square of adult mouse ear tip was taken from each mouse and boiled in 
500p,l CE isolation buffer containing 20mM Tris-HCl (pH7.5), 5mM EDTA, lOmM
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dithiothreitol (DTT) and 2% SDS for 20 mins. After boiling, the dermis could be 
removed from the sample and the CEs pelleted by centrifuging at 5000g. The CEs were 
washed twice in CE wash buffer (as isolation buffer, but with 0.2% SDS) and stored at 
4°C in 200 (ml wash buffer. Samples were gently resuspended and 20pi placed on a slide 
and covered by a coverslip. Nail varnish pedestals were made on the slide such that the 
sample could be placed underneath. Finaltyjthe coverslip edges were sealed in nail 
varnish to prevent drying out of the sample. CEs from three triple knockout and two 
triple heterozygous mice were examined. All the mature envelopes were scored in ten 
randomly selected photographic fields, corresponding to 215 CEs from heterozygous 
mice and 433 CEs from triple knock-out mice. Pictures were taken by phase contrast 
microscopy. The samples were analysed blindly. The surface areas of the CEs were 
measured in pixels using NIH Image software. Statistical analysis was performed using 
GraphPad QuickCalcs software.
2.7.3 Scanning electron microscopy
Samples were taken from adult mouse feet either directly or after fixation, dehydration 
and critical point drying of the feet. Samples were rotary shadowed with platinum and 
observed using a 6700 field emission gun scanning electron microscope (FEG-SEM, 
JEOL, UK).
Preparation o f unfixed samples
Feet were removed from adult mice. SEM metal sample stubs with attached sticky pads 
were used directly on mouse paw skin to ‘tape strip’ away epidermal layers for analysis.
Critical point drying
Samples were obtained and fixed immediately in 2.5% glutaraldehyde/4% PFA in 
Sorensons PBS (made up by EM department, CR-UK). Samples were transferred to 2% 
PFA after fixation. Samples were placed in a critical point drying machine and dried 
according to the Manufacturer’s instructions. After drying the samples were prepared 
for SEM as described for unfixed samples. SEM was done in collaboration with Steve 
Gschmeissner (Electron Microscopy Department, CR-UK).
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2.8 List of suppliers and distributors
Aldrich Chemical Company Ltd. Dorset, UK.
American Tissue Culture Collection (ATCC), Rockville, Maryland, USA.
Amresco, Solon, Ohio, USA.
Amersham Biosciences, Amersham, Buckinghamshire, UK.
Atto -  supplied by Bio-Rad.
BBIntemational, Cardiff, UK.
BDH Laboratory Supplies Inc., Hemel Hempstead, Hertfordshire, UK.
Beckman Instruments, Palo Alto, California, USA.
Becton-Dickinson, Lincoln Park, New Jersey, USA.
Bio-Rad Laboratories Inc. Hemel Hempstead, Hertfordshire, UK.
Boehringer Mannheim UK Ltd. Lewes, East Sussex, UK.
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Chapter 3.
Plakin proteins localise to plasma membrane attachment sites, such as desmosomes and 
hemidesmosomes, via their N~termini (Leung et al., 2002). Endogenous envoplakin and 
periplakin are found at desmosomes and the interdesmosomal membrane (Ma and Sun, 
1986; Ruhrberg et al., 1997; Ruhrberg et al., 1996). The localisation of envoplakin and 
periplakin to desmosomes and the interdesmosomal plasma membrane is important for 
their integral role in forming the comified envelope scaffold on the inside of the plasma 
membrane of keratinocytes (Kalinin et al., 2001; Ma and Sun, 1986; Ruhrberg et al., 
1997; Ruhrberg et al., 1996; Simon and Green, 1984).
The first 584 amino acids of desmoplakin were found to be sufficient to target 
desmoplakin to the desmosomes (Bomslaeger et al., 1996; Kowalczyk et al., 1997). 
Analysis by DiColandrea et al. (2000) found that the equivalent regions of envoplakin 
and periplakin had distinct localisation patterns. The periplakin N-terminus localised to 
actin-rich plasma membrane projections on the apical surface of cultured keratinocytes 
that are known as microvilli and partially colocalised with desmoplakin at the 
desmosomes. In contrasty the envoplakin N-term inus localised to the nucleus and 
cytoplasm. To further understand the role of the envoplakin and periplakin N-termini in 
determining the localisation of the endogenous proteins, envoplakin and periplakin N- 
terminal deletion constructs were analysed by transient transfection of primary 
keratinocytes.
3.1 Analysis of the envoplakin amino terminus -
3.1.1 Localisation of envoplakin deletion constructs
I analysed the envoplakin N-terminus in order to understand why E1/2N does not 
localise to the desmosomes or microvilli. Two possible reasons are the length of the 
envoplakin N-terminus used for analysis or are related to the KGSP repeats which are 
potential protein kinase C (PKC) or mitogen activated protein kinase (MAPK)
♦
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phosphorylation sites (Fig. 3.1 A) (Davis, 1993; Pearson and Kemp, 1991; Ruhrberg et 
al., 1996).
The P1/2N construct encoded the NN, Z, Y and X subdomains while the E1/2N 
construct does not encode a complete X subdomain (DiColandrea et al., 2000). 
However, expression of a construct containing a complete X subdomain (E508) did not 
result in efficient localisation of the protein to the desmosomes or microvilli (Fig. 3.1 
B).
Periplakin (P1/2N), which lacks KGSP repeats, localises efficiently to the microvilli and 
desmosomes (DiColandrea et al., 2000). The KGSP repeats of envoplakin may interfere 
with the localisation of E1/2N to plasma membrane structures through phosphorylation 
or lack of phosphorylation of these repeats affecting the behaviour of the protein. 
Removal of the KGSP repeats at the very N-terminus of envoplakin did not result in 
efficient localisation of the protein to microvilli or the desmosomes of primary human 
keratinocytes (E27-508, Fig. 3.1 C). A construct encoding the KGSP repeats and the 
start of the NN helical domain (E41) was not efficiently expressed or unstable and thus 
undetectable by immunofluorescence.
Although the extreme N-termini of desmoplakin and periplakin have been found to 
target the proteins to their plasma membrane attachment sites, envoplakin may rely on 
another part of its plakin head domain for correct targeting to the desmosomes and 
microvilli. However, a construct incorporating amino acids 500 to 907 of envoplakin, 
up to the start of the envoplakin rod domain, localised to the nucleus and cytoplasm (Fig
3.1 D).
3.1.2 Effect of kinase inhibitors on the localisation of envoplakin.
The two pairs of tandem KGSP repeats preceding the NN subdomain of envoplakin 
each contain a minimal PKC or MAPK phosphorylation site, suggesting that envoplakin 
may be phosphorylated (Davis, 1993; Pearson and Kemp, 1991; Ruhrberg et al., 1996). 
The ability of desmoplakin to localise to the intermediate filament cytoskeleton is 
regulated by a phosphorylation site at its Oterminus. Phoshorylation of desmoplakin by 
protein kinase A negatively affects its ability to interact with intermediate filaments
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Fig 3.1 Envoplakin N-terminal constructs do not efficiently localise to the desmo­
somes or microvilli of prim ary hum an keratinocytes. (A) Schematic of full length 
human envoplakin protein and related N-terminal deletion constructs made for use in tran­
sient transfection experiments. All constructs were tagged at their C-termini with a FLAG 
tag. Domain nomenclature as used in DiColandrea et al. (2000). Double underlining high­
lights the potential phosphorylation sites (KGSP repeats): aa, amino acid. (B-D) Single 
confocal slices of primary human keratinocytes transfected with envoplakin N-terminal 
constructs. (B) E l-508, (C) E27-508, (D) E500-907. Green fluorescence: FLAG tag (M2 
antibody). Scale bar: 20pm
(Stappenbeck et al., 1994). The localisation of envoplakin to sites at the plasma 
membrane may also be regulated by phosphorylation.
The MAPK signal transduction pathway is an intracellular signalling cascade which is 
activated, in keratinocytes, by UV radiation or growth factors such as EGF or 
hepatocyte growth factor (HGF) (Mitev and Miteva, 1999). There are three subfamilies 
of MAPKs; the extracellular signal-regulated kinases (ERK1 and ERK2) which are 
widely expressed and are involved in the regulation of cell division and post-mitotic 
functions in differentiated cells, the c-Jun N-terminal kinases (JNK 1, 2 and 3) which 
regulate transcription and four p38 MAPKs which are regulated by cytokines and 
environmental stresses (Johnson and Lapadat, 2002). The role of MAPK signalling in 
keratinocyte growth and differentiation is not well understood (Mitev and Miteva, 
1999).
Human keratinocytes were transiently transfected with E1/2N in the presence of MAPK 
inhibitors to analyse whether the lack of phosphorylation by MAPK of envoplakin 
would enhance the localisation of E1/2N to plasma membrane structures. Cells were 
treated with U0126, an inhibitor of MEK, the kinase upstream of ERK1 and ERK2 in 
the MAPK cascade. Treatment of E 1 /2N~transfected keratinocytes with U0126 did not 
result in a change in its localisation relative to the localisation seen in DMSO alone 
treated control cells (Fig. 3.2 A-B).
Protein kinase C isoforms are protein serine/threonine kinases which can be subdivided 
into three subfamilies, conventional PKCs, novel PKCs and atypical PKCs according to 
their lipid-and calcium-binding properties (Mitev and Miteva, 1999). PKC isoforms 
have been implicated in the regulation of keratinocyte growth and differentiation 
(Denning et al., 1995; Papp et al., 2003). In order to analyse whether phosphorylation of 
E1/2N by a PKC prevented it localising efficiently to microvilli and desmosomes, 
primary human keratinocytes were transfected with E1/2N in the presence of the PKC 
inhibitor Bisindolylmaleimide I (BimI). BimI is an inhibitor of conventional PKCs 
(a ,p i, |3 2 ,y )  and novel PKCs (6,e). E1/2N did not localise to the microvilli or 
desmosomes in keratinocytes treated with BimI for 30mins or 3hrs (Fig. 3.2 C, E); the 
E1/2N localisation was similar to that seen in control cells treated with DMSO alone 
(Fig. 3.2 D, F).
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Fig 3.2 Envl/2N localisation is not altered by treatm ent with kinase 
inhibitors. Single confocal slices of immunofluorescence staining of trans­
fected primary human keratinocytes. Cells were transfected with E1/2N 
(FLACktagged at C-terminus) in the usual way. Prior to fixation cells were 
treated with kinase inhibitors, as described in Materials and Methods. 
(A,C,E) treated with inhibitors; (B,D,F) mock treated with DMSO alone in 
the same manner. (A-B) U0126 MEK1 inhibitor; (C-D) BimI 5pM, 30 
mins; (E-F) BimI 5|iM, 3hrs. Green fluorescence, anti-FLAG (M2 
antibody). Scale bar: 20pm
In order to confirm that the inhibitor treatments did not affect the localisation of 
endogenous envoplakin to desmosomes, small colonies of keratinocytes were stained 
for envoplakin and desmoplakin. Envoplakin colocalised with desmoplakin at the 
desmosomes of cells treated with U 0126, BimI or DMSO (Fig. 3.3).
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Fig 3.3 Endogenous envoplakin is unaffected by treatm ents with kinase 
inhibitors. Small keratinocyte colonies were grown on coverslips and subse­
quently treated with inhibitors, as explained in text. Green fluorescence, envo­
plakin (CR5 antibody); red fluorescence, desmoplakin (D pll5F  antibody). 
Scale bar; 20pm.
3.2 Analysis of the periplakin amino terminus
The 495 N-terminal amino acids of periplakin (P1/2N), encoding the NN, Z, Y and X 
subdomains, are sufficient to mediate the interactions of periplakin with the 
desmosomes and microvilli (Fig. 3.4 A-C) (DiColandrea et al., 2000). The N-terminal 
133 amino acids of periplakin, which encode the NN subdomain and the non-helical 
region preceding it, were found to localise efficiently to the plasma membrane in 
keratinocytes, colocalising with actin (Fig. 3.4 D-F). The plasma membrane projections 
to which P I33 localises stained with an antibody to CD44, a transmembrane 
glycoprotein component of microvilli (Fig. 3.4 G-I) (Yonemura and Tsukita, 1999). In 
cells treated with Latrunculin B, to depolymerize F-actin, much of the P I33 is 
redistributed into actin-rich clumps (Fig. 3.4 J-L). In conclusion, P133 localises to 
actin/CD44»positive microvilli and redistributes with actin upon latrunculin B treatment, 
as seen previously for P1/2N (Fig. 3.4; DiColandrea et al., 2000).
The predicted structure of PI 33 was analysed further in order to precisely define the 
microvillar localisation region of periplakin. The NN subdomain is predicted to form 
four short a-helixes, which may fold into an antiparallel bundle (Green et al., 1992). 
The region preceding the NN domain is predicted to have a short region of p-turn and 
P-sheet (Fig. 3.5 A). Deletion constructs were generated as shown in Fig. 3.5 B.
P I33 localises to microvilli and the plasma membrane (Fig. 3.6 A-D). Removal of the 
first 15 amino acids of periplakin prevented efficient localisation of the protein to 
microvilli as seen when cells were stained to detect actin or CD44 (Fig. 3.6 M-P and 
Fig. 3.7 G-L). A proportion of P16-133 protein is able to localise to microvilli in some 
cells (arrows Fig. 3.7 J-K). Despite the inability of P I6-133 to localise efficiently to 
microvilli, it does localise to the plasma membrane to some extent (Fig. 3.6 P). Some 
P I6-133 protein could be detected in the nucleus of primary keratinocytes (Fig. 3.6 M- 
O and Fig. 3.7 G-L).
The first 63 amino acids of periplakin, encoding the first a-helical domain of the 
periplakin NHerminus, were incapable of efficiently localising to the microvilli (Fig. 3.6 
I-L and Fig. 3.7 D-F). Microvilli structures, stained with actin or CD44, were not co-
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Fig 3.4 The amino term inal 133 amino acids of periplakin (P133) localisesto 
the microvilli as efficiently as P1/2N and redistributes with actin upon 
latrunculin B treatm ent. Primary human keratinocytes transfected with HA 
tagged P133 (D-L) and P1/2N (A-C) constructs. (J-L) cells were treated with 
latrunculin B (200ng/ml, 3hrs) before fixation. Green fluorescence: HA tag ; red 
fluorescence: F-actin in (A-F, J-L), CD44 in (G-I). C, F, I, L show merged 
images; yellow indicates colocalisation. Scale bar: 20|xm in (A-F), 10|im (G-L).
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Fig 3^  Summary of periplakin defetion analysis. (A) Secondary structure predic­
tions of the N-terminal 133 amino acids of periplakin, based on the algorithms of 
Chou and Fasman (1978) and Gamier and Robson (1978) as implemented by Mac- 
Vector 6.5.3. (B) Schematic diagram of the periplakin constructs used for transient 
transfections. Domain nomenclature as described by Ruhrberg et al. (1997). All 
constructs had C-terminal HA tags.
Fig 3.6 P133 is the minimal unit of periplakin which efficiently localises to the 
keratinocyte plasma m em brane and microvilli. Transfection of primary human 
keratinocytes. Green fluoresence, HA; red fluorescence, F-actin. Confocal projections 
of z-stacks, (A-C, E-G, I-K, M -0) are shown as ortho gonal views in (D,H,L,P) 
respectively. Arrow heads indicate position of orthogonal views. Z-stack size: (D) 3.6 
pm, (H) 7.2 pm, (L) 6.1 pm, (P) 5.6 pm. Scale bar: 20pm.
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Fig 3.7 P80 colocalises with CD44 a t microvilli. Single confocal slices of 
primary human keratinocytes transfected with periplakin deletion constructs 
stained for the HA tag and CD44. (A-C) P80, (D-F) P63, (G-L) P16-133. (G-I) 
show P16-133 not localising to microvilli, (J-L) shows some P16-133 colocal- 
ising with CD44. Arrows mark microvillar staining seen in some cells trans­
fected with P16-133. Green fluorescence, HA; red fluoresence CD44. Scale 
bar: 20pm.
stained with HA antibody detecting P63. P63 staining was seen at the plasma membrane 
and the nucleus to some extent (Fig. 3.6 I-L and Fig. 3.7 D-F). The level of fluorescence 
detected in cells expressing P63, in contrast to the P I33 protein signal, was very low, 
suggesting that the protein was not efficiently expressed or unstable.
The first 80 amino acids of periplakin, encoding the first one and a half a -helica l 
domain^ localised to the plasma membrane, including the microvilli where it colocalises 
with actin and CD44 (Fig. 3.6 E-H and Fig. 3.7 A-C). P80, in contrast to P133, was not 
at microvilli in 100% of cells, suggesting that the efficiency of the localisation is 
increased by the presence of an intact NN subdomain.
3.3 Discussion
In this chapter I have shown that the envoplakin N-terminus does not localise efficiently 
to desmosomes or microvilli (Bomslaeger et al., 1996; DiColandrea et al., 2000). It was 
thought that phosphorylation of E1/2N might prevent its localisation to the microvilli 
and desmosomes since phosphorylation of desmoplakin negatively regulates its ability 
to interact with interm ediate filam ents (Stappenbeck et al., 1994). However, 
phosphorylation of E1/2N by MAPK showed that phosphorylation by ERK1 and ERK2 
is unlikely to be preventing E1/2N localisation to microvilli and desmosomes as 
treatment of transfected cells with U 0126 did not alter its localisation. Treatment of 
cells with the PKC inhibitor BimI did not result in localisation of E1/2N to microvilli or 
the desm osom es. The role o f the atypical PKCs, such as PKCs on<A- 
i, was not analysed, and thus it remains a possibility that they regulate E1/2N 
localisation. However, removal of the N-terminal extension of envoplakin (amino acids
1-41) did not lead to recruitment to microvilli or desmosomes.
My experiments do not exclude the possibility that phosphorylation of envoplakin is 
required for it to localise to the desmosomes and microvilli. Envoplakin may only be 
efficiently phosphorylated in the context of the full length molecule and thus E1/2N 
may remain unphosphorylated in transfected cells. However, the localisation of 
endogenous envoplakin was unaltered in cells treated with inhibitors to MEK and PKC.
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This suggests that envoplakin already at desmosomes remains localised there 
independently of treatment with kinase inhibitors (Fig. 3.3).
One reason that E1/2N does not, but P1/2N does, localise to desmosomes and microvilli 
may be that the envoplakin N-terminus is insoluble. Kalinin et al. (2004) showed that 
the envoplakin head domain (amino acids 1-917) is insoluble when expressed in E. coli, 
in contrast to the periplakin head domain (amino acids 1-948). The difference in the 
behaviour of the two head domains in vitro may explain our differing findings for 
E1/2N and P1/2N localisation in vivo; alternatively the differences may be a result of 
the sequence variation between the envoplakin and periplakin N termini (sequence 
identity <40%). DiColandrea et al. (2000) noted that only a proportion of full length 
envoplakin localised to the desmosomes of stably transfected mouse keratinocytes and 
that envoplakin may depend on periplakin in order to localise to the interdesmosomal 
plasma membrane.
Analysis of the periplakin N-terminus shows that the non-helical region preceding the 
NN-subdomain is important for stable localisation of periplakin to the microvilli. In 
addition, although the first 80 amino acids of periplakin N-terminus were able to 
localise to microvilli, this localisation was more efficient when the whole NN 
subdomain was used. Thus the minimal region of periplakin, that is capable of 
mediating the interaction of periplakin with the plasma membrane and the cortical actin 
cytoskeleton, is P I33. I would predict that deletion of the first 133 amino acids of 
periplakin would prevent membrane localisation of periplakin, although this had not 
been tested.
A proportion of the periplakin deletion constructs showed nuclear staining, particularly 
those proteins that were not able to localise efficiently to the microvilli (P I6-133, and 
P63). We have no evidence that endogenous periplakin localises to the nucleus despite 
the presence of a putative nuclear localisation signal (NLS) within the rod domain. Thus} 
P I6-133 and P63 do not contain an NLS and thus the inability to bind factors to target 
the proteins correctly may result in aberrant localisation of the proteins to the nucleus.
Periplakin N-terminal deletion constructs localise not just to the microvilli but also to 
the plasma membrane (Fig. 3.6). Envoplakin/periplakin heterodimers and periplakin
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homodimers bind phospholipids of synthetic lipid vesicles (SLV) in vitro. Individual 
domains of envoplakin and periplakin (head, rod, tail) did not bind to SLV significantly 
(Kalinin et al., 2004). My analysis suggests that the periplakin N'terminus may have 
some lip id 'b inding  capacity or, alternatively the periplakin N-terminal deletion 
constructs bind proteins at the plasma membrane.
T. DiColandrea (Keratinocyte laboratory, CR-UK) found that periplakin does not bind 
actin directly. I therefore set out to discover what proteins bind P I33 and potentially 
determine its localisation to the plasma membrane.
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Chapter 4.
In this chapter I will present data on the isolation of kazrin, a novel periplakin 
interacting protein. I shall discuss the genomic organisation of the kazrin gene and the 
expression of its alternative splice forms. I shall describe further mapping of the 
interaction between kazrin and periplakin by the yeast tw o-hybrid system and 
verification of the interaction by GST pull-down assay.
4.1 Identification of periplakin-interacting proteins by yeast two-hybrid 
screening.
In Chapter 3 I presented data suggesting that P I33, encoding the first 133 amino acids 
of periplakin, was the minimal unit of periplakin which localised efficiently to the 
plasma membrane and microvilli. In order to identify proteins involved in targeting 
periplakin to the plasma membrane a yeast two-hybrid screen was carried out by K. 
Nishi (Keratinocyte laboratory, CR-UK). Dr K. Nishi returned to Japan shortly after 
isolating a partial kazrin cDNA, the rest of the experiments described in the Chapter 
were performed by myself.
The yeast two-hybrid system allows the identification of novel protein-protein 
interactions in vivo. In the MATCHMAKER GAL4 two-hybrid 3 system (Clontech), a 
‘bait’ gene, in this case the P I33 coding sequence, is expressed as a fusion protein with 
the GAL4 DNA-binding domain (GAL4-BD) (Fig. 4.1 A). A human foreskin 
keratinocyte cDNA library (the ‘prey’) was cloned such that the cDNAs were expressed 
as GAL4 activation domain (GAL4-AD) fusion proteins (Fig. 4.1 A). Interactions 
occurring between P I33 and proteins encoded by the keratinocyte cDNA library bring 
the GAL4 DNA-BD and GAL4-AD into close proximity, activating transcription of 
reporter genes.
The AH 109 yeast strain used in the yeast two-hybrid screen has three selectable markers 
which are activated when proteins interact. The ADE2 gene encodes Ade2p which 
allows the yeast to grow in the absence of adenine in the growth medium. The ADE2
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Fig 4.1 Yeast two hybrid screen set-up and controls. (A) Periplakin P133 was fused to 
the GAL4 DNA-binding domain (vector pGBKT7). A human keratinocyte cDNA library 
was fused to the activation domain of GAL4 (vector pGADIO). (B-C) Periplakin P133, 
fused to the G A M  DNA-binding domain, does not have auto-activating activity. (B) 
Chart of vectors used in the transformations. (C) Selection for the the pGAD and 
pGBKT vectors, to confirm transformation efficiency, carried out on medium lacking 
Leucine/Tryptophan (L-T-). Selection for binding of the proteins encoded by the 
pGBKT7 and pGAD vectors, carried out on medium lacking
Adenine/Leucine/Tryptophan/Histadine (A-L-T-H-).
reporter is a strong nutritional selection marker, but can be used in combination with 
HIS3. The HIS3 gene encodes His3p which enables yeast to grow on media lacking 
histidine. The final reporter gene, MEL1, encodes a-galactosidase, which is secreted 
into the periplasmic space and culture medium. Yeast cells expressing a-galactosidase 
produce blue colonies when spread on agar supplemented with X -a-G al, while 
colonies of yeast not expressing a-galactosidase remain white.
In order to verify that P I33 fused to the GAL4-BD does not activate the reporter genes 
in the absence of a GAL4-AD fusion protein, control yeast transformations were set up 
as shown Fig. 4.1 B,C. To verify that yeast have been transformed with both vectors, 
yeast are grown on agar lacking leucine and tryptophan (L'T' agar), while selection for 
an interaction between P133-GAL4-BD and GAL4-AD alone is analysed on agar 
lacking leucine, tryptophan, adenine and histidine (A'L'T'H' agar). P I33 alone grows 
well on L'T' agar; thus the transformation was successful. There is no growth on A L T ' 
H" agar, showing that PI 33 fused to the GAL4-BD does not have the ability to activate 
the reporter genes alone (Fig. 4.1 C). A positive control provided with the 
MATCHMAKER GAL4 two-hybrid 3 system, encoding murine p53 fused to the 
GAL4-BD and SV40 large T antigen fused to the GAL4-AD, interact in our analysis 
(Fig. 4.1 B-C). A negative control showed that lamin when fused to the GAL4-BD does 
not interact with SV40 large T antigen and therefore does not grow on A'L'T'H' agar 
(Fig. 4.1.B-C).
The yeast two-hybrid screen identified 3 putative interactors of periplakin P I33 at high 
stringency (growth of yeast on A'L'T'H' agar and production of blue colonies on X -a- 
Gal agar). The putative interactors were isolated and retransformed into yeast in the 
presence of P I33 to reconfirm their ability to interact with P I33. Only one cDNA was 
found to bind strongly to P I33 and be in frame to the GAL4-AD. Sequencing of the 
cDNA showed that it encoded a novel protein which we have named kazrin. The kazrin 
sequence, encoding 279 amino acids, was partial as it lacked the translation initiation 
codon.
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4.2 Analysis of kazrin nucleotide and amino acid sequences.
4.2.1 Analysis of the kazrin gene
The partial kazrin nucleotide sequence obtained from the yeast two-hybrid screen was 
screened against the human and mouse genome using BLAT (BLAST-like alignment 
tool). BLAT is designed to find genomic regions of very high homology (95% over 40nt 
or more) to an input sequence, allowing identification of the chromosomal location of 
your sequence of interest. Using the partial kazrin sequence the gene was found on the 
forward strand of human chromosome 1 (band lp36.21) and the reverse strand of mouse 
chromosome 4 (band 4E1).
The kazrin fragment we isolated was composed of several exons. In order to identify 
upstream exons, the nucleotide sequence was searched against the BLAST (basic local 
alignment search tool) human nucleotide sequence database. BLAST searches identified 
several spliced expressed sequence tags (ESTs) which contained the known sequence at 
the 3 ’ end, and additional sequence at the 5’ end. Spliced EST sequences, relating to 
human kazrin, were pieced together and compared to the human genome in order to 
establish the genomic layout of the kazrin gene (Fig. 4.2 A). The kazrin gene is 
composed of 7 exons (exons 2-8) that may be spliced together with one of four 
alternative first exons. The first exons are designated la, lb, lc  and Id, with respect to 
their distance from exon 2, with la  being the furthest upstream from exon 2. The region 
of kazrin isolated in the yeast two-hybrid screen is present in all kazrin isoforms.
Exons la  and lb  contain start codons generating proteins of 421 amino acids (kazrin A) 
and 414 amino acids (kazrin B) (Fig. 4.2 A-B). Exons lc  and Id do not contain in-frame 
start codons. Translation from transcripts containing exons lc  or Id  begin at the start 
codon located in exon 2 (Fig 4.2 A-B). Protein synthesis from exon lc  and exon ld- 
containing mRNAs generate identical 327 amino acid proteins which we refer to as 
kazrin C protein for simplicity. Consensus splice sites were found at the start and end of 
each intron (GU and AG respectively) (Alberts et al., 2002). In-frame stop codons are 
located upstream of the start sites, two within exon lb  and one within exon Id (Fig. 4.2 
B).
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Exon la
1 3 6  CGCTGCCGGTGCCTGGGGGTCGGGGCGCGGGCGAAGCCGGGCCGCGGAGGACACAACAGGCCAAAATCCTGAGCATGATGGAAGACAATAAGCAGCTCGCGCTCCGCATCGATGGGGCGGTCCAGTCGGCCAGCC 
1 M M E D N K Q L A L R I  D G A V Q S A S Q
2 7 1  AGGAGGTGACCAACCTGCGAGCCGAACTCACGGCCACCAACCGGAGACTGGCGGAACTGAGCGGCGGCGGCGGCCCCGGCCCGGGCCCGGGAGCCGCGGCCAGCGCCTCGGCGGCGGGGGACTCGGCGGCGACGA 
23  E V T N L R A E L T A T N R R L A E L S G G G G P G P G P G A A A S A S A A G D S A A T N
1 3 5
2 7 0
4 0 6  ACATGGAGAACCCCCAGCTTGGAGCGCAAG 
6 8  M E N P Q L G A Q V
Exon lb
1 GAGCCGTTCCCACGTGAGAGGCTCCGCGGCCGAATTCCTCGCGTGCAGCAGGCGCGGACCGCCCGGCGTCCGGCCGGACTGAGAGCCCTGGTCCGGCGCGCGCCGCCGGCCGGGCGGGAGGCGGGGGCGGGCTCG 
1 3 6  GCTGCGCCCCGATGCGGCGGCGACCTCCGGGTCTGTGAGCCCGGCGCGCGCCGTCGGAGCCCCTCGCGCAGCCGCTGGTAGCGTCCCCCCGGGCACCCGGCATGCGGGCGGCCGACTCGGGCTCGTGGGAGCGCG 
1 M R A A D S G S W E R V
13 5
2 7 0
2 7 1  TCCGCCAGCTCGCGGCGCAGGGCGAGCCGGCGCCTTCCTGCGGGGCGGGGGCCGGGCCCGCGCGGCCCCCGGGACCCGCAGCCTGCGAGCAGTGCGTGGACGCGGCGGGGCCCGGCGATCGGCCCCGCGCCGGGG 4 05
13  R Q L A A Q G E P A P S C G A G A G P A R P P G P A A C E Q C V D A A G P G D R P R A G V  57
4 0 6  TTCCCCGGGTCCGAGCGGATGGCGACTGCAGCCAGCCCG 4 44
58  P R V R A D G D C S Q P V  70
Exon lc
1 GGGAGAGGGAAGGTCAGGCTTGCCTCCTGTTCACAAGGACAACCTCTGTCTCCCTTGTGGCGGCTTCTATGAAGGTGGGGACTCCAGGCTTTCTCTCGTCTGCTTTTTGGATGCCTTCAAGAGAGGCCAGTTAGA 13 5
1 3 6  GGATATCAATTGTGGCAATTCCCCAGAGCCCTCATCAGATGGCATTAGCCCGTCATGTGCTGCAGTGGCACCCAGTTTGGAGGAAATTCGGAACCAGAAGAGTGTGACAG 2 4 5
Exon Id
1 GCATCAGCAGCTGTCTGCCAGTGTTGACGGAGGGCTCATGGGTGCCAGGCCGCTTGCTGGGGCTTTTTATCTGTCCTCAGGCATTGGCACAGCAGCCCTGGGAGATGAATACTATTGTGATCTTCATTCTCCACA 13 5
1 3 6  CAAGGACAGGGAAGTGACGTGCCAGGGTCAAACAACTACCCAAGGACAGAGCCAGGATTTGAACCAGGCCATCCAGTTCCAGAACCACTGCTCTTCACTGTCATTGTGGCCATTTTACAG 2 5 5
Exon 2-8
1 TG 3TCCTGCGGGAAGAAGTGTCGCGGCTCCAGGAGGAAGTTCACCTTCTCCGGCAGATGAAGGAGATGTTG 3CGAAGGACCTGGAGGAGTCGCAGGGCGGCAAGTCCTCTGAGGTCCTCTCGGCCACCGAGCTCA 1 3 5
,) (L ) (R ) (E ) (E ) (V) (S ) (R) (L ) (Q) (E) (E ) (V) (H) (L ) (L ) (R) (Q) M K E M L \  K D L E S Q G G K S S E V L S A T E L R
1 3 6  GGGTCCAGCTGGCCCAGAAGGAGCAGGAGCTAGCCAGAGCCAAAGAAGCCTTGCAGGCCATGAAAGCTGATCGGAAGCGCTTAAAGGGCGAGAAGACAGACCTGGTGAGCCAGATGCAGCAGCTGTATGCCACAC 
46  V Q L A Q K E Q E L A R A K E A L Q A M K A D R K R L K G E K T D L V S Q M Q Q L Y A T L
2 7 1  TGGAGAGCCGCGAGGAGCAGCTCCGAGACTTCATCCGCAACTATGAGCAGCACCGCAAGGAGAGCGAGGATGCGGTCAAAGCGCTGGCCAAGGAGAAGGACCTGCTGGAGCGTGAGAAGTGGGAGCTGCGGCGCC 
91  E S R E E Q L R D F I R N Y E Q H R K E S E D A V K A L A K E K D L L E R E K W E L R R Q
4 0 5
1 3 5
4 0 6  AAGCCAAGGAGGCCACAGACCACGCCACGGCACTGCGCTCCCAGCTGGACCTCAAGGACAACCGGATGAAGGAGCTGGAGGCCGAGCTGGCCATGGCCAAACAGTCCTTAGCTACGCTGACCAAGGACGTCCCCA 
1 3 6  A K E A T D H A T A L R S Q L D L K D N R M K E L E A E L A M A K Q S L A T L T K D V P K
5 4 0
1 8 0
5 4 1  AGCGGCATTCCCTCGCCATGCCGGGCGAGACGGTGCTCAATGGCAACCAGGAGTGGGTGGTGCAGGCGGACCTCCCGCTGACCGCAGCCATCCGGCAGAGTCAACAGACTCTCTACCACTCACACCCCCCTCACC 
1 8 1  R H S L A M P G E T V L N G N Q E W V V Q A D L P L T A A I R Q S Q Q T L Y H S H P P H P
6 7 5
2 2 5
6 7 6  CTGCGGACCGGCAAGCGGTCAGGGTGAGCCCCTGCCACTCCCGGCAGCCCTCTGTCATCTCCGACGCATCTGCCGCCGAAGGCGACCGGTCGTCCACACCGAGCGACATCAACTCCCCTCGACACCGGACACACT 8 1 0
2 2 6  A D R Q A V R V S P C H S R Q P S V I S D A S A A E G D R S S T P S D I N S P R H R T H S  2 7 0
8 1 1  CCCTCTGCAA(^CGACAGTCCCGGCCCAGTTCAGAAGAACCTGCACAACCCTATTGTACACTCACTAGAGGATCTTGAAGACCA^AACGGAAAAAGAAGAAAGAGAAGkTGGGATTCGGCTCCATCTCCCGCG 94 5
2 7 1  L C N G D S P G P V Q K N L H N P I V Q S L E D L E D Q K R K K K K E K M G F G S I S R V  3 1 5
9 4 6  TCTTCGCCAGAGGGAAGCAGCGGAAGTCCCTCGACCCCGGCCTCTTTGATGGTACCGCCCCTGATTATTACATAGAGGAGGACGCGGACTGGTGA 
3 1 6  F A R G K Q R K S L D P G L F D G T A P D Y Y I E E D A D W *
1 0 4 0
3 4 5
Figure 4.2 Genomic organisation, nucleotide and am ino acid sequences of kazrin. (A)
Intron-exon organisation of the kazrin gene, drawn to scale. The gene consists of 7 exons (exons
2-8) that may be spliced to one of four alternative first exons (la , lb, lc, Id). Arrows; translation 
initiation sites of exons la, lb  and 2; two diagonal lines: 320 kb gap between exons la  and lb; 
TGA: translation termination codon; AATAAA: polyadenylation signal. (B) Nucleotide and 
corresponding amino acid sequences of the 5 ’ UTR and coding regions of kazrin isoforms. ATG 
start sites are shown in bold, underlined; upstream termination codons are underlined; arrows 
indicate exon boundaries; asterisk marks translation termination site. Leucine zipper-like domain 
is marked by solid box and NLS by dashed line box. Amino acids are shown in single letter 
format; those in brackets are not translated from kazrin c and d mRNAs, as their translation initia­
tion site is downstream in exon 2. Sequence data are available from GenBank/EMBL/DDBJ 
under accession numbers AY505119, AY505120, AY505121, and AY505122, corresponding to 
kazrin isoform a, b, c, and d, respectively.
4.2.2 Confirmation of the human kazrin nucleotide sequence
IMAGE (Integrated Molecular Analysis of Genomes and their Expression) clones are 
publicly available clones obtained from oligo(dT)-primed cDNA libraries that typically 
encode full length, spliced cDNAs. The IMAGE clones used to sequence kazrin are 
listed in Table 4.1. IMAGE clones were sequenced using primers specific to the vector 
into which the cDNA was cloned, as well as internal primers, as listed in Chapter 2.1.3. 
The sequence data of the 5 ’UTR and coding regions of kazrin a, b, c and d mRNAs 
were submitted to GenBank/EMBL/DDBJ under accession numbers AY505119, 
AY505120, AY505121, AY505122, respectively (Fig. 4.2 B). The GenBank entries can 
be found in the appendix.
Table 4.1 IMAGE clones containing kazrin cDNA sequences
Kazrin
isoform
IMAGE clone 
number
Source of cDNA library Vector
a 6180253 Dorsal root ganglion pCMV-SPORT6
b 4556194 Uterine leiomyosarcoma cell line pOTB7
c 4651187 Placental choriocarcinoma pOTB7
d 4472821 Liver adenocarcinoma cell line pCMV-SPORT6
4.2.3 In vitro transcription and translation of kazrin isoforms
The kazrin A, B, C proteins have predicted molecular weights (MW) of 46.8, 46.2 and 
37.0 kDa respectively, as calculated by Mac Vector 6.3.5. In order to analyse the kazrin 
proteins encoded by the IMAGE clones, and compare the actual MWs with the 
predicted MWs, in vitro transcription and translation reactions were carried out (Fig. 
4.3). Each of the kazrin isoforms was transcribed from an Sp6 polymerase binding site 
within the IMAGE clone vectors. Fig 4.3 A shows the S 4abelled kazrin proteins 
generated from the IMAGE clones. In the absence of DNA in the reaction mix no 
backgrounds -labelled proteins were generated (Fig. 4.3 A,B).
The upper protein bands generated from kazrin A cDNA are slightly larger than the 
predicted size of 46.8 kDa. The multiple high molecular weight protein bands seen for 
kazrin A suggest either that there are alternate start sites (though these were not found 
by sequencing of the 5 ’UTRs) or that there is post-translational modification, such as
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Fig 4.3 In  vitro transcription and translation of IMAGE clones encoding kazrin cDNAs generate proteins of 
the expected size. (A) 0.5pg of each IMAGE clone, and a negative control lane with no DNA (-), was used in each 
reaction using the Sp6 polymerase and S-methionine. IMAGE clones encoding kazrin a, b, c and d were used. 
IMAGE clone numbers are indicated in Table 4.1. 10% (l|il) of the reaction was run on an SDS-PAGE gel. The gel 
was dried and exposed on film at room temperature for 4 days. Arrows highlight the position of the putative full 
length kazrin protein isoforms. (B) Coo massie stained SDS-PAGE gel of reactions run in (A) to show equal loading 
of lanes. BioRad molecular weight markers shown in kDa.
phosphorylation of kazrin A protein (Joshi et al., 1995; Schubert et al., 1994). The 
major band from kazrin b is a little larger than the predicted size of 46.2 kDa, however 
no other proteins bands were detected in track b which could represent full length kazrin 
B protein (Fig. 4.3 A).
The major protein band seen in tracks c and d (Fig. 4.3 A) is at approximately 37.0 kDa. 
The protein coding region of kazrin c and d should be identical as translation starts 
within common exon 2, yet the protein bands generated in the TNT reactions are not 
identical (Fig. 4.3). At 37 kDa in track c there is a triplet of bands while in track d there 
is one major and one minor band. The additional bands around 37 kDa may be due to 
posttranslational modifications such as phosphorylation (Joshi et al., 1995; Schubert et 
al., 1994). The mRNAs generated from kazrin c and d cDNAs may have different 
stabilities, which may have an effect on the level of protein produced and any 
modifications it undergoes. A larger band, ~60 kDa, is seen in C, which may be the 
result of initiation from an alternative upstream methionine. The sequence of kazrin c 
contains no methionines upstream of the start codon in exon 2, nor stop codons within 
the 5 ’UTR, suggesting that initiation may have taken place from a spurious ATG start 
codon in the vector in frame with the kazrin c mRNA sequence (Fig. 4.3 A).
The lower bands (<35 kDa) found in all the reactions are attributable to translation from 
partially degraded mRNAs, degraded proteins or suboptimal magnesium concentrations, 
which can lead to internal translation (Kozak, 1996) (Fig. 4.3 A).
4.2.4 Analysis of kazrin protein sequences
The deduced amino acid sequences of the kazrin isoforms are composed of 28-30% 
polar, 15-17% acidic and 17-20% basic residues (Table 4.2). A hydrophilicity plot, 
based on the method of Kyte and Doolittle (1982) and implemented by Mac Vector 
6.5.3, revealed that kazrin proteins are hydrophilic (Kazrin C in Fig. 4.4 A). Analysis 
using the von Heijne algorithm for predicting transmembrane regions, as implemented 
by MacVector 6.5.3, suggests that kazrin proteins are not transmembrane proteins 
(Sipos and von Heijne, 1993).
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Fig 4.4 Kazrin is hydrophilic and contains predominantly a-helices and p-turns.
(A) Hydroph/licity plot of kazrin C, based on the method of Kyte and Doolitle (1982), 
as implemented by MacVector 6.5.3. Positive values on the y-axis denote hydrophilic 
regions predicted to be on the outside of the protein; negative values on the y-axis are 
predicted to be on the inside of the protein or inside other hydrophobic environments.
(B) Concensus secondary structure prediction of kazrin A, B and C, based on the algo­
rithms of Chou and Fasman (1978) and Gamier and Robson (1978), as implemented by 
MacVector 6.5.3.
Secondary structure analysis based on the algorithms of Chou and Fasman (1978) and 
Robson and Gamier (1978), as implemented by MacVector 6.5.3, predicts kazrin C has 
a highly a-helical N-terminal region, while its C-terminus is predicted to form a small 
P-sheet, multiple^-turns and 3 a -h e lica l stretches. The N-terminal region unique to 
kazrin A is predicted to form 4 a-helices and a p-turn, while the N-terminal region 
unique to kazrin B is predicted to form two short a-helical stretches and multiple P- 
tums (Fig 4.4 B).
Table 4.2 Amino acid composition of kazrin isoforms
Kazrin
isoform
% polar aa % non-polar aa % basic aa % acidic aa
A 29.7 37.3 17.3 15.7
B 28.1 37.5 18.3 15.9
C 28.0 35.7 19.5 16.5
Kazrin proteins are likely to form coiled coils, as calculated by COILS using the Lupas 
algorithm (1991) (Fig. 4.5). Parallel two-stranded coiled coils consist of two right- 
handed a-helixes wrapped around each other with a left-handed superhelical twist. 
Coiled-coik forming proteins have heptad repeats, (abcdefg)n, in which residues in 
positions a and d are generally hydrophobic and form the interface between the two 
proteins. Coiled-coils are found in many proteins which dimerise, or form higher order 
structures, such as the plakins and keratins (Ruhrberg and Watt, 1997; Strelkov et al., 
2003). The analysis suggests that kazrin proteins may form hetero-or homo-dimers with 
themselves or form dimers with other heptad-repeat containing proteins. The ability of 
kazrin isoforms to form coiled-coil dimers may explain the formation of the >60 kDa 
band seen in Fig. 4.3 A, track c.
Leucine zippers are a specialised form of the coiled coil in which residue d in the heptad 
repeat is a leucine (Alber, 1992). Leucine zipper sequences are generally composed of 3 
to 6 leucine-containing heptad repeats (Bomberg-Bauer et al., 1998). 2ZIP, a program 
used to predict the presence of leucine zipper sequences, suggests a region encoded by 
exon 2, prior to the translation start site of kazrin C, consists of a leucine repeat (three 
heptads) (Fig. 4.6). The leucine zipper-like repeats are predicted to form part of a coiled- 
coil region (asterisk, Fig. 4.5).
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Fig 4.5 Kazrin isoforms are likely to form coiled coils. Probability graphs of the 
likelihood that a particular amino acid is part of a coiled coil, as calculated by the 
Lupas algorithm (Lupas et al. 1991). Kazrin sequences were analysed, with a 28 
amino acid window, for regions with a high probability of forming coiled coils. 
Amino acids with a probability value > 0.9 for 35 consecutive amino acids or more, 
are likely to form coiled coil structures. Asterisks indicate the location of the leucine 
zipper-like repeats of kazrin A and B. k  indicates the non-helical region between the 
predicted leucine zipper region and the large a-helical domain of kazrin.
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Fig 4.6 Kazrin proteins contain putative leucine zipper domains and 
nuclear localisation signals. Schematic diagram (to scale) of structural 
features of the kazrin protein isoforms based on analysis by MacVector 6.5.3, 
NLS prediction and 2ZIP. Light grey box: leucine zipper-like domain; dark 
grey box: a-helical domain; black box: nuclear localisation signal (NLS). 
Sequence of the leucine zipper-like domain is shown with leucines in position 
d of the heptad repeat underlined. Sequence of the NLS is indicated. Numbers 
indicate the amino acid positions at which domains are predicted to start and 
finish.
Proteins destined for the nucleus generally contain a nuclear localisation signal (NLS) 
composed of a cluster of basic amino acids (Makkerh et al., 1996). The NLS is bound 
by a-importin, which facilitates protein transport through the nuclear pore complex. 
The NLS prediction algorithm of Cokol et al. (2000) suggests the presence of an NLS in 
the C-terminus of kazrin proteins (KRKKKKEK) (Fig.4.6). The presence of an NLS 
suggests that a proportion of, or all endogenous kazrin protein may be nuclear.
Searches of the kazrin protein sequences against the NCBI non-redundant protein 
database did not show significant homology between kazrin and other known proteins 
or protein domains. Kazrin does have a weak homology with a-helix-containing regions 
of proteins such as the myosin heavy chains, which are known to form coiled-coils, and 
the ezrin-radixin-moesin (ERM) family of proteins, which are thought to form coiled- 
coils (Bretscher et al., 2002; Weiss and Leinwand, 1996). No significant homology 
between the C-terminal region of kazrin C, largely composed of |3-turns, and known 
protein families or domains was found.
4.2.5 Sequence comparison of kazrin proteins
The mouse kazrin gene, as analysed by BLAT and BLAST, has a similar structure to the 
human gene (compare Fig. 4.2 A and 4.7 A). Kazrin a and b, but not kazrin c or d, 
mRNAs have been identified in mouse EST databases thus far. The predicted amino 
acid sequence of human and mouse kazrin, over the region encompassing kazrin C 
protein are 98% identical. The changes of amino acids between human and mouse 
sequences, over the region encompassing kazrin C, are 17 S to C, 31 A to V, 126 T to 
A, 212 A deleted, 265 N to S. Fig 4.7 B shows the alignment of human and mouse 
exons la  and lb  up to the translation initiation site of kazrin C in exon 2. The N- 
terminal domains of mouse and human kazrin A show 84% identity and 88% similarity, 
while the kazrin B N-terminal sequences show 63% identity and 72% similarity.
BLAST searches of the human kazrin C sequence against the GenBank non-human and 
non-mouse EST translated database indicated the expression of kazrin-like proteins in 
other species. Kazrin homologues are found in many bony vertebrates (Table 4.3). No 
sequences with significant homology to kazrin were identified in the worm C. elegans
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Fig 4.7 H um an and  mouse kazrin  genes are  highly conserved. (A) Schematic of the mouse kazrin gene. Mouse exon la  has been 
identified in EST databases but its location on chromosome 4 relative the rest of the gene is unknown. TGA, termination codon; 
AATAAA, transcription termination signal. (B) Alignment of amino acid sequences encoded by human and mouse exons la  and lb, 
up to the translation initiation site of kazrin C in exon 2. Amino acid numbers are shown above the alignment. Identical amino acids 
are boxed. Amino acid sequences of mouse kazrin isoforms are predicted from publicly available databases.
or yeast. An EST (AI063603) with 36% identity, 76% similarity with the a-helical 
region of kazrin was identified in the fruit fly (Drosophila melanogaster). The kazrin C 
protein sequence was subsequently searched against a BLAST database of Drosophila 
translated ESTs. The search indicated that kazrin C showed homology to a region of 
two Drosophila proteins, from the same gene, known as CGI 1206-PA (1013 amino 
acids; accession no. AAF46835) and RE35867p (653 amino acids; accession no. 
AAQ22463).
Table 4.3 Kazrin is highly conserved amongst vertebrates
Percentage
identity
Percentage
similarity
Species name GenBank 
accession no.
99 99 Rattus norvegicus (Rat) BF548714
94 94 Bos taurus (Bull) AW462068
92 94 Gallus gallus (Chicken) AJ451182
83 92 Danio rerio (Zebrafish) AI332211
89 94 Xenopus laevis (Frog) BI314816
77 80 Xenopus laevis (Frog) BJ032461
77 80 Xenopus laevis (Frog) BG555153
77 80 Xenopus laevis (Frog) BG554572
76 79 Xenopus laevis (Frog) BG410176
73 78 Silurane tropicalis (Frog) BG512962
70 71 Silurane tropicalis (Frog) AL681984
NCBI-BLAS1 searches of t ne human kazrin C amino acid sequence against the
GenBank non-mouse and non-human EST database indicated the expression of kazrin- 
like proteins in other species, all of which belong to the taxon Euteleostomi or bony 
vertebrates. Species included in the list have an EST represented in the database with 
greater than 70% identity at the amino acid level, over a length of greater than 100 
amino acids, with human kazrin C. Percentage identity and similarity at the amino acid 
level and the relevant GenBank accession numbers are shown.
4.3 Further analysis of the interaction between kazrin and periplakin
The yeast two-hybrid screen demonstrated that kazrin C (amino acids 49-327) could 
bind periplakin PI 33. In order to map the regions of periplakin and kazrin necessary for 
this interaction, yeast two-hybrid analysis was carried out with periplakin and kazrin
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deletion mutants. To demonstrate that kazrin could bind endogenous full length 
periplakin, GST pull-downs were carried out.
4.3.1 Mapping of the interaction between kazrin and periplakin by yeast-two hybrid 
screening
Deletion mutants of kazrin (‘prey’) were tested for their ability to interact with P I33 
(‘bait’) by yeast two-hybrid analysis. The binding was analysed by growth of 
transformed yeast on A'L'T'H' agar.
Full length kazrin C and kazrin C aa 49-327 both bound P I33 (Fig. 4.8). Further 
deletions showed that the minimal region necessary for P I33 binding was amino acids 
89-239 of kazrin C, encoding the latter half of the a-helical domain and a series of (3- 
tums (Fig. 4.8).
Periplakin deletion constructs were tested for their ability to bind kazrin C and kazrin C 
amino acids 88-239. P80 and P63 did not detectably bind kazrin C. Kazrin C was able 
to bind P I6-133, indicating that the non-helical region preceding the periplakin NN sub- 
domain is not essential for the interaction. Finally, P I6-133 was found to bind kazrin C 
amino acids 89-239 (Fig. 4.9)
In conclusion, the minimal regions required for the interaction are amino acids 88-239 
of kazrin C and amino acids 16 to 133 of periplakin.
4.3.2 Confirmation of the interaction between kazrin and periplakin by GST pull­
down
To validate the association of kazrin with P I33, kazrin-GST fusion proteins were used 
in pull-down assays with human keratinocyte lysates as a source of periplakin (Fig. 
4.10). The partial clone obtained in the yeast two-hybrid screen (KCA), full-length 
kazrin A, B, and C all bound periplakin, while GST protein alone did not. Envoplakin 
was also pulled down by kazrin-GST fusion proteins but not by GST protein alone.
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Fig 4.8 The minimal region of kazrin that binds P133 encompasses half the a -  
helical domain and a series of (3-turns. Deletion analysis of kazrin C protein by 
yeast two-hybrid analysis. Yeast transformations were performed using P133 in 
combination with different portions of kazrin C protein, as shown above. B/A: bind­
ing activity, assessed by growth of yeast on selective media. A schematic picture of 
the kazrin C protein is shown at top. Dark grey box: a-helical domain; black box: 
nuclear localisation signal. Numbers indicate the amino acid positions at which 
domains start and finish.
Periplakin (bait) Kazrin (prey) Binding activity
Periplakin (P133) Kazrin C (aa 1-327) +
Periplakin (P80) Kazrin C (aa 1-327) -
Periplakin (P63) Kazrin C (aa 1-327) -
Periplakin (P16-133) Kazrin C (aa 1-327) +
Periplakin (P16-133) Kazrin C (aa 88-239) +
Fig 4.9 Periplakin P16-133 binds kazrin C efficiently. Deletion analysis of peri­
plakin N-terminus. Yeast transformations were performed using a variety of peri­
plakin bait vectors, in combination with different portions of kazrin C (prey) 
protein. Binding activity was assessed by growth of yeast on selective media.
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Periplakin
Envoplakin
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■ kazrin A or B - GST
 kazrin C - GST
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Fig 4.10 Kazrin binds periplakin and envoplakin in GST pull-down experi­
ments. lOpg of kazrin-GST fusion proteins or GST alone were bound to GST 
beads and incubated with primary human keratinocyte lysate. As a positive 
control 4% of the cell lysate was run alongside the pull down reactions. Immuno- 
blots were probed with antibodies to periplakin (TD2), envoplakin (CR5), desmo­
plakin (Dpll5F), ERK2 (ERK2 anti-serum) and GST (GST anti-serum). KA: 
kazrin A-GST; KB: kazrin B-GST; KC: kazrin C-GST; KCA: Kazrin C aa 49- 
327-GST; GST: GST alone. Arrows highlight the position of full length kazrin - 
GST fusion proteins and GST protein alone bands.
Desmoplakin was readily detected in keratinocyte lysates, but was either undetectable 
or weakly detectable in the GST pull-downs (Fig. 4.10). An ERK2 control was carried 
out for non-specific interactions. ERK2 was readily detected in the lysate but 
undetectable in pull-down lanes.
4.4 Analysis of the expression pattern of kazrin
The kazrin cDNA we isolated by yeast two-hybrid screening was derived from a 
foreskin keratinocyte cDNA library but, as evidenced from EST databases, kazrin 
expression is not confined to epidermal cells. To identify tissues in which kazrin was 
expressed, a multi-tissue Northern blot was used. In order to analyse whether the four 
kazrin mRNA isoforms were differentially expressed, RT-PCR analysis of RNA from 
various cell lines was performed in collaboration with L. Sevilla (Keratinocyte 
laboratory, CR-UK).
4.4.1 Kazrin expression in mouse tissues
In order to analyse kazrin expression a Northern blot was carried out (Fig 4.11) 
Sequence data from publicly available databases suggest that mouse kazrin a and b 
mRNAs are roughly 3.85kb in length. A 585bp DNA probe, able to recognise both 
kazrin a and b mRNAs, identified a band below the 4.4kb marker, presumably kazrin a 
and b transcripts (Fig. 4.11 A). The data suggest that kazrin mRNAs are highly 
expressed in the brain and kidney. Lower levels of kazrin expression were detected in 
lung, testis and spleen. Kazrin is not expressed or expressed at undetectable levels in 
heart, liver and skeletal muscle (Fig. 4.11 A).
Fig. 4.11 B shows that in addition to the predicted 3.85kb kazrin a and b transcripts 
other transcripts are recognised by the kazrin probe. Transcripts of ~2.3kb and ~5.1kb 
were readily identified using the kazrin cDNA probe in mouse spleen and testis 
samples. The transcripts identified may be other kazrin splice variants or sequences with 
some homology to the kazrin sequence.
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Fig 4.11 Kazrin mRNA is expressed in a range of mouse organs. Message- 
Map northern blots of mRNA from a panel of mouse organs (Stratagene). 
Northern blots were probed with a 585bp probe recognising both kazrin a and 
kazrin b mRNAs. (A) Northern blot showing kazrin mRNA expression in 
brain, kidney, lung, testis and spleen. (B) Northern blot showing RNA from 
mouse testis and spleen. Arrows mark putative kazrin transcripts. Arrow 2 
marks a kazrin transcript of the predicted size, based on analysis of publicly 
available sequence data; arrows 1 and 3 may represent other kazrin mRNA 
splice variants. An actin loading control is shown in each case. The p-actin 
probe binds a-actin, resulting in the appearance of an additional band.
4.4.2 Analysis of the expression of the different kazrin isoforms
To determine whether the splice variants of kazrin are differentially expressed, RT-PCR 
was performed on RNA isolated from primary human keratinocytes (HK), primary 
dermal fibroblasts (HDF), and from three human cell lines, A431 (epidermoid 
carcinoma), EJ/28 (bladder carcinoma), and JAR (placental trophoblastoma). A forward 
primer that binds specifically within each first exon, la, lb , lc , or Id, was used in 
combination with a reverse primer that binds sequences in exons 3 and 4 (Fig. 4.12). 
The RT-PCR products from each set of primers were cloned and sequenced to confirm 
their identity.
Kazrin b and d transcripts were expressed in all cell types examined. Kazrin a 
transcripts were detectable in all cell types except A431. Kazrin c transcripts were only 
detected in JAR cells and to a lesser extent in human dermal fibroblasts (Fig. 4.12).
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Fig 4.12 Expression of kazrin isoforms. RT-PCR analysis of kazrin 
mRNA in a panel of primary cells and cell lines: A431 (epidermoid 
carcinoma), EJ/28 (bladder carcinoma), HDF (human dermal fibro­
blasts), JAR (placental trophoblastoma), HK (human primary keratino­
cytes). Forward primers specific for each of the four alternatively 
spliced first exons (la , lb, lc, Id) were used in combination with a 
reverse primer that binds within the third and fourth exons common to 
all splice forms. As control for the total level of kazrin transcripts, a 
forward primer was used that binds within exon 2 (kazrin all) in combi­
nation with the reverse primer. Primers specfic for GAPDH were used 
to control for the input level of mRNA.
4.5 Discussion
In this chapter I have shown that kazrin is a novel interactor of periplakin. Analysis of 
the nucleotide and amino acid sequences of kazrin isoforms suggests it is highly 
conserved. Mouse homologues of kazrin la, lb, lc  and Id exons have been identified in 
the mouse genome; however, only exons la  and lb  have been isolated as ESTs. Exons 
lc  and Id may not be expressed in the mouse or have simply not yet been reported. The 
predicted size of kazrin c and d mRNAs are ~ 3.67kb and therefore it may not be easy to 
differentiate kazrin a, b, c and d mRNA isoforms on a Northern blot. Northern blotting 
of mouse tissues suggests that further kazrin splice variants or genes with homology to 
the kazrin gene exist. Analysis of the mouse EST database does not reveal the presence 
of other kazrin splice variants at present.
Kazrin homologs were found in many vertebrates, such as Xenopus laevis and chickens. 
Two Drosophila proteins which showed homology to the a-helical region of kazrin 
were also identified. The functions of the Drosophila proteins are not known, although 
analysis using COILS suggests that they, like kazrin, contain a coiled-coil region. The 
similarity seen with the vertebrate kazrin sequences may be suggestive of the existence 
of a kazrin homolog in Drosophila.
Kazrin was isolated in a yeast two-hybrid screen to find interactors of periplakin (P I33) 
which may be involved in targeting periplakin to the microvilli. Yeast two-hybrid 
analysis showed that PI 6-133 could, but P80 could not, interact with kazrin C. Analysis 
of periplakin localisation by transient transfection suggested that P80 could localise to 
the microvilli, while P16-133 could do so much less efficiently. The disparity between 
the yeast two-hybrid analysis and the transient transfections suggests that kazrin is not 
the protein that targets periplakin to the microvilli. Alternatively the yeast system may 
not be a complete predictor of kazrin/periplakin interactions in primary keratinocytes.
The interaction between P I33 and kazrin was mapped to the latter half of the kazrin 
a -h e lica l domain and a series of P-turns. How the interaction is achieved in three- 
dimensions is not known and would require analysis of the crystal structure of 
kazrin/periplakin complexes. It is tempting to speculate that some or all of the short a -
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helical regions of periplakin P I33 form a coiled coil-like structure with the kazrin a -  
helical region. The non-helical section and |3-turns of kazrin may act to stabilise and 
strengthen the interaction with P I33.
Kazrin and P I33 can associate in intact cells, as shown by immunoprecipitation
ccv/’fuuA euJfc
experiments (L Sevilla, Keratinocyte laboratory, CR-UK)>ImmunoprecipitationsAusing 
COS cells co-transfected with C-terminal FLAG-tagged kazrin C and C-terminal HA 
tagged P I33 in COS cells (Groot el al., 2004).
A lack of suitable antibodies capable of immunoprecipitating kazrin or periplakin 
prevented us from showing the interaction of endogenous kazrin and periplakin in 
keratinocytes. LS4, our rabbit polyclonal antibody to kazrin, does not 
immunoprecipitate. We have antibodies capable of immunoprecipitating periplakin, but 
these are all rabbit polyclonals.
Endogenous periplakin binds kazrin in GST pull-down experiments. Envoplakin was 
pulled down by kazrin-GST but not by GST protein alone, suggesting that kazrin and 
envoplakin can interact, presumably indirectly through heterodim erisation of 
envoplakin and periplakin. The pull-down of envoplakin suggests that the binding of 
periplakin and kazrin and the binding of envoplakin and periplakin are not mutually 
exclusive.
Northern blotting data from mouse tissues (Fig. 4.12) suggested that kazrin was 
expressed in several mouse tissues. Real-time PCR analysis of kazrin expression, using 
cDNA preparations of multiple human tissues, indicated that it is expressed widely (K. 
Nishi, Keratinocyte laboratory, CR-UK). Kazrin was expressed highly in brain, kidney, 
lung, placenta and spleen. Expression of kazrin was low in skeletal muscle (Groot et al., 
2004).
Kazrin was detected in many tissues that have previously been shown to express 
periplakin, including bladder, brain, colon, heart, kidney, liver, lung, pancreas, placenta, 
and small intestine (Aho and Kazerounian, 2003; Aho et al., 1998; Ma and Sun, 1986; 
Ruhrberg et al., 1997). Periplakin expression is not confined to epidermal epithelial 
cells, the function of periplakin in transitional, pseudo-stratified and simple epithelia, as
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well as non-epithelial tissues such as the brain, is not well understood (Ruhrberg et al., 
1997). The presence of kazrin in many of the cell types that express periplakin suggests 
the interaction between kazrin and periplakin is not restricted to epidermal cells.
RT-PCR analysis of the kazrin mRNA isoforms suggests that kazrin mRNA splicing 
differs between cell types. Keratinocytes express mRNA isoforms a, b and d and thus 
are predicted to express all three kazrin proteins. All three of these proteins are able to 
interact with periplakin. EJ/28, HDF and JAR cells are also predicted to express all 
three kazrin protein isoforms, while A431 cells, which do not express kazrin a mRNA, 
are expected to express only kazrin B and C proteins. As there is differential expression 
of the different kazrin mRNA isoforms and there are likely to^differences in the relative 
levels of kazrin A, B and C proteins expressed in different tissues, it will be of interest 
to know the function of the unique N-termini of kazrin A and B.
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Chapter 5.
In this chapter I will present data on the localisation of endogenous kazrin in epithelial 
tissues and cultured primary keratinocytes. The localisation and effect of expression of 
individual kazrin isoforms was analysed by means of transient transfection of kazrin 
cDNA constructs into cultured primary keratinocytes and cell lines.
5.1 Kazrin localisation in epithelial cells and tissues
In order to analyse the localisation of endogenous kazrin proteins, a rabbit antiserum 
(LS4) was raised against a peptide corresponding to the C-terminal 20 amino acids of 
kazrin. The sequence used is found in all three kazrin isoforms and is entirely conserved 
between mice and humans. The affinity purified antiserum recognized bands of 
approximately 47 kDa and 37 kDa on Western blots of lysates from A431, EJ/28 and 
primary keratinocytes (Groot et al., 2004). The bands corresponded to the predicted 
molecular weights of kazrin A (46.8 kDa), kazrin B (46.2 kDa) and kazrin C (37.0 
kDa).
5.1.1 Kazrin localises to cell-cell borders
To detect endogenous kazrin in frozen tissue sections the LS4 antiserum was used for 
immunostaining. Kazrin was detected in all layers of the epidermis (Fig. 5.1 A) and in 
the hair follicle (Groot et al., 2004). Periplakin is upregulated in suprabasal cells of the 
epidermis (Fig. 5.1 B). In suprabasal layers, where periplakin is expressed, kazrin 
localised to cell-cell borders. In the basal layer, which lacks periplakin expression, 
kazrin was more diffusely localised (Fig. 5.1 A). Some kazrin signal was detected in the 
dermis, consistent with the expression of kazrin mRNAs in human dermal fibroblasts 
(Fig. 5.1 A and Fig. 4.12).
In oesophageal mucosa and cervical mucosa, kazrin was expressed in all the epithelial 
cell layers. Kazrin partially colocalised with desmoplakin at cell-cell borders; this was
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Fig 5.1 Kazrin localises to cell-cell borders, partially colocalising 
with desmoplakin. Immunofluorescence staining of sections of frozen 
human epidermis (A,B), oesophageal mucosa (C-E) and cervical 
mucosa (F-H). Green fluorescence: kazrin (A, C-H); periplakin (B). 
Blue fluorescence: (A-B) T0PR 03 nuclear counterstain; (C-E) DA PI 
nuclear counterstain. Red Fluorescence: desmoplakin (C-H). Arrows 
mark the position of the basement membrane. Scale bars: (A-B) 50pm; 
(C-H) 42pm. (A-B) Immunofluorescence staining by Lisa Sevilla 
(Keratinocyte laboratory, CR-UK)
observed most prominently in suprabasal layers (Fig. 5.1 C-H). Some kazrin signal was 
detected in the sub-mucosal tissue of the oesophagus and cervix (Fig. 5. C-H). Kazrin 
was detected in the nucleus of some epithelial and non-epithelial cells (Fig. 5.1 C-H). 
However, this was not a consistent finding (Fig. 5.1 A).
5.1.2 Kazrin localises to the desmosomes of epidermis
The immunofluorescence staining of epidermis suggested that kazrin might, like 
desmoplakin and periplakin, be a component of desmosomes. In collaboration with the 
Electron Microscopy Department (CR-UK) we set out to analyse kazrin localisation by 
immuno-electron microscopy. Samples were prepared and stained as detailed in the 
Materials and Methods.
Desmoplakin was found at the desmosomes of adult breast epidermis (Fig. 5.2 A,B). 
Kazrin was found at desmosomes (Fig. 5.2 C-D) and in the nucleus (Fig. 5.2 E), as 
detected using LS4 antiserum. There was little staining of adult breast epidermis in 
negative control samples stained with secondary antibody or protein A alone (Fig. 5.2 
F,G).
5.1.3 Kazrin partially colocalises with desmoplakin and periplakin at the 
desmosomes of cultured cells
Primary human keratinocytes stratify and differentiate in culture. In stratified cultures 
kazrin was observed at cell-cell borders and in the nucleus (Fig. 5.3). At the interface 
between the apical surfaces of basal layer cells and the basal surfaces of suprabasal cells 
large numbers of desmosomes assemble. Kazrin partially colocalised with periplakin, 
which localises to the desmosomes and the interdesmosomal plasma membrane (Fig.
5.3 A-D). Kazrin partially colocalised with desmoplakin at the desmosomes (Fig. 5.3 E- 
H). Periplakin and kazrin were localised to puncta, corresponding to desmosomes, 
where intermediate filaments in neighbouring cells aligned (Fig. 5.3 I-L).
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Fig 5.2 Kazrin localises to desmosomes and the nucleus of interfollicular epidermal 
cells. Adult breast epidermis was subjected to high pressure freezing/freeze substitution 
and sections labelled with antibodies to desmoplakin and kazrin. (A,B) desmoplakin (DP, 
D pll5F  antibody); (C-E) kazrin (K, LS4 antibody); (F) Secondary antibody alone (goat 
anti-mouse IgG conjugated to lOnm gold); (G) protein A conjugated to lOnm gold. 
Boxed areas in A and C are shown as zooms in B and D, respectively. Arrows indicate 
gold particles localised at the desmosomes (A, C) or in the nucleus (Nu) (E). Scale bar: 
200nm (A, F), 90 nm (B), 330nm (C, G), 120 nm (D), 487nm (E).
Fig 5.3 Kazrin localises to the desmosomes of prim ary hum an keratinocytes. Stratified cultures of primary human keratinocytes were stained for 
kazrin (green fluorescence;A-J), periplakin (red fluorescence; A-D, green fluorscence; K-L), desmoplakin (red fluorescence; E-H) and keratin inter­
mediate filaments (red fluorescence; I-L). Boxed areas in A, E, I, K are shown as enlargements in B-D,F-H, J and L, respectively. (A-D, I-L) cells 
were fixed in ice-cold methanol for 2 - 5 mins. (E-H) cells were extracted with CSK buffer for 5 mins prior to fixation with PFA. Scale bars: 20pm 
(A, E, I, K), 7pm (B-D), 8.2pm (F-H), 5.4pm (J,L). (A-D) Immunofluorescence by Lisa Sevilla (Keratinocyte Laboratory, CR-UK).
5.1.4 Kazrin depends on actin but not periplakin for its localisation
Primary keratinocytes were cultured and treated with latrunculin B to disassemble the 
actin cytoskeleton (Fig. 5.4). Treatment with latrunculin B caused the redistribution of 
kazrin into actin-rich patches. Latrunculin B treatment also results in the redistribution 
of periplakin into actin-rich patches, in contrast to desmoplakin, which remains at the 
desmosomes (DiColandrea et al., 2000).
Immortalised keratinocyte lines were generated from wild type mice (Romero et al., 
1999) and periplakin knock-out mice (MKP‘A). The cell lines were grown to confluence 
in high calcium medium to induce differentiation and stratification (see Materials and 
Methods for more details). Kazrin partially colocalised with desmoplakin at the cell-cell 
borders of differentiated wild type and M K PA mouse keratinocytes (Fig. 5.5). The 
results suggest that kazrin is not dependent upon periplakin to localise to cell-cell 
borders. The nuclei of wild type and MKP'A mouse keratinocytes stained strongly with 
LS4 antiserum (Fig. 5.5).
5.1.5 Kazrin can be incorporated into the cornified envelope
To determine whether kazrin, like periplakin, can be incorporated into the cornified 
envelope, confluent keratinocyte cultures were treated with 0.04% Triton X-100 for 5 
hours to induce envelope assembly (Fig. 5.6). Perforations in the plasma membrane, 
formed by Triton X-100 treatment, allow entry of extracellular Ca2+ ions into the cell. 
The extracellular Ca2+ activates the crosslinking of cornified envelope precursors by 
Ca2+-dependent tranglutaminases. Proteins that become cross-linked into the cornified 
envelope are no longer extractable in buffers containing SDS and reducing agents (Rice 
and Green, 1979). Transglutaminase-mediated crosslinking is inhibited by cystamine 
(Ruhrberg et al., 1997; Siefring et al., 1978).
Periplakin was readily detected in control lysates in the presence (Cy) or absence of 
cystamine (-). Periplakin became non-extractable following Triton X-100 treatment (T)
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Fig 5.4 K azrin partially localises to actin-rich patches form ed upon latrunculin 
B treatm ent. Primary human keratinocytes were treated with latrunculin B 
(200ng/ml, 3hr) prior to fixation with 3% PFA and permeabilisation with 0.2% Triton 
X-100. Green fluorescence: kazrin (LS4). Red fluorescence: actin (phalloidin). 
Scale bar. 20pm.
D
D
l-
/
kazrin desmoplakin
Fig 5.5 K azrin localises to cell-cell borders independently of periplakin. Wild type (wt) and periplakin 
knockout (ppl-/-) mouse keratinocyte cell lines stained for kazrin (green fluorescence) and desmoplakin (red 
fluorescence). Boxed areas in A and E are shown as zooms in B-D and F-H respectively. Scale bar: (A,E) 
20|im; (B-D,F-H), 5pm. Cells were extracted with CSK buffer for 5 mins prior to fixation with PFA. (A-H) 
Immunofluorescence staining by Lisa Sevilla (Keratinocyte Laboratory, CR-UK).
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Fig 5.6 K azrin can be incorporated into the cornified envelope 
upon activation of transglutam inases. Primary human keratino­
cytes were treated for 5hrs in serum-free FAD in the absence (-) or 
presence of Triton X-100 (T), or in serum-free medium containing 
20mM cystamine in the absence (Cy) or presence of Triton X-100 
(Cy/T). Immunoblots of the protein extracts were probed with 
antibodies to kazrin (LS4), periplakin (AE11) or plakoglobin (VB3).
and this was inhibited by cystamine (Cy/T), as previously shown (Ruhrberg et al., 1997; 
Simon and Green, 1984) (Fig. 5.6).
A 47 kDa band, corresponding to kazrin A and/or B proteins, was readily detected in the 
control lanes (- and Cy) probed with LS4. Treatment of the cells with Triton X-100 
resulted in the loss of the kazrin A/B band on the Western blot. Following treatment of 
the cells with cystamine and Triton X-100, kazrin A/B could still be detected in the 
lysates; however, there was a reduction in the signal in the Cy/T lane, relative to the 
control lanes (- or Cy). The reduction in the signal is presumably the result of loss, into 
the culture medium, of kazrin proteins. Loss of cellular proteins upon permeabilisation 
of cells has previously been seen for involucrin (a known cornified envelope precursor), 
lactate dehydrogenase and even transglutaminase itself (Rice and Green, 1979; 
Ruhrberg et al., 1996). Kazrin C (37kDa band) was less readily detected in the 
keratinocyte lysates, precluding conclusions on whether kazrin C can be incorporated infco 
the CE.
Plakoglobin, a component of desmosomes that can be incorporated into cornified 
envelopes (Robinson et al., 1997), was found to be only slightly reduced in cells treated 
with Triton X-100 alone (Fig. 5.6), as previously described by Christiana Ruhrberg 
(Keratinocyte Laboratory, Cancer Research UK).
5.2 Analysis of the localisation of transfected kazrin isoforms
To determine the subcellular localisation of kazrin proteins, constructs encoding tagged 
kazrin proteins were made. The constructs encoded N-terminally HA-tagged kazrin A, 
B and C or C-terminally FLAG-tagged kazrin C.
5.2.1 Kazrin localises to the plasma membrane
HA-tagged constructs encoding kazrin A, B or C were transiently transfected into 
primary human keratinocytes (Fig. 5.7). All three kazrin isoforms had similar
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Fig. 5.7 Kazrin isoforms localise to the plasma m em brane. Kazrin isoforms with N- 
terminal HA tags were transiently transfected into primary human keratinocytes. (A-0): 
anti-HA (green), phalloidin-TRITC (red). (A-E) kazrin A; (F-J) kazrin B; (K-O) kazrin 
C. A-C, F-H, K-M are composite images of z-stacks. Arrowheads indicate position of 
orthogonal views shown in D, 1, N. Areas boxed in C, H, and M are shown as single 
confocal slice in E, J, and O, respectively. Z-stack size: (D) 8.2 pm, (I) 11.1 pm, (N) 11.6 
pm. Scale bars: 20 pm (A-D, F-I, K-N); 6 pm (E, J, O).
distributions. Kazrin isoforms were found predominantly at the plasma membrane of 
primary keratinocytes (Fig. 5.7 D, I, N) with some signal in the cytoplasm and variable 
amounts in the nucleus (see below). All three kazrin isoforms partially colocalised with 
actin structures at the apical plasma membrane of keratinocytes (Fig. 5.7). Kazrin 
isoforms partially colocalised with CD44, a marker of microvilli (Fig. 5.8).
N-terminally HA-tagged forms of kazrin C were localised to actin structures at the 
plasma membrane in ~23% of cells (n=82). C-terminally FLAG-tagged forms of kazrin 
C were seen at apical plasma membrane structures, colocalising with actin, in ~26% of 
cells (n=42). The kazrin proteins were pot seen at apical plasma membrane structures in 
every cell, as many of the cells had very small, and/or few, microvilli or ruffle 
structures at their surface (see below).
5.2.2 Kazrin colocalises with P133 at microvilli
Kazrin was identified as a binding partner of periplakin P I33. Primary keratinocytes 
were co-transfected with N-terminally HA-tagged P I33 and C-terminally FLAG-tagged 
kazrin C (Fig. 5.9). Keratinocytes generally have short microvilli over their apical 
surface (DiColandrea et al., 2000). In keratinocytes transfected with P I33, P I33 was 
seen prominently at the microvilli. The microvilli of cells co-expressing P I33 and 
kazrin-C did not always cover the whole apical surface of the cells; however, kazrin C 
and P I 33 could colocalise at apical plasm a membrane structures (Fig. 5. ^ ) . 
Quantitation of the colocalisation suggested that P I33 and kazrin C colocalised at apical 
plasma membrane structures in ~42% of transfected primary keratinocytes (n=l 19). The 
orthogonal views indicated that kazrin is found at plasma membrane projections 
colocalising with P I33 (Fig. 5.9 D). Kazrin, and some P I33, can also be seen in the 
cytoplasm of the transfected keratinocytes (Fig. 5.9 D).
Cells transfected with P I 33 often have large prominent microvilli, while cells 
transfected with kazrin often have very small or mo microvilli on their surface. There 
were a greater number of kazrin-positive apical plasma membrane structures in the 
presence of P I33.
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Fig 5.8 K azrin partially  colocalises with CD44. Composite images of z- 
stacks of primary keratinocytes transfected with N-terminally HA-tagged 
kazrin isoforms. Green fluorescence: kazrin A (A-C), kazrin C (D-F). Red 
fluorescence: CD44 (IM7 antiserum). Scale bar: (A-C) 26pm; (D-F) 20pm.
Fig 5.9. K azrin colocalises with P133. Primary keratinocytes were trans­
fected with P I33-HA-tagged (green fluorescence) and Kazrin-OFLAG (red 
fluorescence). Arrows in (C) mark the position of the orthogonal views 
shown in (D). Boxed area is shown as a single confocal slice at higher magni­
fication in (E-G). Z-stack size: 5.2 pm. Scale bars: (A-D) 20pm; (E-G) 
6.5pm. C-* Gr
A greater proportion of FLAG-tagged kazrin C localised to the cytoplasm than HA- 
tagged kazrin C. A proportion of P I 33 was cytoplasmic in cells cotransfected with 
kazrin C; in contrast when P I33 was transfected alone it did not accumulate in the 
cytoplasm significantly (Fig. 3.4). It is possible that the reason for the differences in the 
subcellular localisation of kazrin tagged at the C-or N-terminus is that the tags interfere 
with additional kazrin binding proteins.
5.2.3 Kazrin localises to the nucleus
N-terminally HA-tagged kazrin A, B and C and C-terminally FLAG-tagged kazrin C 
could be detected in the nuclei of transfected cells, although to different extents. Many 
primary keratinocytes showed weak nuclear kazrin staining (Fig. 5.10 A-B and data not 
shown). Nuclear kazrin proteins were also detected in many A431 cells (epidermoid 
carcinoma cell line; Fig. 5.10 C-D) and most Cos7 cells (African green monkey kidney 
cells, Fig. 5.10 E-H).
At present the variability in the extent of nuclear localisation seen between cells and cell 
types is not well understood. It should be noted that periplakin does have a putative 
NLS and it has been found in the nucleus of some cell types (van den Heuvel et al., 
2002); thus the interaction of periplakin and kazrin may occur both in the nucleus and at 
the plasma membrane.
5.3 Analysis of the effect of kazrin overexpression on primary 
keratinocytes
Many keratinocytes expressing HA-tagged kazrin proteins underwent changes in cell 
shape. The cells spread out in multiple directions, producing thin and/or thick 
membrane projections (Fig. 5.11). The actin cytoskeleton of these cells was altered, 
with the induction of stress fiber-like structures that are not normally observed in 
keratinocytes (Fig. 5.11). The actin cytoskeletons of adjacent untransfected cells were
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Fig 5.10 K azrin localises to the nucleus of some cells. Primary 
keratinocytes (A-B), A431 (C-D) and Cos7 (E-H) cells were trans­
fected with N-terminally HA-tagged kazrin isoforms: kazrin A (KA); 
kazrin B (KB); kazrin C (KC). Green fluorescence: kazrin. Red fluo­
rescence: actin. Blue fluorescence: nuclear counter stain (DAPI). 
Scale bars: (A-B) lOfim; (C-D) 9jim; (E-F) 20.5^m; (G-H)
29.4jim.
Fig 5.11 Overexpression of kazrin  proteins causes changes in cell shape 
and the actin cytoskeleton. (A-F) primary keratinocytes transfected with 
HA-tagged kazrin constructs. Red fluorescence: actin (phalloidin); green 
fluorescence: kazrin. Kazrin A (A-B), kazrin B (C-D), kazrin C (E-F). Scale 
bar: 40pm (A-B), 27.6pm (C-D), 33.6pm (E-F).
unaffected, displaying bands of cortical actin around the edges of the cells, apical 
microvilli and few membrane projections (Fig. 5.11).
The profound changes observed in the actin cytoskeleton were not paralleled in the 
microtubule network (Fig. 5.12 A-I). The microtubule network of cells with altered cell 
shapes did not show gross changes in organisation relative to untransfected cells. The 
keratin filaments of kazrin-expressing cells were also largely unchanged. The cells with 
altered cell shapes were generally much flatter than cells unaffected by kazrin 
expression. At the cell edges where cells were flattest, keratin filaments were often 
reduced in density (arrows, Fig. 5.12 J-M).
In order to quantitate the changes in cell shape and the actin cytoskeleton, primary 
human keratinocytes were transfected in parallel with the HA-tagged kazrin A, B, C and 
as a negative control, GFP. The cells were analysed 16-18hrs post-transfection, at which 
stage the cells expressed low to medium levels of the transfected proteins. The 
keratinocytes were stained with phalloidin and an antibody to the HA tag. The 
transfected cells were scored blindly for changes in their actin cytoskeleton and cell 
shape. A keratinocyte was deemed normal if it was round or cuboidal in shape, with few 
membrane projections. Normal keratinocytes generally had a cortical band of actin, 
numerous microvilli and few stress fibers. A keratinocyte was deemed altered if it was 
no longer round or cuboidal in shape, had loss of the cortical actin belt, reduction or loss 
of apical microvilli and displayed multiple small membrane projections or longer 
membrane projections, as shown Fig. 5.11.
The results of quantitation of cell changes from three different transfection experiments 
were pooled (Fig. 5.13). As not all cells could be assigned to either the normal or altered 
category these cells were removed from the analysis. Over 60% of cells transfected with 
kazrin isoforms were scored as altered, relative to only 14% of cells transfected with 
GFP. The difference was statistically significant: two-tailed p value < 0.0001, by the 
Fisher’s exact test for each kazrin isoform when compared to GFP.
The results of one of the transfection experiments was corroborated by Lisa Sevilla 
(K eratinocyte laboratory, CR-UK), who independently and blindly scored the 
transfected keratinocytes for changes and found a similar trend (data not shown).
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Fig 5.12 Analysis of the m icrotubule and keratin  interm ediate filament cyto- 
skeletons of prim ary  keratinocytes expressing transfected kazrin proteins.
Primary keratinocytes transfected with kazrin A (A-C, J-M), kazrin B (D-F) or 
kazrin C (G-I). Green fluorescence: microtubule cytoskeleton (TUB1A2, A-I); red 
fluorescence: keratin intermediate filament cytoskeleton (LP34, J-M), actin cyto­
skeleton (phalloidin, J-M). Blue fluorescence: HA tag to kazrin proteins (HA Y ll)  
(A-M). Arrows hi^jight cell areas with a reduced density of keratin filaments. (A-I) 
single confocal slices. (J-M) composite images of z-stacks. Scale bar: 26.6pm (A-C), 
20pm (D-F), 22.1pm (G-I), 40pm (G-I).
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Fig 5.13 Quantitation of the changes in cell shape and the actin cytoskeleton 
seen in kazrin*expressing cells. Primary keratinocytes were transfected in parral- 
lel with kazrin isoforms (KA, KB, KC) or GFP. 16-18 hrs post-transfection, cells 
were fixed, stained and scored blindly. Cells that had lost the cortical actin band 
and had undergone changes in their cell shape were scored as altered. In each case 
there were cells that could not be assigned to either the normal or altered category; 
these cells were removed from the analysis. The number of removed cells and the 
total cells counted were as follows; kazrin A, 134 of 437; kazrin B, 93 of 380; 
kazrin C, 80 of 421; GFP, 92 of 464. The graph shows the mean percentage of 
altered cells, with error bars indicating the standard error of the mean.
A K B KC GFP
5.4 Analysis of kazrin proteins in vitro and in vivo
In this section I will discuss the findings that kazrin proteins are phosphorylated and 
may form higher-order structures.
5.4.1 Kazrin proteins are phosphorylated
The HA-tagged kazrin protein isoforms were expressed in Cos7 cells and the proteins 
analysed by Western blotting (Fig. 5.14 A). Kazrin A and B proteins ran at -  52 and 50 
kDa respectively, as seen previously in TNT reactions (Fig. 4.3); kazrin C protein was 
found to run at the predicted size of 37 kDa. The W estern blot suggested that the 
constructs used for transient transfection experiments produced full length kazrin 
proteins.
In addition to the major protein bands identified by the HA Y 11 antibody, multiple 
higher molecular weight bands were visible. Three bands in addition to the major band 
at -5 0  kDa were identified for kazrin B protein. Two bands in addition to the major 
band at -37  kDa were identified for kazrin C protein. (Fig. 5.14 A). Kazrin A protein 
consistently appeared to have a lower level of the higher molecular weight bands, but 
three additional bands could be identified at longer exposures (Fig. 5.14 A). The 
presence of multiple higher molecular weight bands, which are not lost upon boiling of 
lysates in P-m ercaptoethanol/SDS, suggests that kazrin proteins are covalently 
modified.
Many proteins are modified by phosphorylation. Protein phosphorylation can change 
the function, activity, stability and many other characteristics of a protein. Phosphate 
groups may be attached, through the activity of specific protein kinases, to serine, 
threonine, tyrosine or histidine residues. Phosphoserine and phosphothreonine residues 
are thought to account for >97% of protein-bound phosphate in eukaryotic cells 
(Shenolikar, 2004).
Calf intestinal alkaline phosphatases (CIPs) can be used to dephosphorylate proteins 
containing phosphoserine or phosphothreonine residues in vitro. In order to analyse
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mock treated CIP treated
Fig 5.14 K azrin proteins are phosphorylated (A) Cos7 cells were 
transfected with HA-tagged kazrin constructs. Protein extracts were 
made in SDS Laemmli buffer and immunoblotted with an antibody to 
the HA tag (HA-Y11). Multiple bands can be seen for kazrin B and C 
isoforms, marked by arrows and arrowheads respectively. At longer 
exposures faint higher molecular weight bands can be seen for kazrin 
A. (B) Cos7 cells were transfected with HA-tagged kazrin constructs. 
Cells were lysed in Western lysis buffer. Lysates were either treated or 
mock treated with calf intestinal phosphatase (CIP) for 10 mins at 
30°C, as explained in the Materials and Methods. Asterisks mark the 
positions of all kazrin isoforms identified by Western blotting with an 
antibody to the HA tag (HA Y 11). A, B, C are kazrin A, B, C respec­
tively.
whether kazrin proteins were phosphorylated, Cos7 cells were transfected with the HA- 
tagged kazrin isoforms. The cell lysates were either treated or mock-treated with CIP, 
after which the reaction was quenched by the addition of Laemmli sample buffer. In 
mock-treated samples CIP was replaced with an equal volumejwater. Fig. 5.14 B 
shows that kazrin A protein ran as a doublet in both the mock-treated and CIIMreated 
samples; thus kazrin A protein was not significantly phosphorylated on serine or 
threonine residues. Kazrin B protein ran as two doublets in the mock-treated samples, 
but as a single doublet upon CIP treatment; thus kazrin B protein is likely to be 
phosphorylated on two residues, at either serine or threonine residues. Kazrin C protein 
appeared as three bands in the mock-treated samples and upon treatment with CIP one 
band disappeared; thus kazrin C protein is likely to be phosphorylated on either a serine 
or a threonine residue.
The use of lysis buffer containing phosphatase inhibitors in addition to protease 
inhibitors did not alter the number of kazrin protein bands identified in Western blots 
relative to lysates made in the presence of protease inhibitors alone. This suggests that 
there was little loss of specific phospho-kazrin species in the process of lysis of Cos7 
cells (data not shown).
5.4.2 Identification of putative kazrin phosphorylation sites
The kazrin protein sequences were analysed by PROSITE m otif search to identify 
putative phosphorylation sites (Table 5.1). The most com m only predicted 
phosphorylation site was that o f casein kinase 2 (CK2). CK2 is a ubiquitous, 
constitutively active serine/threonine kinase with a large number of target proteins 
(Meggio and Pinna, 2003). Many of the proteins it phosphorylates are involved in gene 
expression, protein synthesis or cell signalling. Other CK2 targets include junctional 
proteins, such as occludin and E-cadherin, and cytoskeletal elements, such as (3-tubulin 
and filaggrin (Meggio and Pinna, 2003).
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Table 5.1 Consensus phosphorylation sites of kazrin proteins as identified by 
PROSITE motif search
Kazrin isoform PKA/PKG PKC CK2
A RKES (184) 
KRHS (256)
* TNR (33) 
SPR (339)
* TNME (65) 
SATE (116) 
SREE (168) 
SQLD (224) 
SAAE (324) 
TPSD (333) 
SLED (367) 
1APD (409)
B RKES (177) 
KRHS (249)
SPR (332) SATE (109) 
SREE (161) 
SQLD (217) 
SAAE (317) 
1PSD (326) 
SLED (360) 
1APD (402)
C RKES (90) 
KRHS (162)
SPR (245) SATE (22) 
SREE (74) 
SQLD (130) 
SAAE (230) 
TPSD (239) 
SLED (273) 
TAPD (315)
Amino acids written in single letter code. Numbers in brackets indicate the amino acid number at which 
the protein is phosphorylated; the amino acid is also underlined. Kazrin isoform unique protein 
phosphorylation sites are marked with an asterisk. PKA/PKG: protein kinase A and G; PKC: protein 
kinase C; CK2: casein kinase 2.
There is a putative PKC phosphorylation site in the C-terminal region of kazrin 
proteins, in addition to a unique site in the N-terminus of kazrin A (Table 5.1). 
Keratinocytes typically express 5 PKC isoforms (classical a ,  novel 6, & J and 
atypical 5)* PKC isoforms have diverse functions in proliferation, differentiation and 
apoptosis in keratinocytes (Denning, 2004). PK C a associates with the plasma 
membrane and desmosomes in suprabasal cells (Wallis et al., 2000) and thus would be 
suitably localised to phosphorylate kazrin there. Alternatively^ the predominantly 
cytoplasmic novel or atypical PKCs may phosphorylate kazrin (Denning, 2004).
There are two putative protein kinase A (PKA)/protein kinase G (PKG) phosphorylation 
sites located within the a-helical domain of kazrin. PKA and PKG are activated by 
cyclic AMP and cyclic GMP, respectively. PKA and PKG have similar phosphorylation 
consensus sequences (Francis and Corbin, 1997). The subcellular localisation of PKA is 
determined by A-kinase anchoring proteins (AKAPs), which can target the kinase to 
e.g. the plasma membrane, nuclear membrane, cytoskeleton and mitochondria (Colledge 
and Scott, 1999).
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The PROSITE motif search did not identify any putative tyrosine phosphorylation sites. 
NetPhos 2.0 calculates the probability that serine, threonine or tyrosine residues within 
a protein sequence are phosphorylated  based upon experim entally verified 
phosphorylation sites. NetPhos2 does not predict which kinases may act on the sites 
found. NetPhos2 analysis predicted 3 tyrosine phosphorylation and three threonine sites 
in the G-terminus of kazrin, in addition numerous serine phosphorylation sites in the C 
terminus of kazrin and unique serine sites in the N-termini of kazrin A and B proteins 
were identified.
5.4.3 Kazrin forms higher-order structures
In Cos7 cells transfected with HA-tagged versions of kazrin B or C and FLAG-tagged 
kazrin C, I frequently observed multiple large protein bands, which were not present in 
empty vector control lanes. Fig. 5.15 A shows lysates from Cos7 cells transfected with 
kazrin B. A large band of monomeric kazrin B (arrowhead) is seen in addition to 4 large 
protein bands (asterisks). The larger proteins bands are -  120 kDa, -190 kDa, -210 kDa 
and >220 kDa. Each of these protein bands most likely represents a protein complex 
which was not disrupted by boiling in Laemmli sample buffer. Each of the protein 
complexes identified contains one or more HA-tagged kazrin B proteins. The existence 
and/or identity of other proteins within these complexes is not known. At present it is 
not possible to conclude whether or not transfected forms of kazrin A are able to form 
higher order structures, as fewer Western blots have been performed with HA-tagged 
kazrin A protein.
Multiple bands were identified in primary keratinocyte lysates using LS4 anti-kazrin 
antiserum. Kazrin A, B and C bands can be clearly seen at the expected sizes, in 
addition to 5 larger protein bands. The larger proteins bands ran at ~62 kDa, -9 6  kDa, 
-120 kDa, -180 kDa and -190  kDa (Fig. 5.15 B). The kazrin antiserum LS4 identifies 
only protein bands of the predicted sizes of kazrin or higher, and the larger protein 
bands are similar to those identified in kazrin B-transfected Cos7 cells; thus the higher 
molecular weight bands are unlikely to be non-specific bands. The protein complexes 
are likely to contain one or more kazrin proteins. The existence and/or identity of other 
proteins within these complexes are not known.
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Fig. 5.15 Kazrin forms higher order structures. (A) Cos7 cells 
were transfected with kazrin B. Lysates were made in CSK buffer, 
spun and the supernatant boiled in the presence of 2%SDS, 10% 
p-mercaptoethanol. Immunoblots were probed with an antibody to 
the HA tag (HA Yll ) .  (B) Immunoblots of primary human kerati- 
nocyte lysates probed with LS4 antibody to detect endogenous 
kazrin. Arrowheads mark the expected size of kazrin proteins; 
asterisks mark protein complexes containing kazrin B protein (A) 
or containing endogenous kazrin proteins (B).
The complexes seen in Western blots remain following boiling of protein lysates in 
-10%  p-mercaptoethanol and -2%  SDS suggesting that the proteins within the 
complexes are tightly bound to each other.
5.5 Discussion
In this chapter I have shown that endogenous kazrin localised to the desmosomes and 
nucleus of keratinocytes. In addition I have shown that transfected forms of kazrin 
localise to the apical plasma membrane of keratinocytes and partially colocalised with 
actin there. Expression of transfected forms of kazrin caused changes in cell shape and 
the actin cytoskeleton.
5.5.1 Analysis of the findings on endogenous kazrin
Kazrin was detected at the desmosomes in a variety of tissues and cultured cells. Kazrin 
was able to localise to cell-cell borders, even in the absence of periplakin (Fig. 5.15). 
The periplakin-negative mouse cells contain the envoplakin gene. Due to the lack of an 
antibody to mouse envoplakin it is not known if in the absence of periplakin, envoplakin 
proteins are produced or localise properly within the cell. Envoplakin may be the factor 
targeting kazrin to the cell-cell borders in the absence of periplakin, as full length 
human envoplakin stably expressed in mouse cell lines can localise to the desmosomes 
to some extent (DiColandrea et al., 2000). It remains to be analysed whether envoplakin 
and kazrin can interact directly. However, it has been found that kazrin localises to cell­
cell borders in all suprabasal layers of the oesophageal epithelium. While periplakin is 
expressed in all suprabasal layers of the oesophageal epithelium, envoplakin is 
expressed only in the very outer layers of the epithelium (Ma and Sun, 1986; Ruhrberg 
et al., 1997).
Desmosomes increase in number and size as keratinocytes differentiate. Desmosomes 
are multiprotein complexes, the protein composition of which changes as cells 
differentiate (Getsios et al., 2004). Kazrin localises to cell-cell borders most 
prominently in the suprabasal layers of epithelia (Fig. 5.1). Desmoglein 1, desmoglein 4
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and desmocollin 1 and plakophilin 1 are upregulated as keratinocytes differentiate and it 
is possible that kazrin associates with these proteins in suprabasal desmosomes 
(Amemann et al., 1993; King et al., 1996; Kljuic et al., 2003; Moll et al., 1997).
Disassembly of the actin cytoskeleton, by latrunculin B, causes kazrin and periplakin to 
accumulate in actin-rich patches; in contrast, desmoplakin is not affected by the 
treatment (Fig. 5.4 and DiColandrea et al., 2000). Transfection experiments and 
endogenous staining suggest that both periplakin and kazrin have some dependence on 
an intact actin cytoskeleton for proper localisation. The importance of actin in the 
plasma membrane localisation of kazrin and periplakin in vivo is not fully understood 
and will require further analysis, for example, by real time imaging of fluorescently- 
tagged proteins.
The colocalisation of endogenous kazrin with periplakin and desmoplakin was not 
complete (Fig. 5.3 and Fig. 5.5). As the cells are stratified and very thin, combined with 
a rather speckled staining obtained with the LS4 antiserum it is not possible to conclude 
whether the non-desmosomal staining is at or merely close to the plasma membrane.
Endogenous and transfected forms of kazrin were detected in the nucleus. In the case of 
endogenous kazrin the extent of nuclear staining was variable in cultured mouse and 
human keratinocytes. The extent of nuclear signal detected was dependent upon the 
fixation method used: the signal was highest in cells fixed in PFA alone; weaker in cells 
extracted with CSK buffer prior to fixation; and weakest in cells fixed in cold methanol. 
Nuclear staining was more prominent in mouse cells than in human cells.
The variability in the extent of nuclear staining seen in tissue sections is more complex 
and as yet not fully understood. All tissue sections were treated with 0.1% Triton X-100 
prior to staining, yet the extent of nuclear staining differed, even when analysing the 
same tissue type from different patients.
Kazrin staining is detected in the dermis of the skin, and the submucosal tissue of the 
oesophagus and cervix (Fig. 5.1). In additionjkazrin transcripts were detected in tissues 
that do not have desmosomes, such as skeletal muscle (Groot et al., 2004). The function 
and subcellular localisation of kazrin in these cells will require further analysis.
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All tissue section and cell stainings with LS4 antibody involved an extraction step in 
order to obtain a clear signal. Thus we may not be analysing the full extent of kazrin 
localisation in cultured cells or tissue sections.
Kazrin appears to be a component of the comified envelope, as it becomes insoluble 
upon treating cells with Triton X-100, and in the presence of cystamine and Triton X- 
100 it remains soluble. Kazrin is found at the cell periphery of suprabasal keratinocytes 
and thus would be well placed to be a transglutaminase substrate in vivo. The comified 
layer of the epidermal sections was not stained with LS4 antiserum; however not all CE 
components can be detected in the CE by immunofluorescence staining due to loss or 
masking of the epitopes involved; for example periplakin as detected by TD2 anti- 
periplakin antiserum (Fig. 5.1 B). It will be of interest to see whether there are kazrin- 
derived peptides in enzymatically digested CE preparations (Steinert and Marekov, 
1999).
5.5.2 Analysis of the localisation and effect on cell shape of transfected forms of 
kazrin
Changes in cell shape and the actin cytoskeleton were observed in primary 
keratinocytes transiently transfected with HA-tagged kazrin proteins and with FLAG- 
tagged kazrin proteins (though in the latter case the effect was not quantified). To 
further corroborate the findings on the effect of kazrin on keratinocyte cell shape and 
the actin cytoskeleton transiently transfected cell lines and stable cell lines which 
efficiently express kazrin proteins should be analysed. For this reason, I made retroviral 
constructs (pBabePuro vector) expressing N-terminally HA-tagged kazrin isoforms. The 
use of a retroviral system allows sustained expression and 100% transduction efficiency 
in keratinocytes (Levy et al., 1998). However, the expression level of HA-tagged kazrin 
isoforms was very low and unstable in the infected keratinocytes. The retrovirally- 
expressing keratinocytes were therefore unsuitable for analysis of the localisation of 
HA-tagged kazrin proteins and for analysis of the effect of their expression on cell 
shape and the actin cytoskeleton. The results suggest that kazrin expression is 
deleterious to keratinocytes, even at relatively low levels.
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Members of the Rho GTPase family of proteins are important regulators of the actin 
cytoskeleton and cell shape and thus may be directly or indirectly involved in the cell 
shape changes induced by kazrin overexpression (Burridge and Wennerberg, 2004). The 
family includes Rho-like GTPases, which are largely responsible for the formation of 
stress fibers and associated focal adhesion complexes, Rac-like GTPases which are 
responsible for the formation of lamellipodia and membrane ruffles, and Cdc42-like 
GTPases which are responsible for the formation of filopodia (Burridge and 
Wennerberg, 2004). There is a lot of interplay between factors that activate and inhibit 
different members of the Rho GTPase family, thereby finely regulating cell shape, the 
actin cytoskeleton and cell migration (Burridge and Wennerberg, 2004). The formation 
of stress fibre-like structures maybe due to the activity of Rho GTPases and cell shape 
changes may be the result of Rac and Cdc42 GTPase activity induced directly or 
indirectly by the expression of kazrin in keratinocytes.
GFP-tagged kazrin proteins were made for live cell imaging in order to analyse the time 
course and mechanism by which the cell shape and actin cytoskeleton changes occur. 
N-terminally GFP-tagged kazrin C was largely excluded from the nucleus, while C- 
terminally GFP-tagged kazrin C localised strongly to the nucleus. Both GFP-tagged 
kazrin proteins formed aggregates, predominantly in the cytoplasm, in a proportion of 
the transfected cells. This suggested that the kazrin fusion proteins were unstable and/or 
misfolding and so no further analysis was performed with GFP-tagged kazrin proteins. 
Thus .further analysis of the effect of kazrin on cells in real time will require the fusion 
of kazrin with other fluorescent tags, such as DsRed, or it will require the parallel 
expression or transfection of kazrin with, for example fluorescent actin. Live cell 
imaging of kazrin-expressing cells together with fluorescent cytoskeletal components or 
in the presence of actin/microtubule depolymerisation or stabilisation factors or in the 
presence of constitutively active and dominant negative forms of Rho GTPases, may 
help us to understand the how keratinocyte shape and actin cytoskeleton changes are 
induced.
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5.5.3 Analysis of kazrin isoforms in vitro
My experiments suggest that kazrin proteins are covalently modified in Cos7 cells and 
that phosphorylation at serine/threonine residues occurs. To further analyse the 
serine/threonine phosphorylation of kazrin, lysates should be treated with more specific 
protein phosphatases such as protein phosphatases 1 and 2A (PP1 and PP2A). The 
addition of okadaic acid or calyculin A, PP1 and PP2A inhibitors, to the reaction, can be 
used to exclude non-specific effects of PP1 and PP2A.
Following CIP treatment all three kazrin proteins appeared as a doublet in Western blots 
(Fig. 5.15 B), suggesting serine/threonine phosphorylation is not the only covalent 
m odification that kazrin proteins undergo in vivo. Kazrin proteins may be 
phosphorylated on tyrosine residues; in order to analyse this, transfected Cos7 lysates 
could be treated with protein tyrosine phosphatase IB , which specifically 
dephosphorylates tyrosine residues (Shenolikar, 2004). Alternatively transfected forms 
of kazrin could be immunoprecipitated and subsequently probed on a Western blot with 
a phospho-tyrosine specific antibody.
The NetPhos2 and PROSITE analysis raises the possibility that there are multiple 
phosphorylation sites within kazrin proteins. The signalling pathways involved in the 
phosphorylation pathways remain to be resolved. Once resolved, kazrin may be 
phosphorylated in vitro by the relevant kinases and the phosphorylated residues 
identified by mass spectrometry.
Both endogenous and transfected forms of kazrin proteins were detected in higher order 
complexes. Higher order complexes were formed by N-terminally HA-tagged and C- 
terminally FLAG-tagged kazrin C proteins, suggesting that the tags do not interfere with 
the protein-protein interactions involved in forming the complexes. All three kazrin 
proteins are strongly predicted to form a coiled coil. Coiled coils are found in many 
proteins that dimerise. Many of the HA-tagged kazrin B containing complexes could be 
formed from kazrin B dimers (~ 100 kDa) or tetramers (~ 200 kDa). At present it is not 
known whether there is endogenous kazrin in Cos7 cells, which could be involved, nor 
is it known whether there are non-kazrin proteins in these complexes. It will be of
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interest to isolate the kazrin complexes in order to elucidate which proteins associate 
with kazrin.
The localisation patterns and effects of kazrin upon cells have not been shown to be 
significantly different between the three kazrin isoforms despite their unique N-termini. 
The kazrin A protein was consistently less modified than kazrin B and C proteins. 
Kazrin A protein contains all of the kazrin C protein sequence, yet only kazrin C is 
consistently significantly modified. The structure of the proteins is not known in three 
dimensions, and it could be that the kazrin A N- terminus somehow interferes with the 
modification reactions on the rest of the protein.
It will be of interest in the future to analyse the effect of kazrin phosphorylation and 
oligomerisation on the subcellular localisation and function of kazrin proteins.
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Chapter 6.
The epidermis functions as a chemical, physical and water barrier, which prevents 
desiccation and protects against infections. The epidermal barrier is largely dependent 
on the comified envelope (CE), the comeocyte lipid envelope (CLE) and the lipid 
lamellae lying in the stratum comeum intercellular spaces. The importance of these 
components of the stratum corneum are highlighted by transglutaminase I (TGase I) 
knock-out mice (Kuramoto et al., 2002; Matsuki et al., 1998).
TGase I is responsible for the crosslinking of CE precursors. TGase I also catalyses the 
covalent attachment of longchain co-hydroxyceramide lipids to CE precursors, to form 
the extracellular CLE. In the absence of TGase I, mice die 4-5hrs after birth due to 
dehydration (Matsuki et al., 1998). TGase I knock-out mice have an almost complete 
lack of CEs and CLEs, and they have disorganised lipid lamellae (Kuramoto et al., 
2002). The rate of trans-epidermal water loss (TEWL) is 1000-fold greater for TGase I 
knock-out mouse skin compared to wild type and heterozygous mouse skin. Similarly^ 
the epidermis is an ineffective barrier to the entry of Lucifer yellow, a fluorescent dye. 
The dye is retained in the upper stratum comeum of control mice while in TGase I 
knock out mice the dye is detected in all layers of the epidermis and even in the dermis 
(Matsuki et al., 1998).
Mutations in human TGase I have been identified in patients with an autosomal 
recessive form of lamellar ichthyosis (LI). LI is characterised by the formation of large, 
thick, dark-brown hyperkeratotic scales (Kuramoto et al., 2002; Matsuki et al., 1998). 
These scales are similar to those formed when TGase L ' skin is grafted onto wild type 
mice. The hyperkeratotic scales are formed, in the absence of an efficient epidermal 
barrier, to reduce evaporation from the skin surface (Kuramoto et al., 2002).
The current model of CE assembly, as described in Chapter 1, suggests that the process 
is highly ordered. Early CE components, involucrin, periplakin and envoplakin, are 
crosslinked at the membrane by TGase I and thought to form a scaffold (Fig. 1.3). Later 
CE components, such as loricrin and the SPR proteins, are subsequently added to the 
CE scaffold to form the final mature CE structure (Fig. 1.4). The co-hydroxyceramide
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lipids, which form the CLE, are crosslinked predominantly to the early CE components, 
periplakin, envoplakin and involucrin (Marekov and Steinert, 1998).
To understand the role of individual CE components in the formation of the CE and 
epidermal barrier function, several knock-out mice have been generated (Aho et al., 
2004; Djian et al., 2000; Koch et al., 2000; Maatta et al., 2001). Loricrin-deficient mice 
have a slight delay in epidermal barrier formation, as indicated by the permeability of 
the skin to toluidine blue dye. At embryonic day 16.5 (E l6.5) loricrin null skin is almost 
completely permeable to the dye whereas the skin of wild type controls is almost 
completely impermeable (Koch et al., 2000). The skin of newborn loricrin'7" mice is 
shiny, erythematous and more sensitive to tape stripping than wild type control skin. 
Newborn loricrin knock-out keratinocytes form CEs, but the CEs are less resistant to 
sonication than those of wild type keratinocytes (Koch et al., 2000). The phenotype of 
loricrin knock-out mice is normalised 4-5 days after birth through upregulation of SPR- 
2D, SPR-2H and other proteins. The SPR proteins are incorporated into the CE together 
with other protein(s) which^like loricrin, are rich in glycine and serine residues (Jamik 
et al., 2002; Koch et al., 2000).
In the absence of involucrin mice develop normally with no gross defects in epidermal 
morphology (Djian et al., 2000). The CEs of involucrin single knock-out mice develop 
normally and are as sensitive to sonication, detergent treatment and proteases as wild 
type control CEs. The absence of involucrin is not compensated for by the upregulation 
of loricrin or SPR-1 at the mRNA level. The upregulation of other CE components has 
not been examined (Djian et al., 2000).
Envoplakin single knock-out mice were generated in our lab (Maatta et al., 2001). 
Envoplakin knock-out mice develop normally and show no gross defects in epidermal 
morphology. CEs isolated from wild type epidermis are of two types: rigid, mature CEs 
which are highly refractile when viewed by phase contrast microscopy; and fragile, 
immature CEs which are less refractile and come from lower layers of the stratum 
corneum (Michel et al., 1988). The mature CEs isolated from envoplakin knock-out 
mice are ~24% larger than those from wild type mice. The envoplakin knock-out mice 
have a slight delay (~1 day) in the formation of a mature epidermal barrier, as measured 
by the penetration of toluidine blue dye into the epidermis (Maatta et al., 2001).
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Periplakin knock out mice do not show a gross phenotype up to one year of age (Aho et 
al., 2004). In the absence of periplakin epithelial morphology is largely normal. 
Envoplakin, involucrin, desmoplakin and plectin protein levels are similar between 
periplakin knock out and heterozygous mice. CEs prepared from periplakin knock-out 
mice show no discernible difference from wild type CEs when examined by phase 
contrast or transmission electron microscopy (TEM). The epidermal barrier forms 
normally, and is complete at around E l7.5 in heterozygous and knock-out mice (Aho et 
al., 2004).
The mild phenotypes of loricrin, involucrin, envoplakin and periplakin single knockout 
mice suggest there are compensatory mechanisms to ensure the formation of a 
functional CE and epidermal barrier in the absence of individual CE components (Aho 
et al., 2004; Djian et al., 2000; Koch et al., 2000; M aatta et al., 2001). In order to 
analyse the consequence of the simultaneous deletion of involucrin, periplakin and 
envoplakin, triple knock-out mice were generated. The envoplakin/periplakin/involucrin 
triple knock out mice were generated by successive crossing of single knock out mice. 
Periplakin single knock-out mice were kindly provided by J. Uitto (Aho et al., 2004). 
Involucrin single knock-out mice were kindly provided by P. Djian (Djian et al., 2000). 
Envoplakin single knock-out mice were generated in our lab (Maatta et al., 2001). 
Mouse breeding was coordinated by Arto Maatta, Lisa Sevilla and Clare Hall transgenic 
services (Cancer Research UK).
Envoplakin/periplakin/involucrin triple knock out mice are viable and do not show any 
gross phenotype up to one year of age. The epidermis of triple knock-out mice appears 
largely normal compared to control mice as analysed using histological stains and by 
TEM. There is no defect in skin wound healing when triple knock out mice are 
compared with wild type and triple heterozygous controls.
In this chapter I shall discuss my analysis of the CEs from triple knock-out mice in 
addition to the assessment of their water barrier function.
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6.1 Analysis of the CEs obtained from envoplakin/periplakin/involucrin 
triple knock out mice
CE samples were prepared from  ear tips of adult triple knock-out and triple 
heterozygous mice. In each sample fragile and rigid CEs could be identified (Fig. 6.1 A, 
B). The fragile CEs are immature envelopes from lower layers of the stratum comeum 
and are thought to be rich in involucrin. The rigid, mature CEs are from the upper layers 
of the stratum comeum; they are thought to be associated with extracellular lipids and 
rich in loricrin (Lazo et al., 1995; Michel et al., 1988; Steinert and Marekov, 1997; 
Steinert and Marekov, 1999).
There was no obvious reduction in the number of CEs generated in triple knock-out 
mouse epidermis compared to the number generated in triple heterozygous mouse 
epidermis. There was no obvious difference in the ratio of fragile versus rigid envelopes 
present between triple knock-out and triple heterozygous mouse epidermis.
The surface area of individual CEs from three triple knock out and two triple 
heterozygous mice was analysed using NIH Image v 1.58, as described in the Materials 
and Methods. The analysis indicated that the CEs from triple knock-out mice were on 
average 17% larger than those from triple heterozygous mice (Fig. 6.1 C). The 
difference in the mean size of the CEs isolated from triple knock-out mice versus triple 
heterozygous mice (1862.19 pixels versus 1591.52 pixels) is statistically significant, as 
analysed by the paired Student’s t test (two tailed P value < 0.0001).
6.2 Barrier function analysis of envoplakin/periplakin/involucrin triple 
knock-out mice
The epidermal barrier begins to form late in embryonic development as keratinocytes 
differentiate. As the epidermal barrier forms at around E l6.5 there is a drastic reduction 
in TEWL and the reduction continues until birth or slightly after birth (Hardman et al., 
1998). Hardman and colleagues have developed a whole mount in situ assay to monitor 
the first stages of barrier formation. Analysis of the permeability of the skin to toluidine
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Fig 6.1 Cornified envelopes (CEs) isolated from triple knock-out mice are larger than 
those isolated from triple heterozygous mice. The surface areas of the mature CEs, 
isolated from triple heterozygous and triple knockout mice, were measured in pixels using 
NIH Image v 1.58. Representative micrographs of the CEs isolated from triple heterozy­
gous (A) and triple knock-out (B) mice, m: mature CE; f: fragile CE. (C) Graph shows 
average surface areas +/- the standard error of the mean. The total numbers of CEs 
counted were 433 from triple knockout mice and 215 from triple heterozygous mice. 
Two-tailed P value < 0.0001, by paired Student’s t test. Scale bar: 100pm.
blue suggests that the epidermal barrier forms in a patterned way (Hardman et al., 
1998). Epidermal barrier formation starts at distinct initiation sites, which form in a 
defined sequence. The first initiation sites are at dorsal regions of the mouse. Later 
initiation sites are found at the head, tail and limbs. The barrier spreads towards the 
dorsal and ventral midlines, to cover the whole body. The barrier forms last at the 
eyelids, eartips and ventral neck region of the mouse (Hardman et al., 1998).
Pairs of mice were mated to generate wild type, triple heterozygous and triple knock out 
litters. See Materials and Methods for further details of the experimental set up. The 
embryos were isolated at E16.5 or E17.5 for analysis. Embryos were first dehydrated in 
a methanol series and subsequently rehydrated in order to allow barrier-dependent entry 
of dye into the epidermis. The embryos were stained in toluidine blue and subsequently 
washed several times in PBS. Epidermal areas which have formed the first stage of the 
epidermal barrier remain white, while areas which have not formed a functional barrier 
stain blue. The methanol treatment is thought to extract polar lipids. Polar lipids are not 
a component of the water barrier but do appear to inhibit the entry of dyes, even in early 
embryonic epidermis which has not yet formed a epidermal water barrier (Hardman et 
al., 1998).
Fig. 6.2 A shows that at E l6.5 triple heterozygous mice have formed barrier initiation 
sites at the back of the head, but these are absent from triple knock out mice. Embryos 
from three individual litters were analysed at E17.5 (Fig. 6.2 B-D). At E17.5 wild type 
embryos were largely impermeable to the dye, indicating the presence of the first stages 
of the epidermal barrier (Fig. 6.2 B). In some cases there was still some blue staining at 
the tips of the tail, the ends of the limbs and the snout of wild type mice (e.g. Fig. 6.2 B 
i). The epidermal barrier of triple heterozygous mice was present over most of the body 
(Fig. 6.2 C), although there was an absence of epidermal barrier on the snout and ends 
of the limbs of some mice (Fig. 6.2 C ii-iii). There is variability in the extent of staining 
within litters irrespective of their genotype and the difference between triple 
heterozygous and wild type mice is probably due to this variation.
Triple knock out mice had delayed barrier formation compared to control wild type and 
triple heterozygous mice (Fig. 6.2 B-D). Some triple knock out mice were almost 
completely stained, indicating a lack of the first stages of epidermal barrier formation
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Fig 6.2 Mice lacking envoplakin, periplakin and involucrin (triple ko) have a delay 
in epidermal barrier formation relative to triple heterozygous (triple het) and wild 
type mice. Toluidine blue staining of embryos at E16.5 (A) and E17.5 (B-D). Blue skin 
indicates dye penetration and thus an immature epidermal barrier; unstained skin indi­
cates a functional epidermal barrier. Arrows in (A) highlight epidermal barrier initiation 
sites. Epidermal barrier formation experiments were performed in collaboration with 
Lisa Sevilla (CR-UK).
triple ko
(Fig 6.2 D vi, viii). In other triple knock out mice the barrier formation fronts had not 
yet fused at the ventral midline and they still had significant levels of staining on their 
snouts and limbs (Fig. 6.2 D i-iii, v, vii). Fig 6.2 D iv shows that the barrier of some 
triple knock out mice was almost complete at E17.5, with only some staining of the 
snout and limbs.
6.3 Generation of cell lines from mice null for CE components
I used neonatal wild type, envoplakin single and periplakin single knock out mice to 
make epidermal keratinocyte lines. The cell lines were grown in low calcium, but could 
be induced to differentiate and produce CEs in culture by the addition of calcium to the 
culture medium. The cells were used to monitor CE formation in culture and to analyse 
the distribution of desm oplakin and periplakin in wild type and mutant cells. 
Desmoplakin and periplakin were found to localise normally in the absence of 
envoplakin (Maatta et al., 2001). As the single knock out cell lines proved useful Lisa 
Sevilla (Keratinocyte Laboratory, CR-UK) used double and triple knock out mice to 
generate similar cell lines.
6.4 Analysis of the stratum corneum by scanning electron microscopy
The stratum comeum of wild type adult mouse skin was analysed by scanning electron 
microscopy (SEM). Samples were taken directly from the surface of the skin and 
analysed after rotary shadowing with platinum. Initial experiments indicated that 
analysis of comified cells from hairy skin such as the mouse back was not feasible. 
Even after shaving samples were contaminated with hair and few comified cells were 
obtained on the SEM stub tape.
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Fig. 6.3 A shows the sheet-like structure of the stratum comeum plantar skin from an 
adult wild type mouse. At higher magnifications (Fig. 6.3 B-C) individual comified 
cells are apparent. The comified cells have ridges, grooves and villi over their surface. 
The overlap between comified cells and cells in the comified layer below can be seen 
(Fig. 6.3. B-C).
Comified cells of triple knock out and wild type control mice can now be compared by 
SEM in order analyse if there are any differences in the surface stmctures of these cells.
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Fig. 6 3  Analysis of cornified envelopes from wild type mouse plantar skin. (A) Samples were taken directly from the foot 
of a mouse using an SEM stub with tape and analysed without critical point drying. Low magnification image showing the 
sheet-like structure of the stratum comeum. (B-C) High magnification image of comified cells from the upper layers of the 
stratum comeum. The outlines of the comified cells from the layer below can be seen on the surface of the CEs. The outlines of 
the comified cells below are highlighted in (C) by dotted lines. Scale bars: 30|im (A), 10pm (B -C ).
6.5 Discussion
The analysis of envoplakin/periplakin/involucrin triple knock out mice has shown that 
the mice are viable. The mice are able to produce rigid, mature CEs in the absence of 
envoplakin, periplakin and involucrin. In this chapter I describe a small effect of 
envoplakin/periplakin/involucrin gene deletion on CE surface area and on skin barrier 
development.
Previously a 24% increase in the surface area of mature envelopes from envoplakin 
single knock out mice relative to wild type mice was reported (Maatta et al., 2001). In 
this study I found a 17% increase in the size of triple knock out mouse CEs compared to 
triple heterozygous mouse CEs. There are several possible reasons for the less dramatic 
difference in surface area between triple knock out and triple heterozygous envelopes. I 
compared triple knock out CEs with triple heterozygous, not wild type, controls. I 
compared CEs derived from adult mouse ears, not newborn back skin. I analysed the 
CEs in this study, while the analysis of CEs from envoplakin single knock out mice was 
performed by A. Maatta (Maatta et al., 2001).
It is, however, possible that the difference in size is biologically significant. In this case 
in the absence of envoplakin, periplakin and involucrin the phenotype may be less 
dramatic due to a more effective protein compensation mechanism compared to that of 
envoplakin single knock out mice. To distinguish between the different possibilities it 
will be important to analyse envoplakin single knock out mouse CEs in parallel with 
those from triple knock out, triple heterozygous and wild type mice from the same body 
site.
There are several possible reasons for the increased size of the CEs of triple knock out 
mice compared with triple heterozygous mice. In the absence of envoplakin, periplakin 
and involucrin, which form the bulk of the early CE components there may be a slight 
delay in the formation of an early CE structure. The delay in expression or crosslinking 
of CE components may allow the cells to flatten, and thus increase surface area, for 
longer during the last stages of terminal differentiation. Alternatively the CEs may be 
less strong and thus become slightly more flattened with increased surface area as the 
cells differentiate.
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To investigate the basis of the difference in size, cells from wild type and triple knock 
out mice could be used. The cells could be placed in suspension to generate CEs 
(Romero et al., 1999). The kinetics of CE formation and CE size could then be 
examined.
The CEs of loricrin deficient mice are more sensitive to sonication than those from 
control mice (Koch et al., 2000). It will be of interest in the future to analyse the 
sensitivity of CEs from triple knock out mice to sonication or other mechanical or 
chemical stresses.
SEM revealed that the cornified cells of wild type plantar skin have many ridges, 
grooves and villi over their surface. These structures are thought to be important for 
interdigitation of cornified cells. The interdigitation and overlapping of the cells 
increases the mechanical stability of the stratum comeum and are particularly prominent 
features of plantar skin (Holbrook, 1994). Analysis of the surface of cornified cells by 
SEM may prove useful in future analyses of the skin of triple knock out mice.
Patterned barrier formation is not restricted to the epidermis. Initiation sites and moving 
fronts of barrier formation can be detected in oral epithelia such as the tongue and hard 
palate (Marshall et al., 2000). Patterned barrier formation is also detected in rats, rabbits 
and humans, although the exact pattern differs somewhat between species because of 
their different body shapes (Hardman et al., 1999; Hardman et al., 1998).
The first stages of epidermal barrier formation, as measured by staining with toluidine 
blue are coincident with the relocalisation of loricrin from keratohyalin L-granules to 
the plasma membrane and with the formation of mature, rigid CEs, which are thought to 
have covalently associated lipids (Hardman et al., 1998; Lazo et al., 1995). After the 
formation of the first stages of the barrier, filaggrin becomes fully processed, LEP 
proteins are expressed and the lamellar lipids become organised into long flat sheets 
(Hardman et al., 1998; Marshall et al., 2001).
The toluidine blue experiments indicated that, though there is variation within a litter, 
the extent of barrier formation was reduced at E l7.5 in all triple knock out mice relative
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to the wild type and triple heterozygous control mice. The delay suggests that the 
deposition of loricrin may occur later than in wild type embryos. Loricrin forms the 
bulk of the CE and it is often found crosslinked to early CE components such as 
involucrin (Steinert and Marekov, 1997; Steinert and Marekov, 1999). In the absence of 
envoplakin, periplakin and involucrin there may be a delay in the expression of 
alternative early CE components or a delay in the deposition of loricrin due to the 
reduced availability of crosslinking sites at the plasma membrane. Alternatively there 
may be a slight delay in the formation of rigid CEs and CLEs. TEM analysis of 
epidermis from triple knock out and wild type mice suggested that there are no gross 
differences between them (Lisa Sevilla, Keratinocyte laboratory). More detailed 
analysis by TEM may reveal subtle changes in the timing of the deposition of loricrin or 
CLE formation which could explain the slight delay in barrier formation.
A fraction of the lipo-peptides present in human CLEs were isolated in experiments by 
Marekov and Steinert (Marekov and Steinert, 1998). Their analysis indicated that >50% 
of the co-hydroxy ceramides of the CLE were attached to envoplakin, periplakin and 
involucrin. Rigid, mature CEs, which can be seen in triple knock out and triple 
heterozygous mice, are thought to have covalently attached lipids (Hirao et al., 2001; 
Lazo et al., 1995). This suggests that a CLE can form in the absence of envoplakin, 
periplakin and involucrin. At present it is not known to which proteins ceramides are 
added in the absence of envoplakin, periplakin and involucrin. Since the CLE is thought 
to be important for the organisation of the lamellar lipids (Behne et al., 2000; Downing, 
1992; Kuramoto et al., 2002), it will be of interest to analyse triple knock out epidermis 
to analyse to which proteins the ceramide lipids are attached.
The analysis of the triple knock out mice demonstrates that envoplakin, periplakin and 
involucrin are not required for CE formation. It is now of interest to determine the 
protein composition of CEs from triple knock out mice. Three strategies have been 
considered. One is to determine the composition of the CEs directly. Second is to study 
CE formation in culture. A third possibility is to analyse gene expression profiles of the 
epidermis of triple knock out and wild type mice by mRNA microarray.
A collaboration with Andrey Kalinin (Laboratory of Skin Biology, NIAMS, NIH) was 
set up in order to analyse the protein composition of the CEs from triple knock out
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mice. Our initial experiments focussed on analysis of CEs from triple heterozygous 
mice. He analysed the protein composition of the CEs in two ways: by mass 
spectroscopic analysis of the peptides released from proteolytically digested CEs and by 
analysis of the relative amino acid levels after complete hydrolysis of the component 
proteins by 6 M HCl/0.5% phenol (Jamik et al., 1996; Steinert and Marekov, 1999). The 
mathematical analysis of the amino acid composition of the CEs suggested that they 
were composed of 82.4% loricrin, 6.3% SPR proteins, 5.2% filaggrin and 6.9% 
envoplakin/periplakin, by weight. However, he couldn’t detect envoplakin or periplakin 
by mass spectroscopic analysis of peptides released from proteolytically digested CEs 
from triple heterozygous mice. The mass spectroscopy sequencing data indicated that 
the predominance of loricrin and the large size of envoplakin and periplakin make it 
difficult to detect envoplakin and periplakin in CE peptide preparations. In the absence 
of envoplakin, periplakin and involucrin the changes in the protein composition of the 
CEs are likely to be too subtle to detect by the sequencing of CE-derived peptides and 
by analysis of the amino acid composition of CEs.
CEs can be generated in stratified cultures of keratinocytes or by growing cells in 
suspension (Romero et al., 1999; Steinert and Marekov, 1999). The CEs generated in 
culture are more immature and have a significantly lower loricrin content than CEs 
generated in vivo (Steinert and Marekov, 1999). The triple knock out and control cell 
lines may therefore be useful to analyse the effects of loss of envoplakin, periplakin and 
involucrin on CE protein composition.
The third approach that can be taken is to obtain gene expression profiles of the 
epidermis of triple knock out, triple heterozygous mice and wild type mice by mRNA 
microarray, for example (Frye et al., 2003). The analysis may yield some answers about 
the nature of the compensatory mechanisms which allow the formation of a functional 
stratum comeum in the absence of three early CE proteins and may reveal perturbations 
in other aspects of the epidermis that have not yet been considered.
Envoplakin, periplakin and involucrin are considered to be important components of the 
CE scaffold on to which the CLE and later components of the CE are added. It is 
remarkable that loss of expression of these three proteins causes only a mild phenotype 
in the mice.
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In any case it seems that loss of envoplakin, periplakin and involucrin expression are not 
essential for the formation of CEs or the formation of the first stages of the epidermal 
barrier.
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Chapter 7
In this general discussion chapter I will summarise the main findings of my thesis and 
suggest directions for future research.
7.1 Envoplakin and periplakin N-termini
I have extended the findings of DiColandrea et al. (2000) to establish that the N - 
terminus of envoplakin does not efficiently localise to desmosomes or microvilli when 
transfected into primary human keratinocytes. In contrast, a similar region of 
perpiplakin localises efficiently to the microvilli and partially colocalises with 
desmoplakin at the desmosomes (DiColandrea et al., 2000). The KGSP repeats found in 
the very N-terminus of mouse and human envoplakin are potential phosphorylation 
sites. I found that removal of the KGSP repeat regions and treatment of transfected cells 
with protein kinase inhibitors did not affect the localisation of envoplakin constructs in 
transfected primary human keratinocytes. Data from stably transfected mouse 
keratinocytes expressing full length human envoplakin indicate that envoplakin can 
localise to the desmosomes and suggest that it may depend upon heterodimerisation 
with periplakin in order to efficiently localise to the interdesmosomal plasma membrane 
(DiColandrea et al., 2000).
The first 495 amino acids of periplakin were found to be sufficient to target periplakin
to the microvilli and to the desmosomes (DiColandrea et al., 2000). By generating
further deletions of periplakin, I found that the first 133 amino acids, up to the end of
the NN subdomain, target periplakin to the apical plasm a membrane, where it
colocalises with the actin cytoskeleton in microvilli. The N-'terminal 584 amino acids of
desmoplakin, which includes the NN, Z, Y and most of the X subdomain, targets the
protein to the desmosomes where it interacts with plakoglobin and plakophilin
(Bomslaeger et al., 1996; Kowalczyk et al., 1997). Sequence comparisons between the
first 133 aa of periplakin and a similar region of desmoplakin indicates that they have
low sequence identity (<17%). However, the first 63 aa of desmoplakin may be
sufficient to target desmoplakin to plasma membrane attachments sites, the desmosome
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in the case of desmoplakin, as they are sufficient to interact with plakophilin 3 in yeast 
two-hybrid assays^but analysis of the localisation of this desmoplakin fragment in cells 
had as yet not been carried out (Bonne et al., 2003). It will interesting to understand 
how the very N* terminal regions and the NN subdomains of plakin proteins convolved 
in their targetting.
7.2 Identification of kazrin
In order to identify proteins which might mediate the interaction of periplakin with the 
actin cytoskeleton or the plasma membrane a yeast two-hybrid screen was performed. 
Using the first 133 amino acids of periplakin as ‘bait’ and a human keratinocyte cDNA 
library as ‘prey’ we identified a novel protein, which we have named kazrin.
The kazrin gene consists of four alternative first exons, la , lb , lc  and Id, which may be 
spliced to exons 2 to 8. The four alternative kazrin transcripts encode three different 
proteins with unique N-termini. Kazrin proteins are highly conserved between mice and 
humans.
Immunofluorescence staining of epidermal tissue sections suggested that kazrin 
localised to the cell periphery of differentiated cells, but it was more diffusely localised 
in basal layers of the epidermis. In stratified cultures kazrin partially colocalised with 
desm oplakin and periplakin at the desm osom es and with periplakin at the 
interdesmosomal plasma membrane. The localisation of kazrin to desmosomes was 
found to be independent of periplakin, as kazrin was detected at cell-cell borders in 
mouse cell lines lacking periplakin expression. Additional staining of kazrin was 
detected in the nuclei of cultured cells and in tissue sections, but the significance of this 
is currently unknown.
All transfected forms of kazrin localised to the apical plasma membrane of primary 
keratinocytes and caused changes in cell shape and the actin cytoskeleton. Transfected 
forms of kazrin proteins are phosphorylated as CIP treatment resulted in the specific 
loss of certain kazrin protein bands, as detected by Western blotting. Future experiments
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will investigate how kazrin affects the cytoskeleton and whether phosphorylation affects 
kazrin localisation and/or function.
7.3 An additional kazrin isoform belongs to the liprin family of proteins
7.3.1 Identification of novel kazrin isoforms
Initial analysis of the human genome using BLAT suggested that there were 4 
alternative human kazrin mRNA isoforms (a to d) and two mouse mRNA isoforms (a 
and b). Analysis of Drosophila*derived cDNA sequences indicated a 36% identity and 
76% similarity between an EST clone (AI063603) and the human kazrin C protein. In 
collaboration with Nick Brown (Wellcome trust/CR-UK, Cambridge) we analysed this 
sequence further. The analysis suggests that AI063603 encodes a novel 1023 amino acid 
protein with sequence similarity to the liprin family of LAR transmembrane protein 
tyrosine phosphatase (PTPase) interacting proteins.
The novel D rosophila  liprin sequence was used to search for kazrin-like liprin 
sequences in human EST databases. A human EST with homology to the liprin family 
of proteins and kazrin was identified (BC036877), and mapped to the human kazrin  
locus. Analysis of the EST sequence suggests it is formed from the splicing together of 
exons la  to exons 2 to 8. A splicing event within exon 8, prior to the translation 
termination codon, results in splicing of exon 8 to novel exons 9 to 1 5 .1 shall refer to 
this novel splice variant as kazrin a l to indicate it is a long kazrin isoform. Kazrin al is 
predicted to encode a 775 aa protein which I shall refer to as kazrin AL (Fig. 7.1 A). A 
mouse liprin-like kazrin isoform has recently been isolated (AK173090). The mouse 
kazrin long isoform includes exon la  and thus I shall refer to this splice variant as 
mouse kazrin al and the protein as mouse kazrin AL. Mouse kazrin AL is predicted to 
be 779 aa in length.
Northern blotting of mouse tissue mRNA identified ~2.3kb, ~3.85kb and ~5.1kb bands 
using a probe against murine kazrin (Fig. 4.11). The ~3.85kb band is thought to relate to 
mouse kazrin a and b mRNAs. The mouse kazrin al mRNA is predicted to be ~4.9kb 
and therefore could represent the 5.1 kb band identified by Northern blotting. Currently
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Fig. 7.1 Kazrin AL protein, a m em ber of the liprin family of proteins. (A) Amino 
acid sequence of human kazrin AL protein. Arrow indicates the start of the protein 
region unique to kazrin AL. The putative NLS is single underlined, the leucine 
zipper-like domain is double underlined. Kazrin AL contains three SAM domains, 1, 
2 and 3, boxed in green, red and blue, respectively. The putative PDZ domain is boxed 
in black. Amino acids are shown in single letter format. Asterisk: translation termina­
tion codon. (B) Schematic (to scale) of human liprin a l ,  human liprin p i, human 
kazrin ALand human kazrin A. Green box: putative leucine zipper-like domain. Blue 
box: coiled coil domains. Yellow box: putative NLS. Red circles: SAM domains. The 
liprin homology (LH) domain encompasses the three SAM domains. Asterisks at the 
very C-termini of human liprin a l ,  human liprin p i and kazrin AL represent putative 
PDZ-binding motifs.
only long kazrin mRNA isoforms containing sequences from kazrin exon la  havebeen 
isolated. It remains to be seen whether exons lb, lc  and Id may also be components of 
kazrin long type mRNAs. The expression of long forms of kazrin mRNA in primary 
human keratinocytes and human dermal fibroblasts, in addition to A431, EJ/28 and JAR 
cells, has been confirmed by RT-PCR (Lisa Sevilla, Keratinocyte Laboratory).
The protein sequences of human, mouse and Drosophila kazrin AL can be found in the 
appendices. The kazrin proteins initially identified, kazrin A, B and C, I shall 
collectively refer to as kazrin short isoforms. It should be noted that the antibody we 
generated to kazrin (LS4) was made against the last 20 aa of the short kazrin isoforms. 
Only the 6 most N-terminal of these amino acids are found in kazrin AL proteins. Thus 
it seems probable that LS4 antiserum does not crossreact with kazrin AL proteins; 
indeed we did not detect any bands -8 5  KDa, the predicted molecular weight of kazrin 
AL, in Western blots carried out with the LS4 antiserum. Generation of an antibody to 
the long kazrin isoform will allow us to determine whether the subcellular localisation 
of kazrin short and long forms is similar.
7.3.2 Liprin family of LAR transmembrane PTPase interacting proteins
The human liprin family of proteins includes four a-type liprins and two P-type liprins. 
Liprin proteins have a conserved domain structure, consisting of an N-terminal coiled- 
coil domain and a C-terminal liprin homology (LH) domain (Fig. 7 .IB). The LH 
domain consists of three sterile alpha motif (SAM) domains (Serra-Pages et al., 1998). 
SAM domains generally function as protein:protein interaction domains (Kim and 
Bowie, 2003).
Like liprin a  and p proteins, all kazrin isoforms have an N-terminal coiled-coil domain. 
The C-terminal region of kazrin AL contains three predicted SAM domains, which 
together constitute the LH domain (Fig. 7.1 B). We identified a putative NLS in all 
kazrin proteins. NLS sequences can be identified in similar regions of liprin a  and p 
proteins (Fig. 7.1 B). However, there have been no reports of nuclear a  or p liprins. 
Kazrin AL, liprin a l  splice form B, liprin p i , and some other members of the liprin
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family of proteins, have PDZ motifs that may be bound by PDZ binding domain- 
containing proteins (Harris and Lim, 2001).
The sequence identity between the four human a  liprins is 69-76% and between human 
liprin p i and 2 is 51% (Serra-Pages et al., 1998). ClustalW amino acid sequence 
alignments show that human kazrin AL and human liprin a l  have 33% identity and 
46% similarity. When compared to human liprin p i, human kazrin AL has 31% identity 
and 45% similarity. The sequence comparisons suggest that kazrin AL is neither an a  
nor a p liprin family member. Future analysis of the liprin and long kazrin isoform 
amino acid sequences from different species will allow us to further define the 
subgroups within the liprin family and may shed light on how this protein family 
evolved.
7.3.3 Liprin protein binding partners and their functions
The N-terminal co iled-co il dom ain of liprin a  and p proteins mediates their 
homodimerisation. Liprins within the a  and p subfamilies can also heterodimerise via 
the N-terminal coiled-coil domain (Serra-Pages et al., 1998). a  liprin family members 
interact with the LAR family of transmembrane PTPases, which includes LAR, PTPo 
and PTP6, through the LH domain. The P liprin family members do not interact with 
LAR PTPases directly but do interact with the C-terminal domain of a  liprins via their 
C-terminal domains (Serra-Pages et al., 1998). The ability of liprin proteins to interact 
with each other through their N-and C-terminal domains suggests that they may form 
higher order structures.
The kazrin A, B, C and kazrin AL proteins all contain an N-terminal coiled-coil domain, 
but only kazrin AL contains the LH domain. Analysis of transfected and endogenous 
forms of short kazrin proteins suggests that they are able to form oligomers (Fig. 5.15). 
Generation of differently tagged kazrin short and long isoforms in addition to a  and P 
liprins, will allow us to analyse the types of interactions that can occur between these 
proteins by immunoprecipitation and colocalisation studies.
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Transfected forms of liprin a l  and j31 localise to the plasma membrane of Cos7 cells 
(Serra-Pages et al., 1998). Indeed transfected forms of liprin a 2  localise to plaques at 
the plasma membrane, in contrast to LAR, which localises to the plasma membrane and 
Golgi of transfected Cos7 cells. Cotransfection of LAR and liprin a 2  causes LAR to 
relocalise, with liprin a 2 , to plasma membrane plaques and membrane ruffles (Serra- 
Pages et al., 1998). The domains necessary for the localisation of a l ,  a 2  and p i liprins 
to plasma membrane structures has not been mapped, but since I have found short 
kazrin isoforms localise predom inantly to the plasma membrane the sequences 
necessary may be located in the N-terminal regions of liprin proteins. Alternatively the 
short kazrin isoforms may be directed to the plasma membrane by endogenous long 
kazrin isoforms.
Liprin proteins contain domains and motifs important for protein-protein interactions 
and are thought to play important roles as protein scaffolds in cellular processes. For 
example, at the presynaptic plasma liprin-containing complexes are important for the 
regulated release of neurotransmitter (Ko et al., 2003b; Schoch et al., 2002). At the post- 
synaptic membrane liprin a  interacts with a variety o f proteins, including 
neurotransmitter receptors and LAR transmembrane PTPases, to form a complex. The 
complex is important for the targeting of neurotransmitter receptors (AMPA-type 
glutamate receptors) to the postsynaptic membrane and their clustering there, processes 
which are important for efficient neurotransmission (Baran and Jin, 2002; Ko et al., 
2003a; Shin et al., 2003; Wyszynski et al., 2002).
Liprin a l  localises to focal adhesions, sites of cell-extracellular matrix adhesion and 
important sites for cell signalling (Serra-Pages et al., 1995). The colocalisation of liprin 
a l  and LAR PTPase at the ends of focal adhesions closest to the nucleus, suggested 
LAR and liprin a l  may regulate focal adhesion disassembly (Serra-Pages et al., 1995).
The overexpression of short kazrin isoforms caused changes in cell shape and the actin 
cytoskeleton. Based on analysis of the roles of liprin proteins kazrin AL may play a 
scaffolding role. It is possible that kazrin short isoforms, which lack the LH domain and 
PDZ motif, may interfere with normal scaffold formation, thereby altering normal 
cellular functions. Such disruptive functions have been shown for human liprin a lA . 
The a lA  splice form, which lacks the C-terminal 17 amino acids, including the PDZ
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motif, does not interact with the scaffold protein GRIP (Wyszynski et al., 2002). 
Overexpression of liprin a l A  interferes with normal AMPA receptor targeting and 
clustering at the postsynaptic membrane as the liprin containing-complexes necessary 
for clustering are disrupted (Wyszynski et al., 2002).
7.4 Future directions and questions
The exogenous expression of kazrin caused changes in the actin cytoskeleton and 
keratinocyte cell shape. Attempts to make retrovirally-infected kazrin-expressing 
keratinocyte lines failed, suggesting that expression of kazrin at low levels is 
detrimental to the cells. In the future, it will be of interest to design RNAi expression 
vectors to specifically knock down the expression of kazrin proteins and analyse the 
effects on keratinocytes or other cell types. I have shown periplakin is not necessary for 
kazrin localisation to cell-cell borders. Knocking down expression of kazrin by RNAi 
may allow us to test whether kazrin is necessary for targeting periplakin to the plasma 
membrane and/or desmosomes.
Previously^ periplakin has been found to interact with and affect a variety of signalling 
molecules (Beekman et al., 2004; Feng et al., 2003; van den Heuvel et al., 2002). 
Periplakin and kazrin are expressed widely and thus the interaction between periplakin 
and kazrin may be important in a wide variety of cell types (Aho et al., 1998; Groot et 
al., 2004; Ma and Sun, 1986; Ruhrberg et al., 1997). It will be of interest to understand 
the effect of the interaction of kazrin with periplakin on kazrin protein:protein 
interactions and on cellular functions.
I carried out in vivo analysis of the function of periplakin and envoplakin using mice 
lacking periplakin, envoplakin and involucrin expression. Triple knock-out mice had a 
slight delay in epidermal barrier formation, as measured by Toluidine blue dye 
penetration, relative to triple heterozygous and wild type mice. The CEs isolated from 
triple knock out mice were -17%  larger than those from triple heterozygous mice. In the 
future it will be of great interest to establish the consequences of deleting the kazrin 
gene in mice.
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aa amino acid
ABD actin binding domain
AD activation domain
BCA bicinchoninic acid
BLAST basic local alignment search tool
BLAT BLAST-like alignment tool
bp base pair
BPAG bullous pemphigoid antigen 1
cDNA complementary DNA
CE comified cell envelope
CIP calf intestinal phosphatase
CLE comeocyte lipid envelope
CR-UK Cancer Research UK
DCS donor calf serum
DMEM Dulbecco’s modified Eagles medium
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
DNA-BD DNA binding domain
dNTP deoxynucleotide
Dsc desmocollin
Dsg desmoglein
EDTA ethylldiaminotetraacetic acid, disodium salt
ERM ezrin, radixin, moesin family of proteins
EST expressed sequence tags
FAD F I2 powder, adenine, DMEM
FBS fetal bovine serum
FCS fetal calf serum
FSG fish skin gelatin
GAPDH glyceraldehyde phosphate dehydrogenase
GFP green fluorescent protein
GS goat serum
GST glutathione S-transferase
HA hemagglutinin
HDF human dermal fibroblast
HICE hydrocortisone, Insulin, Cholera toxin, Epidermal growth factor
HK human keratinocyte
hr hours
HRP horse radish peroxidase
IF intermediate filament
IgG immunoglobulin
IPTG isopropyl b -  D - thiogalactoside
KA kazrin A protein
KB kazrin B protein
KC kazrin C protein
Kazrin AL kazrin A long protein
Kb kilobase
kDa kilodalton
KSFM keratinocytes serum free medium
LAR leukocyte common antigen-related
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LSB Laemmli sample buffer
L-T- agar yeast agar lacking:leucine, tryptophan
L-T-A-H- agaryeast agar lacking:leucine, tryptophan, adenine, histidine
MACF microtubule associated crosslinking factor
MAPK mitogen-activated protein kinase
MEK1/2 mitogen-activated protein kinase-kinase
mRNA messenger RNA
MT microtubule
NLS nuclear localisation signal
°C degrees Celcius
ORF open reading frame
PBS phosphate buffered saline
PBS-ABC PBS with Mg2+ and Ca2+
PCR polymerase chain reaction
PFA paraformaldehyde
PKA protein kinase A
PKB protein kinase B
PKC protein kinase C
PTPase protein tyrosine phosphatase
RNA ribonucleic acid
rpm rotations per minute
RT room temperature
RT-PCR reverse transcription polymerase chain reaction
SDS-PAGE sodium-dodecyl sulphate polyacrylimide gel electrophoresis
SEM , standard error of the mean
SPR small proline rich (protein)
TAE Tris/Acetic acid/EDTA
TGase transglutaminase
Tris tris(hydroxymethyl) aminomethane
UTR untranslated region
v/v volume:volume ratio
w/v weight: volume ratio
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AY505119 1475 bp mRNA linear PRI 02-SEP-2004
Homo sapiens kazrin isoform A mRNA, complete cds.
AY505119
AY505119.1 GI:46276353
Homo sapiens (human)
Homo sapiens
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.
1 (bases 1 to 1475)
Groot,K.R., Sevilla,L.M., Nishi,K., DiColandrea,T. and Watt,F.M. 
Kazrin, a novel periplakin-interacting protein associated with 
desmosomes and the keratinocyte plasma membrane 
J. Cell Biol. 166 (5), 653-659 (2004)
15337775
2 (bases 1 to 1475)
Groot,K.R., Sevilla,L.M., Nishi,K., DiColandrea,T. and Watt,F.M. 
Direct Submission
Submitted (15-DEC-2003) Keratinocyte Laboratory, Cancer Research 
UK, 44 Lincoln's Inn Fields, London WC2A 3PX, UK 
Location/Qualifiers 
1. .1475
/organism="Homo sapiens"
/mol_type="mRNA"
/db_xref="taxon:9606"
/chromosome="1"
/map="lp36.21"
/clone="IMAGE:618 0 2 5 3"
/tissue_type="dorsal root ganglia"
1..209
210..1475 
/codon_start=l 
/product="kazrin isoform A"
/protein_id="AAS86434.1"
/db xref="GI:46276354"
/translation="MMEDNKQLALRIDGAVQSASQEVTNLRAELTATNRRLAELSGGG
GPGPGPGAAASASAAGDSAATNMENPQLGAQVLLREEVSRLQEEVHLLRQMKEMLAKD
LEESQGGKSSEVLSATELRVQLAQKEQELARAKEALQAMKADRKRLKGEKTDLVSQMQ
QLYATLESREEQLRDFIRNYEQHRKESEDAVKALAKEKDLLEREKWELRRQAKEATDH
ATALRSQLDLKDNRMKELEAELAMAKQSLATLTKDVPKRHSLAMPGETVLNGNQEWW
QADLPLTAAIRQSQQTLYHSHPPHPADRQAVRVSPCHSRQPSVISDASAAEGDRSSTP
SDINSPRHRTHSLCNGDSPGPVQKNLHNPIVQSLEDLEDQKRKKKKEKMGFGSISRVF
ARGKQRKSLDPGLFDGTAPDYYIEEDADW"
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36
42
48
54
60
66
72
78
84
90
96
102
108
114
120
126
ggggtctcgg
cctccccccg
tgccggagga
ggaggacaca
gcatcgatgg
cggccaccaa
gagccgcggc
agcttggagc
ttctccggca
cctctgaggt
tagccagagc
agaagacaga
agcagctccg
tcaaagcgct
aagccaagga
accggatgaa
ccaaggacgt
accaggagtg
agactctcta
cctgccactc
cgtccacacc
acagtcccgg
cgatcgctgc
ccgcctcgcc
accggcgctg
acaggccaaa
ggcggtccag
ccggagactg
cagcgcctcg
gcaagtgctc
gatgaaggag
cctctcggcc
caaagaagcc
cctggtgagc
agacttcatc
ggccaaggag
ggccacagac
ggagctggag
ccccaagcgg
ggtggtgcag
ccactcacac
ccggcagccc
gagcgacatc
cccagttcag
tcctcctcct ccttctcctc
accgccgcgg
ccggtgcctg
atcctgagca
tcggccagcc
gcggaactga
gcggcggggg
ctgcgggaag
atgttggcga
accgagctca
ttgcaggcca
cagatgcagc
cgcaactatg
aaggacctgc
cacgccacgg
gccgagctgg
cattccctcg
gcggacctcc
ccccctcacc
tctgtcatct
aactcccctc
aagaacctgc
ctagggctgg
ggggtcgggg
tgatggaaga
aggaggtgac
gcggcggcgg
actcggcggc
aagtgtcgcg
aggacctgga
gggtccagct
tgaaagctga
agctgtatgc
agcagcaccg
tggagcgtga
cactgcgctc
ccatggccaa
ccatgccggg
cgctgaccgc
ctgcggaccg
ccgacgcatc
gacaccggac
acaaccctat
ctcttttttc
aggcgccgct
cgcgggcgaa
caataagcag
caacctgcga
cggccccggc
gacgaacatg
gctccaggag
ggagtcgcag
ggcccagaag
tcggaagcgc
cacactggag
caaggagagc
gaagtgggag
ccagctggac
acagtcctta
cgagacggtg
agccatccgg
gcaagcggtc
tgccgccgaa
acactccctc
tgtacagtca
tcctccgcct
gtcattcctg
gccgggccgc
ctcgcgctcc
gccgaactca
ccgggcccgg
gagaaccccc
gaagttcacc
ggcggcaagt
gagcaggagc
ttaaagggcg
agccgcgagg
gaggatgcgg
ctgcggcgcc
ctcaaggaca
gctacgctga
ctcaatggca
cagagtcaac
agggtgagcc
ggcgaccggt
tgcaacggcg
ctagaggatc
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1321 ttgaagacca aaaacggaaa aagaagaaag agaagatggg attcggctcc atctcccgcg
1381 tcttcgccag agggaagcag cggaagtccc tcgaccccgg cctctttgat ggtaccgccc
1441 ctgattatta catagaggag gacgcggact ggtga
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AY505120 1484 bp mRNA linear PRI 02-SEP-2004
Homo sapiens kazrin isoform B mRNA, complete cds.
AY505120
AY505120.1 GI:46276355
Homo sapiens (human)
Homo sapiens
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.
1 (bases 1 to 1484)
Groot,K.R., Sevilla,L.M., Nishi,K., DiColandrea,T. and Watt,F.M. 
Kazrin, a novel periplakin-interacting protein associated with 
desmosomes and the keratinocyte plasma membrane 
J. Cell Biol. 166 (5), 653-659 (2004)
15337775
2 (bases 1 to 1484)
Groot,K.R., Sevilla,L.M., Nishi,K., DiColandrea,T. and Watt,F.M. 
Direct Submission
Submitted (15-DEC-2003) Keratinocyte Laboratory, Cancer Research 
UK, 44 Lincoln's Inn Fields, London WC2A 3PX, UK 
Location/Qualifiers
1..1484
/organism="Homo sapiens"
/mol_type="mRNA"
/db_xref="taxon:9606"
/chromosome="1"
/map="lp36.21"
/clone="IMAGE:4556194"
/tissue_type="leiomyosarcoma"
1..236
237..1484 
/codon_start=l 
/product="kazrin isoform B"
/protein_id="AAS86435.1"
/db xref="GI:46276356"
/translation="MRAADSGSWERVRQLAAQGEPAPSCGAGAGPARPPGPAACEQCV
DAAGPGDRPRAGVPRVRADGDCSQPVLLREEVSRLQEEVHLLRQMKEMLAKDLEESQG
GKSSEVLSATELRVQLAQKEQELARAKEALQAMKADRKRLKGEKTDLVSQMQQLYATL
ESREEQLRDFIRNYEQHRKESEDAVKALAKEKDLLEREKWELRRQAKEATDHATALRS
QLDLKDNRMKELEAELAMAKQSLATLTKDVPKRHSLAMPGETVLNGNQEWWQADLPL
TAAIRQSQQTLYHSHPPHPADRQAVRVSPCHSRQPSVISDASAAEGDRSSTPSDINSP
RHRTHSLCNGDSPGPVQKNLHNPIVQSLEDLEDQKRKKKKEKMGFGSISRVFARGKQR
KSLDPGLFDGTAPDYYIEEDADW"
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6
12
18
24
30
36
42
48
54
60
66
72
78
84
90
96
102
108
114
120
126
132
138
144
/ /
gagccgttcc
gcccggcgtc
gcgggggcgg
gcgcgccgtc
gggcggccga
cgccttcctg
agtgcgtgga
cggatggcga
aagttcacct
gcggcaagtc
agcaggagct
taaagggcga
gccgcgagga
aggatgcggt
tgcggcgcca
tcaaggacaa
ctacgctgac
tcaatggcaa
agagtcaaca
gggtgagccc
gcgaccggtc
gcaacggcga
tagaggatct
tctcccgcgt
gtaccgcccc
cacgtgagag
cggccggact
gctcggctgc
ggagcccctc
ctcgggctcg
cggggcgggg
cgcggcgggg
ctgcagccag
tctccggcag
ctctgaggtc
agccagagcc
gaagacagac
gcagctccga
caaagcgctg
agccaaggag
ccggatgaag
caaggacgtc
ccaggagtgg
gactctctac
ctgccactcc
gtccacaccg
cagtcccggc
tgaagaccaa
cttcgccaga
tgattattac
gctccgcggc
gagagccctg
gccccgatgc
gcgcagccgc
tgggagcgcg
gccgggcccg
cccggcgatc
cccgtgctcc
atgaaggaga
ctctcggcca
aaagaagcct
ctggtgagcc
gacttcatcc
gccaaggaga
gccacagacc
gagctggagg
cccaagcggc
gtggtgcagg
cactcacacc
cggcagccct
agcgacatca
ccagttcaga
aaacggaaaa
gggaagcagc
atagaggagg
cgaattcctc
gtccggcgcg
ggcggcgacc
tggtagcgtc
tccgccagct
cgcggccccc
ggccccgcgc
tgcgggaaga
tgttggcgaa
ccgagctcag
tgcaggccat
agatgcagca
gcaactatga
aggacctgct
acgccacggc
ccgagctggc
attccctcgc
cggacctccc
cccctcaccc
ctgtcatctc
actcccctcg
agaacctgca
agaagaaaga
ggaagtccct
acgcggactg
gcgtgcagca
cgccgccggc
tccgggtctg
cccccgggca
cgcggcgcag
gggacccgca
cggggttccc
agtgtcgcgg
ggacctggag
ggtccagctg
gaaagctgat
gctgtatgcc
gcagcaccgc
ggagcgtgag
actgcgctcc
catggccaaa
catgccgggc
gctgaccgca
tgcggaccgg
cgacgcatct
acaccggaca
caaccctatt
gaagatggga
cgaccccggc
gtga
ggcgcggacc
cgggcgggag
tgagcccggc
cccggcatgc
ggcgagccgg
gcctgcgagc
cgggtccgag
ctccaggagg
gagtcgcagg
gcccagaagg
cggaagcgct
acactggaga
aaggagagcg
aagtgggagc
cagctggacc
cagtccttag
gagacggtgc
gccatccggc
caagcggtca
gccgccgaag
cactccctct
gtacagtcac
ttcggctcca
ctctttgatg
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CDS
AY505121 1285 bp mRNA linear PRI 02-SEP-2004
Homo sapiens kazrin isoform C mRNA, complete cds.
AY505121
AY505121.1 GI:46276357
Homo sapiens (human)
Homo sapiens
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi 
Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.
1 (bases 1 to 1285)
Groot,K.R., Sevilla,L.M., Nishi,K., DiColandrea,T. and Watt,F.M. 
Kazrin, a novel periplakin-interacting protein associated with 
desmosomes and the keratinocyte plasma membrane 
J. Cell Biol. 166 (5), 653-659 (2004)
15337775
2 (bases 1 to 1285)
Groot,K.R., Sevilla,L.M., Nishi,K., DiColandrea,T. and Watt,F.M. 
Direct Submission
Submitted (15-DEC-2003) Keratinocyte Laboratory, Cancer Research 
UK, 44 Lincoln's Inn Fields, London WC2A 3PX, UK 
Location/Qualifiers
1..1285
/organism="Homo sapiens"
/mol_type="mRNA"
/db_xref="taxon:9606"
/chromosome="1"
/map="lp36.21"
/clone="IMAGE:4651187"
/tis sue_type="placenta"
302. .1285
/codon_start=l
/product="kazrin isoform C"
/protein_id="AAS86436.1"
/db xref="GI:46276358"
/translation^' MKEMLAKDLEE SQGGKS SEVLSATELRVQLAQKEQELARAKEAL
QAMKADRKRLKGEKTDLVSQMQQLYATLESREEQLRDFIRNYEQHRKESEDAVKALAK 
EKDLLEREKWELRRQAKEATDHATALRSQLDLKDNRMKELEAELAMAKQSLATLTKDV 
PKRHSLAMPGETVLNGNQEWWQADLPLTAAIRQSQQTLYHSHPPHPADRQAVRVSPC 
HSRQPSVISDASAAEGDRSSTPSDINSPRHRTHSLCNGDSPGPVQKNLHNPIVQSLED 
LEDQKRKKKKEKMGFGSISRVFARGKQRKSLDPGLFDGTAPDYYIEEDADW"
ORIGIN
6
12
18
24
30
36
42
48
54
60
66
72
78
84
90
96
102
108
114
120
126
/ /
gggagaggga
cggcttctat
gagaggccag
tagcccgtca
gacagtgctc
gatgaaggag
cctctcggcc
caaagaagcc
cctggtgagc
agacttcatc
ggccaaggag
ggccacagac
ggagctggag
ccccaagcgg
ggtggtgcag
ccactcacac
ccggcagccc
gagcgacatc
cccagttcag
aaaacggaaa
agggaagcag
catagaggag
aggtcaggct
gaaggtgggg
ttagaggata
tgtgctgcag
ctgcgggaag
atgttggcga
accgagctca
ttgcaggcca
cagatgcagc
cgcaactatg
aaggacctgc
cacgccacgg
gccgagctgg
cattccctcg
gcggacctcc
ccccctcacc
tctgtcatct
aactcccctc
aagaacctgc
aagaagaaag
cggaagtccc
gacgcggact
tgcctcctgt
actccaggct
tcaattgtgg
tggcacccag
aagtgtcgcg
aggacctgga
gggtccagct
tgaaagctga
agctgtatgc
agcagcaccg
tggagcgtga
cactgcgctc
ccatggccaa
ccatgccggg
cgctgaccgc
ctgcggaccg
ccgacgcatc
gacaccggac
acaaccctat
agaagatggg
tcgaccccgg
ggtga
tcacaaggac
ttctctcgtc
caattcccca
tttggaggaa
gctccaggag
ggagtcgcag
ggcccagaag
tcggaagcgc
cacactggag
caaggagagc
gaagtgggag
ccagctggac
acagtcctta
cgagacggtg
agccatccgg
gcaagcggtc
tgccgccgaa
acactccctc
tgtacagtca
attcggctcc
cctctttgat
aacctctgtc
tgctttttgg
gagccctcat
attcggaacc
gaagttcacc
ggcggcaagt
gagcaggagc
ttaaagggcg
agccgcgagg
gaggatgcgg
ctgcggcgcc
ctcaaggaca
gctacgctga
ctcaatggca
cagagtcaac
agggtgagcc
ggcgaccggt
tgcaacggcg
ctagaggatc
atctcccgcg
ggtaccgccc
tcccttgtgg
atgccttcaa
cagatggcat
agaagagtgt
ttctccggca
cctctgaggt
tagccagagc
agaagacaga
agcagctccg
tcaaagcgct
aagccaagga
accggatgaa
ccaaggacgt
accaggagtg
agactctcta
cctgccactc
cgtccacacc
acagtcccgg
ttgaagacca
tcttcgccag
ctgattatta
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AY505122 1295 bp mRNA linear PRI 02-SEP-2004
Homo sapiens kazrin isoform D mRNA, complete cds.
AY505122
AY505122.1 GI:46276359
Homo sapiens (human)
Homo sapiens
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi 
Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.
1 (bases 1 to 1295)
Groot,K.R., Sevilla,L.M., Nishi,K., DiColandrea,T. and Watt,F.M. 
Kazrin, a novel periplakin-interacting protein associated with 
desmosomes and the keratinocyte plasma membrane 
J. Cell Biol. 166 (5), 653-659 (2004)
15337775
2 (bases 1 to 1295)
Groot,K.R., Sevilla,L.M., Nishi,K., DiColandrea,T. and Watt,F.M. 
Direct Submission
Submitted (15-DEC-2003) Keratinocyte Laboratory, Cancer Research 
UK, 44 Lincoln's Inn Fields, London WC2A 3PX, UK 
Location/Qualifiers 
1. .1295
/organism="Homo sapiens"
/mol_type="mRNA"
/db_xref="taxon:9606"
/chromosome="1"
/map="lp36.21"
/clone="IMAGE:4472821"
/tissue_type="liver adenocarcinoma"
1..311
312..1295 
/codon_start=l 
/product="kazrin isoform D"
/protein_id="AAS86437.1"
/db xref="GI:46276360"
/translation="MKEMLAKDLEESQGGKSSEVLSATELRVQLAQKEQELARAKEAL
QAMKADRKRLKGEKTDLVSQMQQLYATLESREEQLRDFIRNYEQHRKESEDAVKALAK 
EKDLLEREKWELRRQAKEATDHATALRSQLDLKDNRMKELEAELAMAKQSLATLTKDV 
PKRHSLAMPGETVLNGNQEWWQADLPLTAAIRQSQQTLYHSHPPHPADRQAVRVSPC 
HSRQPSVISDASAAEGDRSSTPSDINSPRHRTHSLCNGDSPGPVQKNLHNPIVQSLED 
LEDQKRKKKKEKMGFGSISRVFARGKQRKSLDPGLFDGTAPDYYIEEDADW"
ORIGIN
1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
/ /
gcatcagcag
ggctttttat
tcttcattct
acagagccag
gtggccattt
ttctccggca
cctctgaggt
tagccagagc
agaagacaga
agcagctccg
tcaaagcgct
aagccaagga
accggatgaa
ccaaggacgt
accaggagtg
agactctcta
cctgccactc
cgtccacacc
acagtcccgg
ttgaagacca
tcttcgccag
ctgattatta
ctgtctgcca
ctgtcctcag
ccacacaagg
gatttgaacc
tacagtgctc
gatgaaggag
cctctcggcc
caaagaagcc
cctggtgagc
agacttcatc
ggccaaggag
ggccacagac
ggagctggag
ccccaagcgg
ggtggtgcag
ccactcacac
ccggcagccc
gagcgacatc
cccagttcag
aaaacggaaa
agggaagcag
catagaggag
gtgttgacgg
gcattggcac
acagggaagt
aggccatcca
ctgcgggaag
atgttggcga
accgagctca
ttgcaggcca
cagatgcagc
cgcaactatg
aaggacctgc
cacgccacgg
gccgagctgg
cattccctcg
gcggacctcc
ccccctcacc
tctgtcatct
aactcccctc
aagaacctgc
aagaagaaag
cggaagtccc
gacgcggact
agggctcatg
agcagccctg
gacgtgccag
gttccagaac
aagtgtcgcg
aggacctgga
gggtccagct
tgaaagctga
agctgtatgc
agcagcaccg
tggagcgtga
cactgcgctc
ccatggccaa
ccatgccggg
cgctgaccgc
ctgcggaccg
ccgacgcatc
gacaccggac
acaaccctat
agaagatggg
tcgaccccgg
ggtga
ggtgccaggc
ggagatgaat
ggtcaaacaa
cactgctctt
gctccaggag
ggagtcgcag
ggcccagaag
tcggaagcgc
cacactggag
caaggagagc
gaagtgggag
ccagctggac
acagtcctta
cgagacggtg
agccatccgg
gcaagcggtc
tgccgccgaa
acactccctc
tgtacagtca
attcggctcc
cctctttgat
cgcttgctgg
actattgtga
ctacccaagg
cactgtcatt
gaagttcacc
ggcggcaagt
gagcaggagc
ttaaagggcg
agccgcgagg
gaggatgcgg
ctgcggcgcc
ctcaaggaca
gctacgctga
ctcaatggca
cagagtcaac
agggtgagcc
ggcgaccggt
tgcaacggcg
ctagaggatc
atctcccgcg
ggtaccgccc
Human kazrin A long protein sequence as derived from BC036877
Sequence compiled by Nick Brown (Wellcome/CR-UK, Cambridge)
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Human kazrin A long 775 AA PROT 
Pearson file capture
SYN 20-AUG-2004
Non-sequence data from original file:
>kazrin [org=Homo sapiens] kazrin isoform a protein
ORIGIN
1 MMEDNKQLAL RIDGAVQSAS QEVTNLRAEL TATNRRLAEL SGGGGPGPGP GAAASASAAG
61 DSAATNMENP QLGAQVLLRE EVSRLQEEVH LLRQMKEMLA KDLEESQGGK SSEVLSATEL
121 RVQLAQKEQE LARAKEALQA MKADRKRLKG EKTDLVSQMQ QLYATLESRE EQLRDFIRNY
181 EQHRKESEDA VKALAKEKDL LEREKWELRR QAKEATDHAT ALRSQLDLKD NRMKELEAEL
241 AMAKQSLATL TKDVPKRHSL AMPGETVLNG NQEWWQADL PLTAAIRQSQ QTLYHSHPPH
301 PADRQAVRVS PCHSRQPSVI SDASAAEGDR SSTPSDINSP RHRTHSLCNG DSPGPVQKNL
361 HNPIVQSLED LEDQKRKKKK EKMGFGSISR VFARGKQRKS LDPGLFDDSD SQCSPTRQSL
421 SLSEGEEQMD RLQQVELVRT TPMSHWKAGT VQAWLEWMA MPMYVKACTE NVKSGKVLLS
481 LSDEDLQLGL GVCSSLHRRK LRLAIEDYRD AEAGRSLSKA AELDHHWVAK AWLNDIGLSQ
541 YSQAFQNHLV DGRMLNSLMK RDLEKHLNVS KKFHQVSILL GIELLYQVNF SREALQERRA
601 RCETQNIDPV VWTNQRVLKW VRDIDLKEYA DNLTNSGVHG AVLVLEPTFN AEAMATALGI
661 PSGKHILRRH LAEEMSAVFH PANSTGIREA ERFGTPPGRA SSVTRAGKEE NSSGLKYKAG
721 RLPLGKIGRG FSSKDPDFHD DYGSLQNEDC GDDDPQSRLE QCRLEGYNSL EVTNV*
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Drosophila melanogaster kazrin-like liprin protein sequence as derived from
BT009994 and NM206200.
Protein sequence compiled by Nick Brown (Wellcome/CR-UK, Cambridge).
LOCUS DMKAZRIN1. 1023 AA PROT SYN 27-AUG-2004
DEFINITION -
ACCESSION
KEYWORDS
SOURCE
FEATURES Location/Qualifiers
DOMAIN 589..657
/note="SAM"
DOMAIN 669..733
/note="SAM"
DOMAIN 754..826
/note="SAM"
ORIGIN
1 MTADNQPLQQ QLQHHQHRSP AYPGKPAEAA GGVPQQQQQQ QQLPNGIGSS HCNSNSNGIS
61 STCNSGTAMI HANNSNLIAA GHLAQAAGPA HNAPSSGSAL NAVDKRNANL SEPDQDLPPN
121 LNVNLSPNPS LALGAPHSPT SAASAALLLL ESCDGNRNDE SRFHHLHSAP RPEATMKLRE
181 ENDRLNAELL RLRRLLELST DGAVGGVDTA PEMEAVASGE GSAAKERIER LESELRSVKN
241 QLLTMRLERK KLRTDKSDLL GQVKQLCASL QEKEQELRDF IRNYQERVRE TETTNAKISG
301 DRDRERFQLL KQARDEAERS LALAQQLSAR DLQLQRLQEQ LQEARRQLTG CLSDQESLHS
361 FAPLTPPSAA SGMLSQMAAA SGMGGGLAGM RGTTEDSGRG NSLSAFSGSL SGGSGATAGD
421 RNSCSNDSGL RNSSDRESTG GELNFSDGTC DNGPCITVDP DSISLVSSQN MYQFGTPKER
481 SPTLSPLNSA AYSRSVEQLG SPVDPEGPGN GAISRKFANA SKSGPLGARN GRGGTWGSIS
541 RVFARSRNKN KALSADGVTE YADYSWNPLT EEGYAEKLRL LREASQLPID RWRATQVLAW
601 LEVALGMPQY SARCAENVKS GKVLLELNDV ELEAGLGLAH PMHRKKLRLA IEEQRRPEMV
661 RYPLITQLGH TWVATEWLPD IGLPQYAEPF VQSLVDARML DTLSKKELEK FLGVTRKFHQ
721 ASIVHGIHVL RIVKYDRQTL AMRRVQSETV DTDPIVWTNQ RFIRWVRSID LGEYADNLKD
781 SGVHGGLWL EPSFSGDTMA TALGIPPSKN IIRRHLNTEF DALILPARAT LGQGIRSGCG
841 WPLTGPGGL QHYATTDRRS SGNLRISAWK GSQSSLSKAF RFNSKPHRTG DRSSFGNSTS
901 PTPSYSSSEG GGGIYATIGH QYPNPHTNLQ QQHYHHFLPP PTTAPPPIPS AGGIYSHGPP
961 PGHRVSAPPV GGALDAVSTD PQMLYEQSRR RVKSISDIGA STSAGSVGAC SLGGISASSE
1021 SPE*
/ /
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Future experiments and directions.
Analysis of the kazrin protein and its function.
Im m unofluorescence studies indicated that a proportion o f kazrin protein localises to the 
nucleus. Analysis of endogenous kazrin levels in nuclear, cell membrane and cytoplasmic cell 
extracts will determine what proportion of kazrin localises to the nucleus.
Transfected forms of kazrin were found to localise to the nucleus though the proportion of cells 
having nuclear kazrin varied between cell types (Fig. 5.10). A putative NLS was identified in 
the kazrin protein sequence. Mutation of the NLS will determine if it is required for nuclear 
localisation.
My analysis indicated that kazrin proteins may be phosphorylated on either serine or threonine 
residues. Follow ing CIP treatm ent, which specifically  rem oves serine and threonine 
phosphorylation, a doublet remained in each case suggesting further covalent modification of 
the kazrin protein e.g. tyrosine phosphorylation. Activators and inhibitors of signalling pathways 
will be used to identify the kinases involved in kazrin phosphorylation.
To identify the phosphorylated residues recombinant kazrin will be phosphorylated in vitro by 
the relevant kinase and the phosphorylated residues identified by mass spectrometry. Kazrin 
constructs in which the serine, threonine or tyrosine residues which are phosphorylated are 
mutated to alanine, a non-phosphorylatable residue, or aspartic acid/glutamic acid, phospho- 
mimicking residues, should be generated. The kazrin mutants will allow us to identify factors 
which bind kazrin in a phosphorylation-dependent manner.
My analysis has demonstrated that kazrin is widely expressed. At present the function of kazrin 
is not well understood. Kazrin-related sequences have been identified in Xenopus tropicalis EST 
databases. U sing  the X. tropicalis  kazrin sequence m orpholino-m odified antisense 
oligonucleotides have been designed to specifically knock-down expression of kazrin in the 
developing embryo. Analysis of the development of the embryo in the presence of a kazrin- 
targeted morpholino and a control morpholino will help to establish a functional role for kazrin. 
An alternative approach is to ablate the kazrin gene in mice. The targeting of the kazrin gene 
with the incorporation of lox P sites will allow the generation of both complete kazrin knockout 
mice and tissue-specific kazrin knockout mice by crossing kazrin-targeted mice with mice 
expressing Cre recombinase in a tissue-specific fashion.
In vitro analysis of transfected and endogenous forms of kazrin suggested that kazrin proteins 
could be part of a higher-order protein complex. The identity of the other proteins within the 
complexes are not known. The N-terminal a-helical domain of kazrin is predicted to form a 
coiled-coil thus the complexes may be formed by the association of the kazrin coiled-coil 
domains with each other or other coiled-coil domain-containing proteins. The generation of 
differently tagged kazrin proteins will allow us to identify whether kazrin proteins can 
homodimerise and/or heterodimerise. Im m unoprecipitation o f transfected forms of kazrin 
proteins will allow us to isolate kazrin-interacting proteins. The kazrin-interacting bands can 
subsequently be identified by mass spectrometry.
Bioinformatic analysis suggested the existence of a long isoform of kazrin which had homology 
to the liprin family of LAR PTPase interacting proteins. Further analysis suggests that the long 
form o f kazrin is expressed in a number o f epithelial cell lines. The liprin family of proteins are 
known to hetero- and homo-dimerise via their N-terminal coiled-coil domains and their C- 
terminal liprin domain. It will be of interest to understand if kazrin proteins are able to interact
with other members of the liprin family of proteins or with the LAR PTPases. The ability of 
kazrin to interact with these proteins will be determined by immunoprecipitation experiments.
The activation of TGase I activity in keratinocytes by treatment of the cells with 0.1% Triton- 
X I00 suggested that kazrin is a CE component. Analysis of peptides from proteolytically 
digested CEs would confirm if kazrin is a CE component. In addition using our LS4 anti-kazrin 
antibody could be used to stain CEs isolated from human or mouse keratinocyte cultures.
Analysis of mice triple knockout for involucrin, periplakin and envoplakin.
The general ultrastructure of the epidermis from triple knockout mice appears largely normal. 
To analyse the lipid component of the epidermis the samples should be post-fixed in osmium 
tetraoxide to allow more detailed analysis of the lamellar lipids and CLE. This fixation method 
will allow us to identify if the lack of periplakin, envoplakin and involucrin causes a mild defect 
in the manner or timing of deposition of lamellar lipids and their attachment to CE proteins. 
Such a mild defect would not be visible by analysis of the epidermis by conventional EM.
Marekov and Steinert (1998) previously isolated lipo-peptides from proteolytically digested 
CEs. Their analysis suggested that the majority of the hydroxyceramides which form the CLE 
are covalently linked to the proteins envoplakin, periplakin and involucrin. Isolation of 
lipopeptides from CEs from triple knockout mice may allow us to identify to which proteins the 
hydroxyceramides are attached in the absence of envoplakin, periplakin and involucrin.
Epithelial barrier formation is patterned not only in the epidermis but also in oral epithelia 
(Marshall et al., 2000). I found that the formation of a functional epidermal barrier is slightly 
delayed in triple knockout mice compared to control mice. It would be interesting to analyse the 
formation of epithelial barrier function in the tongue and hard palate to see if the formation of an 
epithelial barrier oral epithelia is also delayed in the absence of envoplakin, periplakin and 
involucrin expression.
The SEM proved a useful technique with which to analyse the surface of comified cells. This 
technique may in future be used to compare the structure of comified cells from triple knockout 
and control mice.
The CEs isolated from newborn loricrin-deficient mice were more sensitive to sonication that 
the CEs isolated from control mice (Koch et al., 2000). It would be of interest to analyse the 
sensitivity of CEs from triple knockout mice compared to CEs from control mice.
My results indicated that the CEs from triple knockout mice were larger than those from triple 
heterozygous mice. The epidermal cells of triple knockout mice may be larger than the 
epidermal cells of triple heterozygote mice thereby leading to the formation of larger CEs. Cell 
size could be measured by analysis of the number of cells in a given area of epidermis. 
Alternatively the cell lines generated from the triple knockout, triple heterozygote and wild type 
mice may be used to analyse cell size in vitro.
In order to further investigate the delay in formation of the epidermal barrier by triple knockout 
mice versus triple heterozygote and wild type mice mRNA will be isolated from the mouse 
epidermis. The mRNA will be applied to mRNA microarray analysis in order to identify factors 
that are up-regulated in the absence of envoplakin, periplakin and involcurin expression. The 
analysis of the whole epidermis by microarray could allow us to identify factors not previously 
considered important for the formation of a functional epidermal barrier.
